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 Zusammenfassung 
Die Schwangerschaft ist ein komplexes Phänomen, bei dem es zu einer Interaktion zwischen 
dem mütterlichen Immunsystem und dem Fetus kommt. An der feto-maternalen Grenze 
kommt es zur Auslösung einer inflammatorischen Reaktion, die für eine normale Implantation 
und Schwangerschaft notwendig ist. Allerdings kann eine exzessive Entzündungsreaktion zu 
Schwangerschaftskomplikationen wie dem immunologisch vermittelten Sponatanabort füh-
ren. Das zytoprotektive Enzym Hämoxygenase-1 (HO-1) spielt eine sehr wichtige Rolle bei 
der Kontrolle inflammatorischer Reaktionen. Inwiefern HO-1 für das Gelingen und Bestehen 
einer Schwangerschaft unabdingbar ist, wurde bisher nicht untersucht. Unsere Hypothese ist, 
dass HO-1 eine bedeutsame Rolle während der Schwangerschaft spielt. Die Beantwortung 
dieser wichtigen Frage ist deshalb Hauptziel dieser Dissertation.  
Es konnte gezeigt werden, dass eine spezifische Hochregulation des HO-1 Moleküls mittels 
Gentherapie in einem Mausmodell für Spontanabort zur signifikanten Reduktion der Abortra-
te führte. Dieser protektive Effekt war mit einer erhöhten Th2/Th1 Zytokinen-Ratio und mit 
verminderter Apoptose assoziiert.  
Ein weiteres Teilziel dieser Arbeit bestand darin, die Rolle des HO-1 Moleküls während der 
Plazentation zu untersuchen. Dafür wurde eine Trophoblastenstammzelllinie benutzt, die in 
der Lage ist, zu Riesenzellen zu differenzieren. Die mittels Zinkprotoporphyrin (ZnPPIX) 
induzierte Expressionssuppression von HO-1 führte zur Verminderung der Überlebensrate von 
Trophoblastenstammzellen und zur Hemmung von deren Ausdifferenzierung in 
Trophoblastenriesenzellen. 
Um die Rolle des HO-1 Moleküls in anderen Schwangerschaftsprozessen zu untersuchen, 
wurden Hämoxygenase-1 defiziente (Hmox1-/-) Mäuse benutzt. Da die Verpaarung von 
Hmox1-/- Mäuse zu keinem erfolgreichen Abkömmling führt, war ein weiteres Teilziel dieser 
Arbeit gewesen, den zu Grunde liegenden Mechanismus aufzuklären. Es zeigte sich, dass 
Hmox1-/- Weibchen im Vergleich zu den Hmox1+/+ Weibchen weniger Oozyten produzieren. 
Auch konnten die Hmox1-/- Oozyten weniger erfolgreich als die Hmox1+/+ Oozyten fertili-
ziert werden. Verschiedene Verpaarungsexperimente mit Hmox1+/+, Hmox1+/- und Hmox1-
/- Mäusen ergaben einen indirekt proportionalen Zusammenhang zwischen HO-1 Expression 
und Aborthäufigkeit. 
Die hier gewonnenen Daten deuten daraufhin, dass HO-1 eine entscheidene Rolle in der 
Schwangerschaft spielt. Die gewonnenen Erkenntnisse tragen zum Verständnis der Pathologie 
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 des immunologisch vermittelten Spontaborts bei und können darüber hinaus helfen neue Be-
handlungsstrategien gegen diese gefürchtete Schwangerschaftskomplikation zu entwickeln. 
Schlagwörter 
Häm Oxygenase-1, Schwangerschaft, Toleranz, Reproduktionsimmunologie 
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 Abstract 
Mammalian pregnancy is a parabiotic union of two genetically different individuals, the fetus 
and the mother. At the feto-maternal interface, inflammatory processes can occur due to an 
immune reaction against alloantigens. It is known that some degree of systemic or uterine 
inflammation is necessary for both normal implantation and pregnancy. However, if this in-
flammation becomes too excessive it can cause pregnancy complications such as abortion. 
Heme oxygenase-1 (HO-1), the enzyme responsible for the degradation of free heme, plays a 
key role in inflammatory processes. Viewing pregnancy mainly as an inflammatory process 
had led us to the idea that HO-1 may play an important role in pregnancy. Therefore, the main 
aim of this work was to analyze the role of HO-1 in the different processes related to preg-
nancy by means of functional studies employing in vivo as well as in vitro models.  
First, we could show that a specific up-regulation of HO-1 in abortion-prone animals by 
means of an adenoviral vector is able to reduce the abortion rate. This HO-1 up-regulation 
improved pregnancy outcome by up-regulating the Th2/Th1 cytokines ratio and protecting 
tissues from apoptosis, suggesting an important role of HO-1 in pregnancy.  
In a second part of the work, we aimed to analyze the role of HO-1 in placentation. For that, a 
trophoblast stem cell line capable of differentiate into trophoblast giant cells was used. Inter-
estingly, a down-regulation of HO-1 by means of ZnPPIX led to diminished survival of the 
trophoblast stem cells. Furthermore, these cells were unable to differentiate into trophoblast 
giant cells in the absence of HO-1, strongly suggesting a crucial role of HO-1 in placentation. 
Finally, a closer look into the role of HO-1 in pregnancy was performed by using heme oxy-
genase-1 deficient mice (Hmox1-/- mice).  Interestingly, Hmox1-/- females produce much less 
oocytes than wild type females. Analyses of the ovaries of both types of females showed dif-
ferences in follicle development. Furthermore, when fertilized in vitro, a significant diminu-
tion in the fertilization rate of Hmox1-/- oocytes when compared to Hmox1+/+ oocytes was 
found. Since the mating of Hmox1-/- mice does not yield progeny, we also aimed to clarify 
whether this is due to problems in the female, in the male or in both. For this, different mating 
combinations of mice partially or totally deficient in Hmox1 were performed. The analysis of 
the pregnancy outcome showed that, the less HO-1 in the combination, the higher the fetal 
rejection.  
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 In summary, a central role of HO-1 in different processes of reproduction could be demon-
strated in this work which helps understanding the mechanisms behind pregnancy success. 
Keywords: 
Heme oxygenase-1, pregnancy, tolerance, reproductive immunology 
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1 Introduction 
Mammalian pregnancy is a complex phenomenon that allows that the maternal immune sys-
tem supports its “semi-allogeneic fetus” during the gestation period without rejecting it. At the 
same time, the maternal immune system has to be alert and respond to foreign antigens. Since 
Medawar in 1953 (Medawar, 1953) postulated that the fetus could be considered as an “anti-
genic foreign body”, many related hypothesis have been proposed in order to explain the 
paradoxical success of pregnancy from the immunological point of view. Since then, the fetus 
is usually compared to an “allograft”, and it is thought that mechanisms leading to successful 
pregnancy are comparable to those leading to transplant acceptance.  
1.1 Tolerance at the feto-maternal interface 
Tolerance can be defined as a state of antigen–specific immunological unresponsiveness 
(Tsokos et al., 2001), as a result of inactivation or death of antigen-specific lymphocytes, in-
duced by the exposure to certain antigens (Abbas and Lichtmann in: Cellular and Molecular 
Immunology, 2003). Tolerance to self antigens is a common feature of the adaptive immune 
system. Tolerance mechanisms are initiated during fetal life in the thymus for T-lymphocytes 
and in peripheral lymphoid organs for B-cell clones by a mechanism of clonal deletion. These 
early mechanisms eliminate the autoreactive T- and B-cell clones. The autoreactive clones that 
escape clonal deletion can be neutralized by mechanisms of peripheral tolerance. One of the 
proposed mechanisms of peripheral tolerance is clonal anergy, which is a process that inca-
pacitates or disables autoreactive clones, and these clones loss the ability to respond to stimu-
lation with the corresponding antigen (Tsokos et al., 2001). Tolerance to foreign antigens may 
be induced under certain conditions of antigen exposure, e.g. it can be induced if protein anti-
gens are administered systemically at high doses without adjuvants or by oral administration 
of certain protein antigens (Abbas and Lichtmann in: Cellular and Molecular Immunology, 
2003).  
Pregnancy is normally considered as a natural state of tolerance against foreign antigens, but 
how this tolerance is achieved is still controversial. In 1953, the Brazilian Sir Peter Medawar 
initiated the modern immunology of reproduction by asking: “how does the pregnant mother 
contrive to nourish within itself, for many weeks or months, a foetus that is an antigenically 
foreign body?” (Medawar, 1953). In this article, three theories were proposed in order to ex-
plain the lack of an immunological reaction from the mother against the fetus:  
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1. The anatomical separation of the fetus from mother: according to this theory, it was 
thought maternal and fetal blood circulations were separated by a barrier impermeable to 
cells. This theory was proved to be wrong, since it is now known that the fetal-maternal 
interface is a bi-directional exchange surface. Not only maternal immune cells are present 
at the feto-maternal interface, but also fetal cells are found in maternal circulation. This 
phenomenon is called feto-maternal microchimerism, being microchimerism defined as a 
small nonhost cell population (or DNA quantity) from one individual harboured by an-
other individual (Adams and Nelson, 2006). Many reports indicate that microchimerism 
persists in mother and child even decades later (Bianchi et al., 1996; Lo et al., 1996; Ma-
loney et al., 1999), and new studies have shown that feto-maternal chimerism occurs even 
very early in pregnancy (Khosrotehrani et al., 2005; Diploma thesis from Nadja Ahmad), 
showing that the anatomical separation between fetus and mother consists of a “perme-
able” barrier. 
2. The antigenic immaturity of the fetus: this theory pointed out that the fetus is “antigeni-
cally immature”, not expressing histocompatibility antigens. This theory collapsed very 
quickly, since fetal skin dendritic cells that are positive for MHC class I but negative for 
MHC class II are very potent accessory cells in polyclonal T cells responses (Elbe-Bürger 
et al., 2000). 
3. The immunological inertness of the mother: although this theory is not fully rejected, it 
still does not explain why immune responses against foreign pathogens are normal in 
pregnancy. However, this theory gave rise to the concept of active tolerance mechanisms 
against the fetus. Nowadays, it is considered that the mother achieves a state of tolerance 
against the fetus, still being able to elicit normal immune responses against infections. 
This was nicely shown by a work from Tafuri et al. where it was demonstrated that mater-
nal T cells are aware of the presence of paternal antigens during pregnancy, where they 
acquire a transient state of tolerance specific for paternal antigens (Tafuri et al., 1995). 
1.2 Biology of pregnancy 
Despite the differences between the placentas of humans and mice, the immunological 
mechanisms leading to a successful pregnancy in both species are similar, which validates the 
use of a mouse model in order to study the role of different molecules in pregnancy. These 
similarities encourage one to use animal models to find alternative therapies to avoid preg-
nancies complications. 
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Many steps are involved in the development of a successful pregnancy, such us proper ovula-
tion and receptiveness of the uterus, fertilization, implantation, placentation, as well as a 
proper immune response allowing the acceptance of the developing fetus.   
1.2.1 Ovulation 
Ovulation (i.e., follicular rupture) is a distinct morphological phenomenon that occurs during 
the transformation of an ovarian follicle into a corpus luteum. The changes that take place in 
the tissue are pathophysiological in nature since they require acute disruption of dense layers 
of collagenous tissues. This local damage includes hemorrhage in the vicinity of the lesion on 
the surface of the ovary (Espey et al., 2004).  
The hormonal regulation of ovulation is regulated by different levels of luteinizing hormone 
(LH), progesterone (P4) and oestrogen (E2) (red and blue in Fig. 1). In humans, ovulation 
takes place when LH and E2 expression reach their maximum. In mice, this is also accompa-
nied by an augmentation in P4 levels. A schematic representation of hormonal levels during 
the menstrual cycle is represented in Fig. 1 (from Wang and Dey, 2006).  
  
Fig. 1 : Hormonal changes controlling the menstrual cycle in humans (A) and mice (B) 
Fig. taken from Wang and Dey, 2006 
LH: luteinizing hormone; P4: progesterone; E2: oestrogen 
 
Although it is normally assumed that ovulation is a relatively simple phenomenon, it is now 
evident that the ovulatory process is dependent on the expression of numerous genes, mostly 
associated with acute inflammatory reactions. These genes include immediate-early genes like 
tumor necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2), genes involved in steroido-
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1.2.2 Fertilization and blastocyst formation 
bryo involves the fertilization of the 
genesis, pro-inflammatory genes like interleukin-1β (IL-1β)  and IL-6 and genes related to 
oxidative stress. Concomitant with the inflammatory cascade, there is a cluster of genes that 
yield protein products to counteract the oxidative stress that is generated in inflamed tissues 
(reviewed in Espey et al., 2004). 
The first step in the development of the mammalian em
oocyte with the sperm. Fertilization is followed by continued cell division, the establishment 
of cell polarity and compaction to form a morula, followed by a lineage differentiation to 
form a blastocyst. This period is called pre-implantatory phase and occurs in the oviduct and 
uterine lumen. A schematic representation of this phase is depicted in Fig. 2 (Wang and Dey, 
2006). If the fertilization occurred in a receptive phase, this stage will be followed by the im-
plantatory phase, at which the blastocyst adheres and implants in the endometrium. 
 
Fig. 2: Preimplantation embryo development in mice 
1.2.3 Implantation 
ss in which a receptive endometrium allows the attachment of the 
Fig. taken from Wang and Dey, 2006 
Implantation is the proce
blastocyst. The independently developing pre-implantation blastocyst becomes then depend-
ent on the maternal environment for its continued development. The main purpose of implan-
tation is to ensure that trophoblast cells firmly anchor into the endometrial stroma, and suc-
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cessful implantation is most likely a function of both embryonic and maternal processes (Sen-
turk and Arici in: Immunology of pregnancy). It occurs during a specific period of time called 
the “implantation window”, that is 96-100 h after fertilization of the ovum in the mouse (Finn 
and Martin, 1967; Tabibzadeh and Babaknia, 1995), and at between day 19 and day 24 of a 
normal 28 day cycle in humans (Bergh and Navot, 1992). Females experience physiological 
changes before implantation takes place: ovulation, copulation and fertilization. These events 
induce changes in the metabolism as well as in the hormone and cytokine balance, preparing 
the reproductive tract for the subsequent blastocyst implantation. In order for implantation to 
be successful, the embryo must have reached a proper stage of development and the endo-
metrium must be receptive (Abrahamsohn and Zorn, 1993). This receptiveness results from 
adequate exposure of the uterus to progesterone and estrogen (Psychoyos, 1976). During this 
period, the uterine membrane morphology presents pinopodes, which are large cytoplasmic 
projections from the uterine epithelium. Although their importance for implantation is unclear, 
they appear to provide a useful morphological correlate of the receptive state (Sharkey, 1998). 
Regarding the blastocyst, the loss of the zona pellucida is probably the last event that precedes 
the beginning of implantation in rodents (Abrahamsohn and Zorn, 1993). The general aspects 
of the implantation process are similar in humans and rodents, starting with erosion of the 
uterine epithelium and invasion of the uterine mucosa by trophoblast cells (Arvola and Matts-
son, 2001).  Mouse trophoblasts penetrate the surface epithelium by displacement penetration, 
where a number of surface epithelial cells detach from their basement membrane and from 
each other. These cells degenerate and are then phagocytized by trophoblasts, being the tro-
phoblasts exposed to the bare basement membrane (Tabibzadeh and Babaknia, 1995). When 
the trophoblasts of the blastocyst contact and attach to endometrial epithelium, it induces the 
local formation of decidua. The female uterus undergoes changes during this period, process 
called “decidualization”, a reason why the maternal part at the feto-maternal interface receives 
the name of decidua during pregnancy. A schematic representation of the implantation process 
is depicted in Fig. 3 (Wang and Dey, 2006). 
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Fig. 3 : Preimplantation embryo development in mice 
Fig. taken from Wang and Dey, 2006. T: trophectoderm-derived trophoblast cells; En: blastocyst, represented by 
the embryonic endoderm; LE: luminal epithelium; S: stroma; D: decidual cells.  
1.2.4 Placentation 
The implantation period is followed by the formation of the placenta, a process called placen-
tation. The placentas are very different between species, but they all have in common the exis-
tence of two separate circulatory systems (maternal and fetal). The placental barrier or inter-
hemal membrane (Benirschke and Kaufmann, 2001) derives from fetal tissues such as the 
blastocyst wall (trophoblast), which following fusion with the fetal mesenchyme is called 
chorion, together with the allantois and the yolk sac. All are complemented by the amnion, 
which forms the second fetally derived membranous sac surrounding the embryo. A represen-
tative scheme is showed in Fig. 4 (from: Benirschke and Kaufmann, 2001): 
 
Fig. 4 : Representation of the fetal membranes that contribute to the formation of a placenta 
Fig. taken from Benirschke and Kaufmann, 2001 
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The classification of the different placenta types (Benirschke and Kaufmann, 2001) is defined 
according to the outer shape, the structure of the feto-maternal barrier, the kind of 
feto-maternal interdigitation, and the materno-fetal blood flow interrelations. Regarding the 
placental shape, both human and mouse placentas are a single disk-like zone of intimate 
feto-maternal contact, being called discoidal placenta. This type of placenta possesses the 
highest degree of feto-maternal interdigitation. Human and mouse placenta have also a similar 
feto-maternal barrier, which is called hemochorial placenta, which has the highest degree of 
invasion of the trophoblast, that destroy the maternal vessels completely, with the trophoblas-
tic surface directly facing the maternal blood. 
However, mouse and human placenta differ in the type of feto-maternal interdigitation and 
blood flow interrelations. In humans, the placenta is constituted by villi (villous placenta), 
which fit into corresponding endometrial cripts or are directly surrounded by maternal blood. 
Mice placentas have the most effective kind of interdigitation, the labyrinthine placenta, 
where the trophoblast is penetrated by web-like channels that are filled with maternal blood or 
fetal capillaries. Here, the blood flow interaction is countercurrent, being maternal and fetal 
capillaries arranged in parallel but with flow in different directions, facilitating passive diffu-
sion. In humans, the blood flow interrelation is called multivillous flow. 
A schematic representation of human feto-maternal interface is shown in Fig. 5 (from: Arvola 
and Mattsson, 2001). The tree-like structure of the chorionic villi constitutes the part of the 
human placenta at which the exchange of nutrients and waste occurs. The yolk sac can be 
observed between the amnion and the chorion in early pregnancy. By the end of the third 
month of the human pregnancy, the amnion and chorion have fused (Arvola and Mattsson, 
2001).  
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Fig. 5 : schematic drawing of the human placenta and organization of the fetal membranes 
Fig. taken from Arvola and Mattsson, 2001 
 
A schematic representation of the mouse placenta is depicted in Fig. 6. Here, the labyrinthine 
trophoblast constitutes the area of maternofetal interdigitation. In contrast to the human fetus, 
the mouse fetus is enclosed by the yolk sac (Arvola and Mattsson, 2001). 
 
Fig. 6 : schematic representation of the mouse placenta and organization of the fetal membranes 
Fig. taken from Arvola and Mattsson, 2001 
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1.2.5 Immune cells at the feto-maternal interface 
Throughout the pregnancy, many immune cells are present at the feto-maternal interface. The 
dominant lymphocytes during human and murine healthy implantations and later on, are 
pregnancy associated uterine natural killer cells (uNK cells) (Ashkar and Croy, 2001). It is 
thought that these uNK cells are bone marrow-derived leukocytes that migrate in large num-
bers to the pregnant uterus. After migration, uNK proliferate, differentiate, and accumulate in 
large numbers in specific areas of the uterus between days 2.5 and 12 of murine pregnancy 
(Redline, 2000). After day 12, uNK cells undergo extensive apoptosis and are dramatically 
decreased in number and activation (Linnemeyer and Pollack, 1994; Croy et al., 1997). These 
uNK produce IFN-γ at the feto-maternal interface, which contributes to the initiation of vascu-
lar modification, decidual integrity and uNK maturation and senescence (Ashkar et al., 2000). 
In both mice and rats, uNK contain inducible nitric oxide synthase (iNOS) (Hunt et al., 1997).  
Macrophages are also present in the uterus during implantation. These cells, together with 
elevated levels of inflammation-associated cytokines such as IL-1 are associated with early 
implantation (Hunt, 1989). However, other cytokines and growth factors produced mainly by 
uterine epithelial cells such as TNF-α, TGF-β and GM-CSF are also necessary for facilitation 
of implantation. All these facts suggest that a limited inflammatory response seems to be a 
natural component of successful pregnancies (Hunt et al., 2000). 
Dendritic cells are also present at the feto-maternal interface, and are likely to regulate im-
mune responses to both uterine infections and placental trophoblast cells (Liang and Ho-
ruzsko, 2003). A model proposed by Juretic et al. points out that the presence of extravillous 
cytotrophoblast cells in human pregnancies promotes the recruitment of immature dendritic 
cells (iDC) and NK cells at the implantation site. It is postulated that, if the stimulation of iDC 
at implantation site is governed by a strong Th2 response, the function of DC would be 
tolerogenic, but if they are stimulated under a strong Th1 response, they would become potent 
antigen presenting cells (Juretic et al., 2004). However, it is known that Th1 cytokines are 
needed at the time of implantation, making this theory contradictory. 
Regarding T cells, it was found that activated γ/δ TCR positive cells are significantly enriched 
in the decidua as well as in peripheral blood of healthy pregnant women (Szekeres-Bartho 
et al., 2001). In abortion-prone mice, it was found that TGF-β-producing γ/δ T cells presented 
suppressor activity dependent on the presence of soluble signals from fetal trophoblast (Clark 
et al., 1997). Two populations of γ/δ T cells have been described in the murine decidua: an 
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early population producing Th1 cytokines, and a Th2/3 cell subset that appears later (Arck et 
al., 1999). It was also suggested that γ/δ T cells suppress the anti-fetal immune response 
through TGF-β production (Suzuki et al., 1995).  
1.2.6 Apoptosis at the feto-maternal interface 
Apoptosis is a physiologically active mode of cell death that mediates the “safe” deletion of 
unwanted cells (Gobe and Harmon, 2005). This suicidal pathway is characterized by mem-
brane blebbing, the appearance of highly condensed chromatin and activation of an endonu-
cleolytic process, which leads to the sequential cleavage of genomic DNA. As a result, cells 
shrink and condense into small membrane-bound “apoptotic bodies”, which are then removed 
by macrophages (Wu et al., 2001). This removal does not produce pro-inflammatory cyto-
kines; on the contrary, it increases the production of anti-inflammatory cytokines (Sepiashvili 
et al., 2001). 
At the feto-maternal interface, it is known that apoptosis plays a role in placental remodelling 
(reviewed in Jerzak and Bischof, 2002). However, changes in apoptosis at the feto-maternal 
interface may lead to failing pregnancies, as shown by decreased expression of Bcl-2 and in-
creased expression of Bax in the decidua of failing human pregnancies (Lea et al., 1999). 
However, it is impossible to determine in the human system if low levels of Bcl-2 and high 
levels of Bax are a consequence or a cause of the abortion. 
A review by Mor and Abrahams (Mor and Abrahams, 2003) points out that during implanta-
tion, there is a constant turnover necessary for the appropriate growth and function of the pla-
centa. Furthermore, during the third trimester of human pregnancies, there is increased pla-
cental apoptosis that may be involved in the process of parturition. In pregnancy 
complications such as pre-eclampsia and fetal growth restriction, it was found that an insuffi-
cient trophoblast invasion is accompanied by a greater incidence of placental apoptosis. 
In spontaneous abortion, there is no evidence that apoptosis may play a determinant role. In 
murine failing pregnancies, it was shown that apoptosis is not augmented in failing pregnan-
cies, probably due to higher levels of the anti-apoptotic molecule Bcl-2 at the feto-maternal 
interface (Bertoja et al., 2005). 
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1.2.7 Factors determining the success or failure of pregnancy 
There are many hypotheses trying to explain the onset of a successful or failing pregnancy in 
murine models as well as in the human situation. Some of these theories are: 
1. Th1/Th2 balance: many scientists have given importance to the Th1/Th2 cytokines in the 
onset of pregnancy. They proposed that an excess of Th1 cytokines would be deleterious 
for pregnancy outcome, leading to pregnancy complications such as spontaneous abortion 
or pre-eclampsia. This was based on the fact that failing murine and human pregnancies 
are associated with high Th1 and low Th2 levels (Raghupathy et al., 2000; Zenclussen et 
al., 2001). Lin as well as Wegmann proposed in 1993 (Lin et al., 1993; Wegmann et al., 
1993) that the balance of pro-inflammatory Th1 cytokines and anti-inflammatory Th2 cy-
tokines is critical to normal pregnancy. According to this, a higher level of Th2 cytokines 
locally at the feto-maternal interface from human or mouse is related to normal pregnancy 
(Wegmann, 1993; Piccinni et al., 1998; Krishnan et al., 1996; Saito, 2000; Zenclussen et 
al., 2001; Zenclussen et al., 2003). Although a Th1/Th2 balance is very important 
throughout the whole pregnancy, and this has been confirmed by several groups, this ex-
planation turned out to be not sufficient for the explanation of the success or failure of 
pregnancy, since IL-4/IL10 genetically deficient mice develop normal pregnancies 
(Svensson et al., 2002). Accordingly, mice lacking simoultaneously IL-5, IL-19, IL-13 and 
IL-4 do not present abnormal pregnancies, suggesting that these cytokines are not essen-
tial for fetal survival (Fallon et al., 2002). In humans, the Th1/Th2 paradigm has also been 
questioned, since lymphocytes, monocytes and granulocytes from normal pregnant pa-
tients produce more IL-12 than those from spontaneous abortion patients (Zenclussen et 
al., 2002). 
2. Protective role of asymmetric IgG antibodies: asymmetric antibodies are non-precipitating 
antibodies that posses an asymmetric structure, due to a high manose carbohydrate group 
present in only one of the two Fab regions of the molecule (Margni and Binaghi, 1988). 
They do not form insoluble complexes with antigen, they do not fix complement, and they 
do not induce clearance of the specific antigen. When they combine with an antigen, they 
act in a competitive way when they are mixed with precipitating antibodies of the same 
specificity (Margni, 1994). It was shown that, during pregnancy, the production of asym-
metric IgG is considerable increased, and the IgG is of maternal origin and fixed to the 
membrane of the placental cells (Malan Borel et al., 1991). It is proposed that the pres-
ence of these antibodies protect the fetus from being rejected, as these antibodies are not 
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able to develop an immune response. It is still a valid theory that is in accordance with 
data pointing out low levels of IL-6 (known to stimulate the production of symmetric 
normal antibodies), in normal pregnant patients (Zenclussen et al., 2000) and may have a 
connection with the HLA-G expression by the trophoblast (explained later). 
3. Tryptophan catabolism: tryptophan deprivation might reduce or inhibit some immune cell 
responses (Thellin et al., 2000). Indoleamine 2,3-dioxygenase (IDO) is an enzymatic pro-
tein that catabolizes tryptophan. IDO is synthesized and secreted by the syncytiotro-
phoblast, and acts by catalysing tryptophan destruction in maternal immune cells that are 
localised in the placental area. Although Munn et al. first proposed that IDO is essential 
for the success of pregnancy in the mouse (Munn et al., 1998; Mellor and Munn, 1999), 
the same authors showed later that mice lacking IDO develop normal pregnancies (Baban 
et al., 2004), pointing out that IDO might be beneficial but not essential for the develop-
ment of a normal pregnancy. Furthermore, IDO is not expressed in human placentas until 
14 weeks of gestation, 13 weeks after implantation (Kamimura et al., 1991) and in mice 
until day 8 (Munn et al., 1998; unpublished data from our lab).  
4. HLA-G expression by the human trophoblasts: until the moment, the expression of MHC 
class II in trophoblasts could not be demonstrated. Human trophoblast cells express one 
class Ia molecule (HLA-C) and all three class Ib molecules (HLA-E, -F and –G) (Hunt et 
al., 2005). These “non-classical” molecules are recognized by the mother´s immune sys-
tem as demostrated by the fact that anti-HLA paternal antibodies are common in pregnant 
women. It is tempting to speculate that these antibodies are of asymmetric nature, but un-
fortunately no reports could be found on this aspect. It has been proposed that the expres-
sion of HLA-G by trophoblast cells may regulate immune cells, targeting all of the major 
immune cell subsets and programming them into an immunosuppressive phenotype. Thus 
HLA-G has been proposed to be essential to immune privilege in pregnancy (Hunt et al., 
2005). However, definitive proof that HLA-G is required remains elusive, since in vivo 
experiments are difficult to design (Hunt et al., 2005). 
5. Regulatory T cells: In both rodent and human systems, there are many evidences that there 
is a special population of cells with immunoregulatory activity, which are called regula-
tory T cells (Treg cells). These cells were first described as the population in charge of 
neutralizing autoimmune reactive cells in the periphery that escaped clonal selection in 
thymus (Sakaguchi et al., 1995). There are many attempts to characterize this population 
of cells and to understand the mechanism by which they exert their regulatory action. So 
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far, there is some evidence that the immune suppression by this subset of cells is depend-
ent on IL-10 and TGF-β (Hara et al., 2001; Kingsley et al., 2002). One of the markers 
found in many populations of cells with regulatory activity is CD25. However, it is not an 
exclusive and stable marker for Treg cells, because recently activated T effector cells also 
express CD25. Additionally, there are some models, in which CD4+CD25- cells also have 
regulatory function (Wood and Sakaguchi, 2003). Nevertheless, the sorting of CD25-
expressing cells is still a useful way of enriching Treg cells of this subset, and there are 
many evidence that this CD4+CD25+  population plays a regulatory role both in vitro and 
in vivo (Gregori et al., 2001; Chai et al., 2002; Kingsley et al., 2002). There are many 
other possible candidates as markers for the Treg population, such as Cytotoxic 
T-lymphocyte antigen-4 (CTLA-4), glucocorticoid-induced tumour necrosis factor 
(GITR), CD122, CD103 and foxp3 as a possible specific molecular marker (Wood and 
Sakaguchi, 2003). A novel molecular marker may be also Neuropilin-1 (Bruder et al., 
2004).  
In pregnancy, it was first described by Heikkinen et al. in human and by Aluvihare et al. 
in murine pregnancies (Heikkinen et al., 2004; Aluvihare et al., 2004) that the onset of 
pregnancy is dependent on the presence of this population of cells. Data from our group 
showed for the first time that mice developing spontaneous abortion have less number of 
naturally occuring CD4+CD25+ Treg cells (Zenclussen et al., 2005). Moreover, in abor-
tion-prone females receiving Treg cells arising from normal pregnant mice, fetal rejection 
could be completely reverted, confirming a very important role of Tregs during pregnancy 
(Zenclussen et al., 2005b). In murine pregnancies, it is thought that Tregs induce a privi-
leged tolerant microenvironment at the fetal-maternal interface (Zenclussen et al., 2006). 
This microenvironment would be characterized by augmented TGF-β, leukaemia inhibi-
tory factor (LIF), and heme oxygenase-1 (Zenclussen et al., 2006a). In humans, it has 
been reported that Treg mediate a potent inhibition of CD4+CD25- T cells, and that this 
effect requires cell to cell contact (Sasaki et al., 2004). However, it is not described in the 
literature whether they induce the expression of any of these molecules at the feto-
maternal interface. 
6. Leukemia inhibitory factor (LIF): LIF is a pleiotropic cytokine of the IL-6 family and has 
different biological actions in various tissue systems (Hilton and Gough, 1991). Nowa-
days, there is an accumulation of evidence of the importance of LIF in different stages of 
reproduction. In a mice model, LIF has been shown to be one of the essential cytokines 
for implantation, since mice lacking LIF could produce normal embryos, but the embryos 
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failed to implant. Interestingly, when embryos from LIF-deficient mice were transferred 
into the uteri of wild-type mice, normal implantation occurred, confirming that LIF pro-
duced by endometrium is critical for murine implantation (Stewart et al., 1992). LIF 
seems also to affect sperm survival rates and motility in the fallopian tube, thus playing 
also a role even in the fertilization process (Attar et al., 2003). There is also evidence sug-
gesting that LIF plays an important role in human reproduction, and is considered as a 
possible cause of unexplained infertility and multiple failures in implantation (Hambart-
soumian, 1998; Steck et al., 2004). 
1.2.8 Spontaneous abortion 
Between the possible pregnancy complications that may occur during mammalian gestation, 
spontaneous abortion is one of the most common. It occurs between the first and third month 
of pregnancy, and ends with the rejection of the embryo. About 20% of all pregnancies end in 
spontaneous abortion (Essentials of Clinical Immunology), whereas two-thirds of fetuses are 
lost even before the woman realizes that she is pregnant, reason why it is thought that the per-
centage of women suffering spontaneous abortion is even higher. 
Spontaneous abortion can be caused by genetic disorders, infections, endocrine abnormalities, 
or autoimmune states as i.e. antiphospholipid syndrome (Essentials of Clinical Immunology). 
When the cause of abortion does not respond to anatomical, genetical or endocrinological 
causes, it is very probable that the cause of abortion is of immunological origin. Thus, when a 
woman suffers from three or more consecutive spontaneous abortions and all other factors 
have been discharged, the causes of the losses are thought to be immunological. In these 
cases, the immune system of the pregnant woman does not adapt to the situation and rejects 
the growing embryo. 
1.2.8.1 The CBA/J x DBA/2J model of spontaneous abortion 
In the mouse, a useful model of abortion was described for the first time by Clark and 
co-workers in 1980 and further characterized by Chaouat and co-workers in 1988. In this 
model of immunological abortion, the combination of CBA/J females with DBA/2J males 
leads to spontaneous abortion (Clark et al., 1980; Chaouat et al., 1988). The mentioned mice 
combination develops between 20 and 30% of abortion, and these immunological rejections 
occur spontaneously without being caused by any treatment of the pregnant mice. Because 
CBA/J females bear H2k antigens and DBA/2J males bear H2d antigens, this model employs 
mice that differ in the antigens of the major histocompatibility complex. Different to the 
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transplant situation, this does not lead to rejection as it is even thought that an allostimulus is 
necessary for pregnancy to occur. Interestingly, when mating the same females with a 
BALB/c male, also bearing H2d antigens like the DBA/2J males, these females undergo nor-
mal pregnancies. This fact excludes the possibility that the rejection of the fetus may be due to 
differences in the major histocompatibility antigens.  
1.3 Heme Oxygenase-1 (HO-1) 
In 1964, Wise and Drabkin (Wise and Drabkin, 1964) first described an enzymatic reaction 
that converted heme to biliverdin and carbon monoxide. They described that this reaction re-
quired NAD and ATP, and that, interestingly, the enzyme source was the light mitochondrial 
fraction of hemophagous organ of the dog placenta. This report was followed by reports of 
Tenhunen and co-workers (Tenhunen et al., 1968; Tenhunen et al., 1969; Tenhunen et al., 
1972) who described a bile-pigment producing system located in the microsomal fraction of 
the rat liver, and they named it “microsomal heme oxygenase”. This enzyme was described to 
be responsible for the cleavage of heme at the α-methene bridge resulting in the formation of 
biliverdin and CO, being biliverdin rapidly reduced to bilirubin by NADPH-dependent 
biliverdin reductase. A further characterization of the enzyme (Tenhunen et al., 1969) allowed 
the description of the enzymatic reaction as being dependent on the presence of molecular 
oxygen and of NADPH or an operational NADPH-generating system. It was also suggested 
that cytochrome P-450 would play an essential role in the reaction. Further studies (Maines 
and Kappas, 1974; Yoshida et al., 1974; Maines and Kappas, 1975) led to the identification of 
the enzyme as a distinct microsomal entity in which its activity does not require cytochrome 
P-450. 
Nowadays it is widely know that Heme Oxygenase (HO), encoded by the Hmox1 gene, is the 
enzyme catalyzing the first and rate limiting step in the degradation of heme, to yield equimo-
lecular quantities of biliverdin, CO, and free iron. Biliverdin is then converted to bilirubin via 
the action of biliverdin reductase, and free iron is sequestered into ferritin, reaction that is 
schematised in Fig. 7 (Ryter et al., 2002). 
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Fig. 7 : Scheme of the reaction of heme oxygenase-1 
Fig. taken from Ryter et al., 2002 
 
To date, three different mammalian isoforms have been identified: HO-1, HO-2 and HO-3 
(Montellano, 2000; Otterbein and Choi, 2000; Morse and Choi, 2002). HO-1, also known as 
heat-shock protein (HSP) 32, is very sensitive to several stimuli and agents that cause oxida-
tive stress and pathological conditions, such as heat shock, ischemia, radiation, hypoxia, hy-
peroxia (Maines, 1997), cytokines (IL-1, IL-6, or TNF-α), heavy metals and nitric oxide. The 
HO-2 isoform (Maines et al., 1986; Trakshel et al., 1986) is normally referred as constitu-
tively expressed, and is not inducible by the agents capable of inducing HO-1. The list of in-
ducers of HO-2 is limited and include developmental factors, adrenal glucocorticoids, opiates 
and possibly nitric oxide (reviewed in Maines and Panahian in: Hypoxia: from genes to the 
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bedside). In human pregnancy, different levels of HO-2 were found between placentas of 
normal pregnant or abortion patients (Zenclussen et al., 2003b) as well as in patients with 
pre-eclampsia and fetal growth restriction (Barber et al., 2001), suggesting HO-2 may be 
regulable in human placenta. The third isozyme, HO-3, was isolated from rat tissues and it 
presents 90% of aminoacid homology with HO-2 (McCoubrey et al., 1997) but acts as a less 
efficient heme catalyst (Morse and Choi, 2002). 
1.3.1 Tissue distribution and sub-cellular localization 
Heme oxygenase is widely expressed in different tissues in mammals, as well as in various 
species, including unicellular organisms (Maines in: Heme Oxygenase, Clinical Applications 
and Functions, 1992). Several reports indicate that at least in the rat, HO-1 specific activity is 
being the highest in the spleen, followed by bone marrow, liver, brain, kidney, and lung, in 
decreasing order (Tenhunen et al., 1969). In most other tissues not directly involved in eryth-
rocyte turnover or hemoglobin metabolism, low detectable levels of HO-1 are detectable un-
der basal conditions but responds to rapid transcriptional activation by diverse chemical and 
physical stimuli (Ryter et al., 2006). HO-2 highest activity occurs in the testes, being also 
expressed in brain and central nervous system, vasculature, liver, kidney and gut (Maines in: 
Heme Oxygenase: Clinical Applications and Functions, 1992; Maines, 1986; Maines, 1997).  
In cells, HO-1 enzymes have been characterized as endoplasmic reticulum (ER)-associated 
proteins due to the abundant detection of HO-1 activity in microsomal (104,000 g) fractions 
(Ryter et al., 2006). Both HO-1 and HO-2 contain a COOH-terminal hydrophobic domain that 
suggests a general membrane compartmentalization (Shibahara et al., 1985). Other reports 
have also described the presence of HO-1 in mitochondria (Converso et al., 2006; Slebos et 
al., 2007) and in caveolae (Kim et al., 2004). However, recent reports showed that HO-1 can 
also localize to the nucleus and activate transcription factors important in oxidative stress (Lin 
et al., 2007), and that this form of HO-1 seems to lack the C terminus (Lin et al., 2007).  
1.3.2 Relationship between the HO and the NO system 
There is some similarity between the systems that generate the gaseous heme ligands carbon 
monoxide (CO) and nitric oxide (NO). Both the HO and the nitric oxide synthase (NOS) sys-
tems have inducible and constitutive forms. The inducible form of the synthase, iNOS, is re-
sponsive to some of the stimuli activating HO-1, such as bacterial endotoxins, cytokines, and 
reactive oxygen intermediates (Nathan, 1992; North et al., 1996). HO-1 and iNOS are highly 
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induced in inflammatory cells, neutrophils, polymorphonuclear and mononuclear cells (Nath 
et al., 1992; Willis et al., 1996), whereas HO-2 and neuronal and endothelial forms of NOS 
are similar in the sense that both are regulated by adrenal glucocorticoids (Weber et al., 1994; 
Maines et al., 1996), being HO-2 up-regulated and NOS down-regulated (Weber et al., 1994). 
CO and NO share affinity for the heme molecule, but, unlike NO, which is a free radical and 
can react with oxygen-derived radicals, CO is not a free radical and cannot produce tissue 
damage associated with inflammation and cytotoxicity to invading organisms that is caused 
by free radical species (Maines, 1997).  
Induction of HO-1 is likely to modulate NO production, whereas NO has been shown to both 
inhibit and activate HO activity depending on the conditions (reviewed in Maines, 1997). The 
proposed regulatory interactions between the HO and the NO system are shown in Fig. 8 
(from Maines, 1997). 
 
Fig. 8 : schematic representation between the HO and the NOS systems 
Fig. adopted from Maines, 1997. 
 - 18 -
Introduction 
---------------------------------------------------------------------------------------------------------------------------------------- 
1.3.3 Beneficial effects of HO-1 in different fields of medicine 
The most studied isoform of the Heme Oxygenase is the HO-1, a 32 kDa inducible isoform, 
being its beneficial effects described for many diseases such as atherosclerosis, pulmonary, 
cardiovascular and renal diseases, as well as in organ transplantation (Morse and Choi, 2002).  
The activity of this enzyme is of great importance in cells to protect themselves against oxida-
tive injury. Additionally, HO has been shown to have anti-inflammatory, anti-apoptotic and 
anti-proliferative effects.  
There are many possible explanations to account for the beneficial effects of HO-1. One of 
them, proposed by Stocker in 1990, suggests that an augmentation of HO-1 represent an anti-
oxidant defence operating at two different stages simultaneously: 
1. it decreases the levels of potential pro-oxidants such as heme and heme proteins 
2. it increases the tissue concentration of antioxidatively active bile pigments 
As it can be seen in Fig. 9 (from Stocker, 1990), the heme molecule serves as a prostetic 
group of various hemoproteins such as those that transport oxygen or electrons, activate oxy-
gen, or degrade peroxides, which favours a pro-oxidant state. Besides, free heme is capable of 
catalyzing oxygen radical reactions and is therefore a potent pro-oxidant (Stocker, 1990). Free 
heme not only stimulates lipid peroxidation (Tappel, 1953), it also causes oxidative damage to 
DNA and protein (Aft and Müller, 1983, Aft and Müller, 1984) and is cytotoxic to various cell 
types (Linn and Everse, 1987). Moreover, the iron in the core of the heme structure becomes 
available to participate in the generation of free radicals (Soares et al., 2001).  
 
 
Fig. 9 : Pathway of heme metabolism 
Fig. taken from Stocker, 1990. 
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It has been shown that an increase in HO activity is generally accompanied by a decrease in 
the cellular concentrations of total and free heme (Maines and Kappas, 1974; Granick, 1975; 
Maines, 1984) and the lowering of this potent pro-oxidant may already explain some of the 
beneficial effects associated with HO-1.  
An additional protective effect of the HO-1 reaction is related with the accumulation of 
bilirubin caused by the rapid conversion of biliverdin (product of the HO-1 reaction) to 
bilirubin by biliverdin reductase. Bilirubin is considered a physiological important antioxidant 
and will be explained later. 
Besides the fact that HO-1 has beneficial effects by decreasing the heme levels, it is also 
thought that its protective effects are due to the effect of the three products of the catalyzed 
reaction (CO, biliverdin, free iron). 
Beneficial effects of HO-1 have been described in different fields of medicine, such as trans-
plantation (Soares et al., 1998; Coito et al., 2002; Tullius et al., 2002; Braudeau et al., 2004), 
atherosclerosis (Juan et al., 2001), sepsis (Fujii et al., 2003), autoimmune neuroinflammation 
(Chora et al., 2007) and infections such as malaria (Pamplona et al., 2007). In pregnancy, 
works from our group (Sollwedel et al., 2005) as well as work obtained and presented in this 
thesis clearly show that up-regulation of HO-1 have beneficial effects in pregnancy, at least in 
an experimental model(Zenclussen ML et al., 2006).  
1.3.4 Products of the HO enzymatic reaction and their effects 
1.3.4.1 Carbon monoxide (CO) 
CO is a gaseous second messenger that arises in biological systems during the oxidative ca-
tabolism of heme by HO. The endogenous production of CO was described even before the 
characterization of the HO enzyme (Wise and Drabkin, 1964; Coburn et al., 1967), although it 
was considered for many years as a waste product with toxic effects but no specific functions. 
Nowadays, besides its toxic effects at high doses, it is known to mediate salutary effects when 
applied at low doses.  CO is a signal molecule for the generation of cGMP in biological sys-
tems (Maines, 1997), and can regulate vasomotor tone as well as neurotransmission, having a 
regulatory function that may indeed account for the anti-inflammatory effects of HO-1 (Otter-
bein and Choi, 2000). CO is also known to inhibit platelet aggregation and endothelin-1 pro-
duction by endothelial cells (Buelow et al., 2001). Besides, anti-apoptotic and anti-
proliferative effects were described for CO (Brouard et al., 2000; Pae et al., 2004). Moreover, 
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CO has been shown to affect several intracellular signalling pathways, including guanylate 
cyclase and the mitogen-activated protein kinases (MAPK) (Otterbein et al., 2000), and these 
pathways mediate, in part, the known vasoregulatory, anti-inflammatory, anti-apoptotic and 
anti-proliferative effects of this gas (Ryter and Otterbein, 2004). Recently, it has been reported 
that CO alone leads to the generation of reactive oxygen species (ROS) which play a major 
role as signalling molecules to up-regulate peroxisome proliferator-activated receptor-γ 
(PPARγ), and that PPARγ accounts for the anti-inflammatory effects of CO in vitro and in 
vivo (Bilban et al., 2006).  
CO was shown to mimic the effects the HO-1 in many models (Sass et al., 2003; Akamatsu 
et al., 2004; Chora et al., 2007; Pamplona et al., 2007), even administered during an ongoing 
disease process (Hegazi et al., 2005). However, the effects of CO are lost in hmox1-/- macro-
phages, suggesting the need for HO-1 up-regulation for the inhibitory effects of exogenous 
CO (Hegazi et al., 2005). It has been suggested that CO initiates an amplification mechanism 
that results in the production of another product of HO-1, which is the real mediator of the 
therapeutic effect (Bach, 2005). Alternatively, CO might mediate all of the beneficial effects, 
but the amplification steps generated by each of the products of HO-1 degradation are essen-
tial to generate enough CO at the site of injury to manifest the those effect (Bach, 2006). An 
interesting theory was proposed by M. Soares at the 5th International Congress Heme Oxy-
genase 2007, by which it is postulated that complications that are different in nature and out-
comes such as artherosclerosis, autoimmune neuroinflammation or malaria present a common 
feature: the presence of exacerbated inflammation. Interestingly, he proposed that these com-
plications can be reverted by counteracting the exacerbated inflammation by the application 
of CO, known to have anti-inflammatory properties. Although this theory is based so far only 
in experimental models, it could be shown e.g. in the case of malaria, that this carbon monox-
ide may act not only by up-regulating HO-1, but also by binding to free cell hemoglobin, pre-
venting hemoglobin oxidation and the generation of free heme, a potent oxidant that would 
trigger the pathogenesis of experimental cerebral malaria (Pamplona et al., 2007). 
1.3.4.2 Iron (Fe2+) 
The iron released from heme by HO potentially enters a pool of “labile” or “chelatable” iron, 
where it may be available for cellular processes that depend on iron (Ryter and Tyrrel, 2000). 
Normally, the free iron is rapidly sequestered into the protein ferritin, and such sequestration 
can itself lower the pro-oxidant state of the cell by removing the free iron (Balla et al., 1992; 
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Otterbein and Choi, 2000), avoiding iron-dependent oxidative stress. Ferritin-mediated iron 
chelation inhibits cell-cycle progression, leukocyte migration and fibroblast and endothelial 
cell apoptosis (Buellow et al., 2001). Ferritin has been implied as a cytoprotective molecule in 
different in vitro models (Balla et al., 1992; Lin and Girotti, 1998), and has been proposed as 
a contributory mechanism underlying HO-dependent protection (Ryter et al., 2006). In vivo, it 
has been shown that the over-expression of H-ferritin protects rat livers from ische-
mia/reperfusion injury and prevents hepatocellular damage upon transplantation and that its 
protective effect is related with inhibition of endothelial cells and hepatocyte apoptosis in vi-
tro and in vivo (Berberat et al., 2003).  
1.3.4.3 Biliverdin and bilirubin 
Biliverdin, the first product of HO-catalyzed heme cleavage, is enzymatically reduced by 
biliverdin reductase (BVR) to produce bilirubin. Under normal conditions, biliverdin and 
bilirubin are processed for rapid elimination (Ryter et al., 2006). Bilirubin is known as a waste 
product, but it was also shown to be a potent anti-oxidant (Maines, 1997). It has been seen 
that both biliverdin and bilirubin can act as potent in vitro anti-oxidants with possible physio-
logical implications (Stocker et al., 1987; Stocker and Peterhans, 1989; Neuzil and Stocker, 
1993). Biliverdin has been also shown to be anti-inflammatory (Vachharajani et al., 2000), 
and to induce tolerance to cardiac allografts (Yamashita et al., 2004). In ischemia/reperfusion 
injury, both biliverdin and bilirubin have been shown to be protective in vivo (Nakao et al., 
2005; Adin et al., 2005).  
1.3.5 Heme oxygenase-1 deficiency 
So far, only one human case of total heme oxygenase-1 deficiency was described (Yachie et 
al., 1999). A schematic representation of the observations done in the case of human Hmox1 
deficiency is summarized on Fig. 10.  
Briefly, the male patient showed growth retardation, in addition to fever, rash, hepatomegaly, 
arthralgia without swelling and generalized lymphadenopathy. He also presented fragmented 
red blood cells in serum, together with giant platelets and dysmorphic monocytes in periph-
eral blood, with hematuria and proteinuria constantly present. He showed generalized in-
flammation, disturbances in the coagulation/fibrinolysis system, nephropathy, vascular endo-
thelial cell injury, and asplenia (reviewed in Koizumi, 2007). The patient unfortunately died at 
the age of 6, but the discovery of this case was of great importance for understanding the im-
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portance of HO-1 in the well functioning of the immune system as well as in the metabolism 
in general. Interestingly, the mother (who presented a heterozygous mutation for HO-1) pre-
sented previously two intrauterine fetal deaths (abortions), suggesting that HO-1 plays an im-
portant role also in human pregnancies. 
 
Fig. 10 : Schematic representation of the pathophysiology of Hmox1 deficiency in humans 
Adapted from Koizumi, 2007. 
 
Mice deficient for heme oxygenase-1 (Hmox1-/- mice) were first generated and described by 
Poss and Tonegawa in 1997, in the (129/Sv x C57BL/6) hybrid strain background. These mice 
were slightly smaller than Hmox1+/+ or Hmox1+/- littermates from birth to early adulthood, but 
were otherwise indistinguishable (Poss and Tonegawa, 1997). However, after 25 weeks of age 
they died prematurely or became less active. Besides, after 20 weeks of age Hmox1-/- mice 
presented hypoferremia and anemia with accumulation of tissue iron. These observations led 
to the authors to propose that these mice have a defect in iron reutilization. Furthermore, these 
mice presented a progressive chronic inflammatory disease, demonstrated by enlarged spleens 
and lymph nodes, high splenic and lymph node CD4+:CD8+ T-cell ratios with numerous acti-
vated CD4+ T cells and hepatic inflammatory cell infiltrates (Poss and Tonegawa, 1997). Re-
garding the maintenance of the colony it was described that matings between heterozygous 
mice for Hmox1 did not yield the expected mendelian ratio, being it only 20% of the expected 
Hmox1-/- mice (8% instead of 25%). Even more interesting is the fact that no viable litters 
were obtained when mating Hmox1-/- females and males, suggesting an essential role of HO-1 
in pregnancy. 
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Another colony of Hmox1 deficient mice was generated by Yet et al. in 1999, in a 
(129Sv x BALB/c) mixed genetic background. Consistent with the data of Poss and To-
negawa, the matings of Hmox1+/- did also not yield the expected mendelian ratio, which led 
the authors to propose that homozygous mutants present partial embryonic or neonatal lethal-
ity (Yet et al., 1999). These mice also present enlarged spleen, but are otherwise macroscopi-
cally indistinguishable from Hmox1+/+ or Hmox1+/- mice (personal observations). 
1.3.6 Role of HO-1 in tolerance 
A very interesting paper published in 2005 by Fritz H. Bach (Bach, 2005) points out that 
many molecules act through a so called “HO-1 amplification funnel”. According to this the-
ory, the beneficial effects associated to molecules such as IL-10, rapamycin, 15-PGJ2, or aspi-
rin, are in fact due to the up-regulation of HO-1 by these molecules. By definition, a given 
molecule would only function via the “amplification funnel” if both of two conditions obtain: 
1. the molecule functions only when HO-1 is present and induced, and a product of HO-1 
can mediate the functions ascribed to the given molecule in the absence of that other 
molecule.  
2. HO-1 can amplify the therapeutic effects of the other molecule. 
 
Fig. 11 : HO-1 therapeutic amplification funnel 
Fig. taken from Bach, 2005. 
 
There are many molecules that appear to function via the HO-1 funnel, and they are repre-
sented in Fig. 11 (Bach, 2005). Although these molecules are not related, they all require the 
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presence of HO-1 to exert its action, and their actions can be mimicked by HO-1 or its prod-
ucts. The effects obtained in all the cases are related to the achievement of a tolerant state. 
1.3.6.1 HO-1 in organ transplantation 
Tolerance plays a central role in organ transplantation, and in this regard, HO-1 has been 
shown to play an important role. Almost all transplanted organs suffer certain degree of 
ischemia/reperfusion injury, characterized by primary microcirculatory flow disturbances 
caused by the production of oxygen free radicals and cytokine-mediated inflammatory dam-
age (Katori et al., 2002). Besides, after organ transplantation, large amounts of free hemopro-
teins are released, and it is known that acute exposure to heme is a highly cytotoxic event. In 
these cases, there are mechanisms to protect the cells against these damages, and in these 
processes the HO-1 molecule plays a central role. In this regard, many works have already 
shown that the up-regulation of HO-1 is able to avoid graft rejection. The use of HO-1 induc-
ers such as cobalt protoporphyrin (CoPPIX) has shown beneficial effects through the 
up-regulation of the HO-1 expression in a steatotic rat liver model of ex vivo cold ische-
mia/reperfusion injury (Amersi et al., 1999), and in a mouse model of transplantation of islets 
of Langerhans (Pileggi et al., 2001). Additionally, in a model where animals tolerated their 
transplants by means of a treatment with anti-CD40L antibody plus donor-specific transfu-
sion, tolerance could not be achieved in Hmox1-/- mice or in mice treated with the HO-1 in-
hibitor zinc protoporphyrin (ZnPPIX) (Yamashita et al., 2006), suggesting that HO-1 is essen-
tial for the tolerance to transplanted organs. 
1.3.6.2 HO-1 in pregnancy 
Considering the similarities between an allotransplant and a fetus from an antigenically point 
of view, it is to expect that HO-1 may play an important role in favouring the tolerance 
against the allogeneic fetus. Although little was known in the last years about the role of 
HO-1 in pregnancy, many recent studies point out a key role of this enzyme. So far, we could 
show that mice undergoing abortion presented down regulated levels of HO-1 and HO-2 at 
the feto maternal interface when compared to normal pregnant mice (Zenclussen et al., 2005). 
Accordingly, human miscarriage was associated with diminished placental HOs levels (Barber 
et al., 2001; Zenclussen et al., 2003b). Besides, Kreiser et al. reported that the injection of an 
adenoviral vector containing HO-1 into 15-day pregnant rats lead to increased pup weight 
(Kreiser et al., 2002). As previously explained, mice lacking HO-1 (Hmox1-/- mice) present a 
variety of disease symptoms, including anemia, abnormal iron-loading, and chronic inflam-
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mation, showing Hmox1-/- embryos and mice abnormalities like impaired cellular stress re-
sponse and abnormal responses to endotoxin (Poss and Tonegawa, 1997). Interestingly, 
Hmox1-/- mating pairs did not yield viable litters (Poss and Tonegawa, 1997). These data re-
flex the fact that no successful pregnancy can be achieved without HO-1, pointing out a key 
role of this enzyme in pregnancy.  
The hypothetical scenario depicted in Fig. 12 (adapted from Zenclussen et al., 2002b) points 
out that during pregnancy, specially due to the inflammatory nature of blastocyst implanta-
tion, there are huge amounts of free heme that need to be degraded.  
 
Fig. 12 : Hypothetical scenario of the role of HOs in pregnancy and Th1-mediated abortion. 
Adapted from Zenclussen et al., 2002b. 
 
In a spontaneous abortion situation (B), HO-1 would be expressed but not at sufficient levels, 
thus being insufficient to degrade the free heme present in the system. The accumulation of 
free heme, a potent pro-oxidant, would lead to damage of endothelial cells and trophoblasts. 
In addition, it would enhance the expression of adhesion molecules, which would allow fur-
ther trafficking of Th1 lymphocytes into the feto-maternal interface, known to be pregnancy-
deleterious. In a normal pregnancy situation (A), heme oxygenase would be expressed in suf-
ficient amounts and would be thus able to degrade all the free heme present at the feto-
maternal interface, being the previously described cascade avoided.  
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1.3.7 HO-1 and regulatory T cells (Treg) 
Some works point out that there might be a relationship between HO-1 and Tregs. In 2003, 
Pae found that human CD4+CD25+ cells from blood constitutively express HO-1, whereas 
CD4+CD25- did not (Pae et al., 2003). Later in 2005, it was demonstrated that HO-1 expres-
sion could be induced by Foxp3 gene transfection, and that HO-1 was involved in Foxp3-
mediated immune suppression (Choi et al., 2005).  
In pregnancy, as already mentioned, a link between Tregs and HO-1 was also found, as mice 
receiving Tregs to be rescued from spontaneous abortion showed augmented levels of HO-1 
at the feto-maternal interface when compared to mice developing spontaneous abortion (Zen-
clussen et al., 2006). Additionally, the up-regulation of HO-1 by Cobalt Protoporphyrin 
(CoPPIX) led to augmented levels of mRNA of Neuropilin-1, a suggested marker of Treg 
(Sollwedel et al., 2005). Interestingly, in a work where tolerance to islet allografts is achieved 
by inducing HO-1 has shown that if Treg are depleted prior to transplantation, this tolerance is 
no longer achieved (Lee et al., 2007). All these data suggest a relationship between both sys-
tems. However, it has still to be proven that there is in fact a functional important feedback 
between both systems. Some other authors point out that there is no such relationship between 
HO-1 and Tregs. For example, the work of Zelenay et al. (Zelenay et al., 2007) showed that 
the frequency of CD25+ or foxp3+ Tregs does not differ between Hmox1-/- and Hmox1+/+ mice, 
and that Treg isolated from these animals are equally efficient in controlling the proliferation 
in vitro and the expansion in vivo of CD4+CD25- T cells. 
1.4 Gene Therapy 
The basic concept of gene therapy involves the introduction of a foreign gene with the pur-
pose of correcting genetic diseases or in order to deliver new therapeutic functions to target 
cells (Walther and Stein, 1996). However, the use of gene therapy for clinical trials is still 
controversial and facing many obstacles before the use of DNA as a drug becomes common-
place (Thyagarajan et al., 2001). Nevertheless, the use of gene therapy is still of great use in 
animal models especially in helping to understand the function of certain molecules in differ-
ent experimental models. 
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1.4.1 Viral expression systems used in gene therapy 
One of the most important aspects of gene therapy is the safe and efficient delivery of DNA, 
and for that, the choice of the vehicle for delivery. Any ideal vector used as DNA delivery 
vehicle should have the properties of easy and sustained production and should be immu-
nologically inert. It is desirable that it delivers only in certain cell types and that it can infect 
both dividing and non dividing cells. An ideal vector should have no size limit regarding the 
genetic material it can deliver, and in some cases a site-specific integration into the chromo-
some of the target cell is convenient (Somia and Verma, 2000). There are at the time no ideal 
vector fullfilling all these properties but it is important that the chosen vector has so many of 
them as possible. 
Although there exist non-viral systems to introduce foreign DNA in tissues or cells, they have 
as disadvantage an inefficient gene transfer and a transient expression of the foreign gene 
(Somia and Verma, 2000; Wood and Prior, 2001). Therefore, viral vectors still represent the 
most suitable vehicles for gene therapy trials. 
Viral vectors are obtained by replacing genetic components from the original virus with the 
therapeutic gene. Depending on the integration of the genetic information into the host ge-
nome or not, these vectors are divided in two categories. 
• Integrating virus: in this group three main vectors are included: retroviral, lentiviral and 
adeno-associated viral vectors. 
• Non-integrating virus: to this group belongs the adenoviral vector type, which is main-
tained as an episome. 
Some of the viral vectors that are most used in gene therapy trials are described below: 
a) Retroviral vectors:  these vectors are the most used in gene therapy trials and derive from 
Moloney murine leukaemia virus (MoMuLV). Retroviral vectors derived from MoMuLV 
promote the efficient transfer of genes into a variety of cell types, and cause no detectable 
harm as they enter their target cells. The retroviral nucleic acid becomes integrated into chro-
mosomal DNA, ensuring its long-term persistence and stable transmission to all future prog-
eny of the transduced cell (Boulikas, 1998). Retroviruses have three essential genes which are 
usually provided separately in packaging cells, in order to make them deficient of replication 
in the absence of the packaging cell line, being therefore safer. These genes are the gene gag, 
which encodes for viral structural proteins, the gene pol encoding for reverse transcrip-
tase/integrase, and the gene env, which encodes viral envelope glycoprotein. The gag and pol 
 - 28 -
Introduction 
---------------------------------------------------------------------------------------------------------------------------------------- 
genes are separated from the env gene, making the regeneration of a replication competent 
virus unlikely (Somia and Verma, 2000). A schematic representation of the production of ret-
roviral vectors is schematized in Fig. 13 (Somia and Verma. 2000). 
 
Fig. 13 : Retrovirus-based vectors 
Adapted from Somia and Verma, 2000. a) The retroviral genome contains normally the gag, pol and env genes. 
The Ψ is the packaging sequence and is recognized by the viral proteins for packaging. b) The vector genome, 
where the gag, pol and env are replaced by the therapeutic gene. c) The packaging cell. The vector genome, by 
virtue of the Ψ  sequence are encapsulated along with the Pol and Gag proteins and assembled under the mem-
brane. The virus buds off from the packaging cell, where it is able to infect other cells but not to replicate.   
 
Other advantage of the retroviral vectors, is that by changing the envelope protein it is possi-
ble to change the target cells from ecotropic (infecting only rodent cells) to xenotropic (infect-
ing most mammalian cells except rodent cells), amphotropic (infecting all mammalian cells) 
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and pantropic (infecting various species) (Danos and Mulligan, 1988; Markowitz et al., 1988; 
Burns et al., 1993). One of the disadvantages of these vectors is that they can infect only di-
viding cells, which constitutes the main limitation of their use. Other mentionable disadvan-
tage is the low viral titers obtained when working with these viruses, and they may be too low 
to achieve therapeutic levels of gene expression (Boulikas, 1998). Despite these disadvan-
tages of the retroviral vectors, the already mentioned advantages make them one of the most 
used vectors in gene therapy trials. 
b) Lentiviral vectors: they are part of the retrovirus family, and their advantage is that they are 
able to infect non-dividing cells (Somia and Verma, 2000). One disadvantage that they have is 
the possibility of recombination and generation of infectious HIV and the non-specific inte-
gration in the chromosome. Although there are many trials trying to overcome this disadvan-
tage, their use remains very limited. Additionally, they present the disadvantage of low titer 
production and decreasing levels of transgene expression over time (Buchschader and Wong-
Stall, 2000). 
c) Adeno-Associated Viral Vector (AAV):  AAV is a small-single stranded DNA virus, non-
pathogenic, which requires a helper virus (adenovirus or herpesvirus) for replication and 
propagation (Somia and Verma, 2000; Mathieu et al., 2002). The AAV is capable of integrat-
ing into the host genome and can transfer genes in both quiescent and replicative cells 
(Mathieu et al., 2002). The problems related with these vectors are the coding capacity (re-
stricted to 4.5 kb (Somia and Verma, 2000)), and the initial time delay before the beginning of 
transgene expression (Mathieu et al., 2002). 
d) Adenoviral vectors: adenoviruses are double-stranded DNA viruses, with a genome flanked 
by inverted terminal repeats (ITRs), which serve as origins of replication. The wild type ade-
noviral genome possess 4 major classes of genes: early E1 gene encoding products that acti-
vate transcription of the other viral genes; the E2 gene encode proteins that enable DNA repli-
cation, while the products of the E3 gene function in counter host cell defence mechanism. 
Finally, the products of the E4 gene count on the regulation of the viral life cycle (Thyagara-
jan et al., 2001). The most commonly used replication defective adenoviruses are viruses con-
taining deletions of the E1 and E3 regions, which are also referred as first generation vectors 
(Graham, 2000). Deletion of E1 renders the adenovirus replication-defective, thus E1 genes 
are provided in trans to allow the production of adenoviruses in cell lines. The E3 gene is 
normally replaced by the desired (therapeutic) transgene (reviewed in Thyagarajan et al., 
2000). Their advantages for the use in gene therapy are that they allow inserts up to 7.5 kb 
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and that they are produced at high viral titers (Wilson, 1996). Adenoviruses have the ability to 
transduce dividing and non-dividing cells efficiently, and although they can not integrate into 
the host genome, they have many advantages that make them very useful in many gene ther-
apy clinical trials, especially in those trials where short-term expression of immunomodula-
tory molecules can be efficient for the induction of the protective effect, e.g. tolerance. These 
short-term expression is a consequence of the loss of adenoviral episomes in progeny cells, 
and the humoral and cellular immune response of the host against the adenoviral antigens, 
aiming to clear the transduced cells. In adult animals, the transgene is expressed for only a 
short time, between 5 and 20 days post-infection (Dai et al., 1995). Nevertheless, their ability 
to transduce dividing and non-dividing cells makes them one of the most used vectors for 
gene therapy. An overview of the immune response generated after the inoculation of an ade-
noviral vector is shown in Fig. 14 (from Bangari and Mittal, 2000), in the situation of a first 
inoculation with an adenoviral vector. Briefly, the first use of an adenoviral vector leads to a 
strong innate as well as adaptive immune response, resulting in the elimination of transduced 
cells as well as in the development of neutralizing antibodies. In the case of a high dose of 
administered vector, a strong innate immune response is obtained, resulting in the proinflam-
matory cytokines and chemokines that lead to an acute toxic response and hepatotoxicity (re-
viewed in Bangari and Mittal, 2000).  
There are different possibilities to manipulate the immune system through gene therapy. One 
of them is the ex vivo gene transfer of the target molecule e.g. by using adenoviral or retrovi-
ral gene transfer, with different therapeutic genes. The advantage of both systems is the local 
production of the molecule of interest. The disadvantage of the adenoviral gene transfer is that 
it produces a transient gene expression, being the expression and effects of the molecule of 
interest limited. Alternatives to overcome this particular disadvantage are offered by retroviral 
gene transfer, since the integration of the gene of interest to the host genome allows the long 
term expression of the target molecule. Other possibility is the modification of certain types of 
cells, e.g. cells of the immune system and they are used as cellular therapy. 
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Fig. 14 : Development of adenoviral vector immunity. 
Figure taken from Bangari and Mittal, 2000. Briefly, the application of an adenoviral vector leads to innate and 
adaptive immune responses that ultimately lead to the neutralization of the adenovirus as well as to the elimina-
tion of the transduced cells. 
 
One of the most interesting target cells in this regard are T lymphocytes, since they play a key 
role in immune responses, and they are able to be genetically modified by retroviral vectors. 
In this case, the retroviral vectors bring the possibility of permanently modify the genome of 
the T cells, further enabling the selection of the modified cells through a selection marker. 
This allows the obtainig of a high number of modified T cells that are able to transmit the ge-
netic information to other generation of T cells. Adenoviral vectors have been used so far in 
many different approaches such as the transfer of factor IX gene in hemophilia B dogs via 
vein injection (Kay et al., 1994) and in mice (Smith et al., 1993), for the transfer of the VLDL 
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receptor gene for the treatment of familiar hypercholesterolemia in a mouse model (Kozarsky 
et al., 1996), and for the ex vivo transduction of T cells from ADA-deficient patients, between 
others (Blaese et al., 1995). In humans, trials have been overshadowed by the tragic death of a 
18-year-old patient in a Phase I clinical trial in 1998 (reviewed in Somia and Verma, 2000), 
but nevertheless adenoviral vectors are still widely used in animal models. 
The route of administration of the vector determines the efficiency of transgene expression in 
experimental models. In 1995, Huard et al. systematically studied the efficiency of transduc-
tion of various adenovirus-recombinants via different routes of administration: intramuscular, 
intracardiac, intraperitoneal, buccal, gastric, rectal, intravenous and nasal. They found out that 
the route of administration has a major role in determining the transduction efficiency of the 
different tissues (Huard et al. 1995). This should be taken into account when planning ex-
periments tending to obtain a molecule over-expressed in a determined tissue. 
1.4.2 Gene transfer to pregnant animals 
In reproductive medicine, experimental trials have been made so far only for correcting gene 
defects in utero. The use of gene therapy for improving pregnancy-rate success or avoiding 
pregnancy-related diseases i.e. miscarriage or pre-eclampsia remains a very distant goal with 
unresolved moral and ethical aspects. However, gene therapy may be a useful tool in deter-
mining the role of genes with a proposed protective role in supporting fetal growth and/or 
avoiding its rejection experimentally and might further help to identify new targets of inter-
vention. Gene therapy strategies to avoid fetal rejection may include for example the transfer 
and expression of cytoprotective molecules locally at the fetal-maternal interface. In addition, 
the ex-vivo genetic modification of immune cells and further transfer into pregnant animals 
for tolerance induction represents a novel and tempting approach.  
Interestingly, as reported by Koi et al., the placental “receptivity” to adenovirus depends on 
the trophoblast differentiation stage (Koi et al. 2001). Natural infection of human villous tro-
phoblasts by adenovirus is reduced as the cells differentiate into syncytiotrophoblasts (Mac-
Calman et al. 1996, Parry et al. 1998). As reported by Senoo et al. (2000), the administration 
of the virus into the amniotic space on 14-days pregnant mice resulted in the expression of the 
desired gene in the lung, skin surface and epithelium of the digestive tract, while the admini-
stration of the recombinant virus into the intra-peritoneal space of the fetus resulted in gene 
expression in the peritoneum and upper digestive tract. Further, the same authors introduced 
the adenovirus directly into the systemic circulation of guinea pig fetuses through the umbili-
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cal vein and found out that the gene was expressed in multiple organs (Senoo et al. 2000), 
being this route the most effective one for effective fetal somatic therapy. The highest gene 
expression after gene transfer was found in the liver (80%). Additionally, the administration of 
recombinant adenovirus per se did not have a detrimental effect on the fetuses (Seeno et al. 
2000). It is also possible that the low lymphocyte infiltration described by these authors 
(Seeno et al., 2000) is due to the immaturity of the fetus or most probably, to the tolerant state 
at the fetal-maternal interface. Further publications confirm that adenovirus-mediated gene 
transfer into the fetal systemic circulation resulted in the transgene expression primarily in the 
liver (Schachtner et al. 1999; Themis et al. 1999). Although successful, the diffused delivery 
of vector throughout the fetus, the immune response to the vector and the transfer of genetic 
material to the mother in this report point out the technical obstacles to be solved if systemic 
in utero gene therapy should became a reality for correcting fetal diseases (Themis et al. 
1999, Walsh 1999). 
Regarding murine placenta, Senoo already reported very low placental transgene expression if 
the vector was applied into the amniotic space or intra-peritoneally into the fetus on day 14. 
Accordingly, Laurema et al. recently reported that the injection of LacZ-adenovirus into the 
exocoelomic cavity of rat fetuses led to expression of the gene expression on giant cells while 
no transduction could be observed in fetuses or rat dams (Laurema et al. 2004). These data 
confirm that the exocoelomic cavity does not offer a route for gene transfer into the fetus. 
Fetal membranes may act as a barrier, which may naturally prevent adenoviral particles from 
passing between embryonic cavities (Laurema et al. 2004). Interestingly, a work by Okada 
and co-workers showed that placenta specific gene incorporation can be achieved by lentiviral 
transduction of murine blastocysts only after the removal of the zona pellucida (Okada et al., 
2007).   
Ex vivo gene transfer 
One tempting approach to be used in this emerging field is the transfer of ex vivo generated 
immune cells, which are specific for paternal antigens and carry therapeutic genes as i.e. anti-
inflammatory, immunomodulatory or cytokine genes. Experimental protocols from the trans-
plantation immunology (Wood and Fry 1999; Hammer et al. 2002) suggest that the use of 
gene-engineered cells may be very effective in pregnancy models since they would act locally 
at the fetal-maternal interface and may thus prevent inflammatory events, which are known to 
end in miscarriage. By transferring gene-modified cells into pregnant animals in abortion or 
pre-eclampsia models (Chaouat et al. 1988, Zenclussen et al. 2004), gene therapy would be 
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useful to verify the role of certain genes and to unravel novel pathways involved in pregnancy 
outcome. Gene therapy approaches in these models could further help designing therapies 
tending to avoid e.g. immunological rejection of the fetus. Other advantages of this method 
for using it experimentally in pregnancy models would be the possibility of localization of 
immunosuppressive/immunoregulatory molecules to targeted sites and the possibility of ma-
nipulation of the fetal genotype before implantation takes place since the use of retroviral vec-
tors ensures that the genotype of the target cells in question are permanently modified. 
Aims of the work 
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2 Aims of the work 
Mammalian pregnancy is a parabiotic union of two genetically different individuals, the fetus 
and the mother. It is now known that some degree of systemic or uterine inflammation is nec-
essary for both normal implantation and pregnancy, but if this inflammation becomes too ex-
cessive it can cause pregnancy complications such as abortion. Heme oxygenase-1 (HO-1), 
the enzyme responsible for the degradation of free heme, plays a key role in inflammatory 
processes. Viewing pregnancy mainly as an inflammatory process let us hypothesized that 
HO-1 may play an important role in pregnancy. Therefore, the main aim of this work was to 
analyze the role of HO-1 in the different processes related to pregnancy by means of func-
tional studies employing in vivo as well as in vitro models.  
The present work is divided didactically in 4 parts: in vivo up-regulation of HO-1, 
up-regulation of HO-1 in T cells, effect of HO-1 in the survival and differentiation of tro-
phoblast cells and analysis of the effect of a partial or total loss of Hmox1 on implantation and 
fertility. The objectives of each part are indicated below: 
 
I. In vivo up-regulation of HO-1 
Since it is postulated that a systemic up-regulation of HO-1 is enough to prevent the rejection 
of allografts, and because the fetus is normally considered as a semi-allogeneic allograft, the 
aims of this part of the work were: 
a) To specifically up-regulate HO-1 in mice undergoing abortion through adenoviral gene 
transfer.  
b) To determine whether this up-regulation improves pregnancy outcome.  
c) To investigate possible mechanisms by which HO-1 would exert its action. 
 
II. Up-regulation of HO-1 in T cells 
Considering the cytoprotective characteristics of the HO-1 molecule, the aim of this second 
part of the work was to generate T cells over-expressing HO-1, and to test their potential in 
the inhibition and modulation of the immune response in vitro. 
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The fulfilment of these aims included: 
a) Generation of modified T-lymphocytes over-expressing HO-1 (THO-1-lymphocytes). 
b) Analysis of the function of the generated THO-1-lymphocytes in vitro. 
 
III. Effect of HO-1 on the survival and differentiation of trophoblast cells 
The use of the trophoblast stem cell line Rcho-1 helps to elucidate the mechanisms necessary 
for the differentiation of these cells into giant trophoblast cells, and therefore to understand 
the mechanisms underlying placentation. The aims of this part of the study were: 
a) To analyze the effect of an HO-1 inducer (CoPPIX) or inhibitor (ZnPPIX) on the survival 
of the trophoblast stem cell line. 
b) To analyze the ability of the Rcho-1 cells to differentiate under the influence of CoPPIX 
or ZnPPIX, in order to determine the role of HO-1 during trophoblast cell differentiation. 
 
IV. Analysis of the effect of partial or total loss of Hmox-1 on implantation and fertility 
As animals deficient in Hmox1 are not able to yield progeny and the mating of mice heterozy-
gous for Hmox-1 does not yield the expected Mendelian rate, further aims of this work were: 
a) To analyze the pregnancy outcome in different combinations of Hmox1+/+, Hmox1+/- or 
Hmox1-/- mice in order to determine whether Hmox1 expression is important at the mater-
nal or paternal side or in both. 
b) To determine whether the lack of Hmox1 has any effect on the fertility of the mice by per-
forming in vitro fertilization. 
c) To analyze whether Hmox1 is necessary in the oocytes, in the maternal uterus, or in both, 
for implantation to occur. 
Materials and Methods 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Technical Equipment 
 
Autoclave SL-216/1 WEBECO, Bad Schwartau 
Balance Sartorius, Berlin 
Electrophoresis Power supply EPS 3501 XL Amersham Biosciences, Freiburg 
Freezers New Brunswick Scientific GmbH, Nürtingen 
Glas material Schott, Mainz 
ZIEGRA Chip-ice automat Ziegra Eismachinen GmbH, Isernhagen 
Pasteur pipettes Sarstedt, Nümbrecht 
pH-Meter PH 211 Hanna Instruments, Padova, Italy 
Refrigerators Liebherr, Ochsenhausen 
 
3.1.2 Equipment and material for cell culture 
15 ml Tubes BD FalconTM BD Labware, Franklin Lakes, USA 
50 ml Tubes BD Falcon TM BD Labware, Franklin Lakes, USA 
Cell culture flasks BD FalconTM BD Labware, Franklin Lakes, USA 
Cell culture plates BD FalconTM BD Labware, Franklin Lakes, USA 
Cell strainers (100 µm pores) BD FalconTM BD Biosciences Discovery Labware,  
Bedford, USA 
Centrifuge Sigma 3K15 Sigma Laborzentrifugen GmbH,  
Osterode am Harz 
Cryo TubeTM Vials Nunc, Roskilde, Denmark 
Descosept Dr. Schumacher GmbH, Melsungen 
Filters 0,2 µm Schleicher & Schuelll, Dassel 
Filters 0,45 µm Schleicher & Schuelll, Dassel 
Humified incubator Heraeus, Berlin 
Laminair HBB2448 Heraeus, Berlin 
Light microscope Olympus CK2 Olympus, Hamburg 
Neubauer counting camera Fein-Optik, Blankenburg 
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Nitrogen tank MVE Cryosystem 2000 CHART/MVE, Burnsville, USA 
S1 Laminar Flow Nuaire Sarstedt, Nümbrecht 
Sterile Pipetes (5,10 and 15 ml) BD FalconTM BD Labware, Franklin Lakes, USA 
Vacuum Filtration Unit Schleicher & Schuelll, Dassel 
Vivaspin 20 Vivascience, Hannover 
    
3.1.3 Equipment and material for Western Blot 
Biometra Fastblot Biometra, Göttingen 
Biometra Minigel Biometra, Göttingen 
Chromatography paper Whatman® Whatman International Ltd, Maidstone,  
England 
ECLTM detection agents Amersham Biosciences, Buckinghamshires, 
England 
HypercassetteTM Amersham Biosciences, Buckinghamshires, 
England 
Kodak BioMax MR film Kodak, Cedex, France 
Mini Trans-Blot® cell Bio-Rad Laboratories, Hercules, USA 
Mini-PROTEAN® 3 electrophoresis cell Bio-Rad Laboratories, Hercules, USA 
Power supply Amersham Biosciences, Freiburg 
Protec 45 Compact PMA Bode GmbH, Hamburg 
Trans-Blot® Transfer Medium Bio-Rad Laboratories, Hercules, USA 
 
3.1.4 Equipment and material for flow cytometry 
5 ml Polystyrene round-bottom tubes BD Falcon, Erembodegem, Belgium 
Cell strainer, 100 μm Nylon BD Falcon, Erembodegem, Belgium 
BD Plastipak, 1 ml Syringe BD Falcon, Erembodegem, Belgium 
FACS Calibur Becton Dickinson, Heidelberg, Germany 
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3.1.5 Equipment and material for molecular biology 
ABI PRISM 7700 sequence detection system Applied Biosystems, Darmstadt 
Agilent 2100 bioanalyzer Agilent Technologies, Waldbronn 
Filter tips RNase/DNase free 100 (100 μl) Greinder BIO-ONE GmbH, Frickenhausen 
Filter tips RNase/DNase free 1000 (G) (1000 
μl) 
Greinder BIO-ONE GmbH, Frickenhausen 
Filter Tips RNase/DNase free 10E (10 μl) Greinder BIO-ONE GmbH, Frickenhausen 
HE 99X Max submarine unit Amersham Biosciences, San Francisco, USA 
HP 845x UV-Visible system software Hewlett Packard, Palo Alto, USA 
HP spectrophotometer 8453 Hewlett Packard, Palo Alto, USA 
iCycler iQ Real-Time PCR Detection System Bio-Rad, Munich 
Mastercycler personal Eppendorf, Hamburg 
Precision cells made of Quartz SUPRASIL® Hellma, Müllheim 
Safe lock tubes (0.5 ml, 1.5 ml, 2.0 ml) Eppendorf AG, Hamburg 
Thermo-Fast® 96, non skirted PCR plates ABgene, Epsom, UK 
Ultra Clear cap strips ABgene, Epsom, UK 
Ultra-Turrax T25 homogenisator Janke & Kunkel, IKA Labortechnik, Staufen 
Work station  ABgene, Epsom, UK 
 
3.1.6 Equipment and material for immunhistology and immunhistochem-
istry 
ABComplex/HRP DakoCytomation, Glostrup, Denmark 
Accustain® Eosin Y solution aqueous Sigma-Aldrich Chemie GmbH, Steinheim 
AEC+ substrate DakoCytomation, Glostrup, Denmark 
Aquatex® Merck, Darmstadt 
Cover glasses  Menzel-Glaser, Braunschweig 
Cryostat HM 500 OM Microm, Walldorf 
Jung tissue freezing medium® Leica Microsystems Nussloch GmbH,  
Nussloch 
Light microscope Olympus BX40 Olympus, Hamburg 
Microscope slides R. Langenbrinck, Teningen 
Microtome HM 400 Microm, Walldorf 
Roti®-Histokitt Roth, Karlsruhe 
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VECTASHIELD® Mounting medium for 
fluorescence with DAPI 
Vector Laboratories, Burlingame, USA 
 
3.1.7 Equipment and material for in vitro fertilization and embryo transfer 
Leica MZ75 high performance  
stereomicroscope 
Leica Microsystems GmbH, Wetzlar 
Sterile Petri dishes (35 mm) BD Biosciences, Edembodegem, Belgium 
Sterile Petri dishes (60 mm) BD Biosciences, Edembodegem, Belgium 
 
3.1.8 Chemicals 
1,4-Dithio-DL-threitol (DTT) Fluka Chemie GmbH, Buchs 
30% Acrylamid/Bis solution Bio-Rad, Munich 
3-aminopropyltriethoxysilane Sigma-Aldrich Chemie, Steinheim 
[3-[3-Cholamidopropyl)dimethyl  
ammonio]-1-propansulfonate] (CHAPS) Fluka Chemie GmBH, Buchs 
Agarose 1000 Invitrogen Ltd., Paisley, UK 
Ammonium persulfate Bio-Rad Laboratories, Hercules, USA 
Ampicilin Merck, Darmstadt 
AmpliTaq DNA-Polymerase, Buffer + MgCl2 Applied Biosystems, PE, Rodgau-Jügesheim 
Aqua ad injectabilia Delta Pharma, Pfüllingen 
Boric Acid Sigma-Aldrich Chemie GmbH, Steinheim 
Bovine serum albumin, Fraktion V (BSA) Fluka, Buchs, Switzerland 
Bromophenol blue Sigma-Aldrich Chemie, Steinheim 
Calcium Chloride Merck, Darmstadt 
Carboxyfluorescein diacetate succinimidyl 
ester 
Molecular Probes, Leiden, 
(CFDA-SE) The Netherlands 
Chloroform Sigma-Aldrich Chemie GmbH, Steinheim 
Citric acid monohydrate Merck, Darmstadt 
Cobalt protoporphyrin chloride (CoPPIX) Sigma, Steinheim 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Chemie GmbH, Steinheim 
Di-sodium hydrogen phosphate heptahydrate Merck, Darmstadt 
DMEM Lifetechnologies, Karlsruhe 
DNase I RNase free Stratagene, Amsterdam, The Netherlands 
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DNase RNase free Ambion, Huntingdon, UK 
dNTPs Amersham  Pharmacia, Uppsala, Sweden 
Dulbecco´s Phosphate Buffer Solution (PBS) PAA Laboratories, Pasching 
Ethanol absolut puriss. p.a. Riedel-de Haёn, Seelze 
Ethanol Herbeta Arzneimittel, Berlin 
Ethidiumbromide Carl Roth GmbH, Karlsruhe 
Ethyldiamintetracetic acid (EDTA) Calbiochem, Darmstadt 
Fetal bovine serum (FBS) Biochrom, Berlin 
Fetal bovine serum (FBS) Cambrex Bio Science Verviers, Verviers,  
Belgium 
Fetal calf serum (FCS) Seromed, Berlin 
FicoLite-M  Linaris, Bettingen am Main 
Geneticin (G418 Sulfate) Gibco Invitrogen, Paisley, UK 
Glycerol Serva, Heidelberg 
Glycine Serva, Heidelberg 
Guanidine thiocyanate Fluka Chemie GmbH, Buchs 
Hematoxylin solution according to Mayer Fluka Chemie GmbH, Buchs 
Horse serum Gibco Invitrogen, Paisley, UK 
Hydrocloric acid fuming 37% Merck, Darmstadt 
Ionomycin Sigma-Aldrich Chemie GmbH, Steinheim  
L-Glutamine Sigma-Aldrich Chemie GmbH, Steinheim 
Methanol JT Baker 
Mineral oil (mouse embryo tested) Sigma-Aldrich Chemie GmbH, Steinheim 
N,N,N´,N´-Tetramethyl-ethylene diamine 
(TEMED) 
Bio-Rad, Hercules, USA 
Oligo DT Amersham Pharmacia, Freiburg 
Paraformaldehyd  Merck, Darmstadt 
PCR-Mastermix  Eurogentec, Seraim, Belgium 
Penicillin, Streptomycin Gibco Invitrogen, Paisley, UK 
Peracetic acid Herbeta Arzneimittel, Berlin 
Piruvic acid- sodium salt Sigma-Aldrich Chemie GmbH, Steinheim 
Phorbol 12-mystirate 13-acetat (PMA) Sigma-Aldrich Chemie GmbH, Steinheim 
Polybrene Sigma-Aldrich Chemie GmbH, Steinheim 
Poly-L-lisine  Gibco Invitrogen, Paisley, UK 
Potasssium dihydrogen phosphate Merck, Darmstadt 
Potassium chloride Merck, Darmstadt 
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Potassium hydrogen carbonate Merck, Darmstadt 
Protease inhibitor Sigma-Aldrich Chemie GmbH, Steinheim 
Reaction buffer Promega, Mannheim 
Reverse transcriptase Promega, Mannheim 
RNA-marker Ambion, Huntingdon, UK 
RNase inhibitor Promega, Mannheim 
Saponin Sigma-Aldrich Chemie GmbH, Steinheim 
Skim milk Fluka Chemie GmbH, Buchs 
Sodium azide Merck, Darmstadt 
Sodium carbonate Sigma-Aldrich Chemie GmbH, Steinheim 
Sodium chloride Merck,Darmstadt 
Sodium hydrogen carbonate  Merck, Darmstadt 
Sodiumdodecylsulphate (SDS) Sigma-Aldrich Chemie GmbH, Steinheim 
Trizma®-base Sigma-Aldrich Chemie GmbH, Steinheim 
TRIzol® reagent Invitrogen, Paisley, UK 
Trypan blue Biochrom AG, Berlin 
Trypsin-EDTA  Gibco Invitrogen, Paisley, UK 
Zinc (II) protophorphyrin IX (ZnPPIX) Frontier-Scientific, Lancashire, UK 
β-mercaptoethanol Sigma-Aldrich Chemie GmbH, Steinheim 
 
3.1.9 Kits 
Annexin-PE apoptosis detection kit I BD Pharmingen, San Diego, USA 
Avidin/Biotin blocking kit Vector Laboratories, Burlingame, USA 
Biorad protein assay Bio-Rad Laboratories, Munich 
CD4+ T cell isolation kit Miltenyi Biotec, Bergisch Galdbach 
CD4+CD25+ regulatory T cell isolation kit Miltenyi Biotec, Bergisch Galdbach 
Caspase-3 assay kit, colorimetric Sigma-Aldrich Chemie GmbH, Steinheim 
ChariotTM Active Motif, Rixensart, Belgium 
In Situ Cell Death Detection kit, POD Roche Diagnostics GmbH, Penzberg 
OptEIATM Mouse TNF-α ELISA set BD Pharmingen, San Diego, USA 
OptEIATM Mouse IFN-γ ELISA set BD Pharmingen, San Diego, USA 
OptEIATM Mouse IL-4 ELISA set BD Pharmingen, San Diego, USA 
OptEIATM Mouse IL-10 ELISA set BD Pharmingen, San Diego, USA 
peqGOLD Tissue DNA Mini Kit Peqlab Biotechnologie GmbH, Erlangen 
 - 43 -
Materials and Methods 
---------------------------------------------------------------------------------------------------------------------------------------- 
RNase-free DNase Set Qiagen, Hilden 
RNeasy Mini Kit Qiagen, Hilden 
Strata Prep Total RNA Miniprep kit Stratagene, Amsterdam, The Netherlands 
 
3.1.10 Antibodies for Immunhistochemistry 
Anti-Bcl-2 (Clone N-19) Santa Cruz Biotechnology, Santa Cruz, USA 
Anti-goat Ig, biotinylated Vector Laboratories, Burlingame, UK 
Anti-Heme Oxygenase-2 Stressgen, Victoria, Canada 
Anti-rabbit Ig, horseradish peroxidase Santa Cruz Biotechnology, Santa Cruz, USA 
Anti-VEGF (Clone P-20), goat plyclonal 
antibody 
Santa Cruz Biotechnology, Santa Cruz, USA 
CD3-e (Clone 48-2b) armenian hamster 
monoclonal IgG 
Santa Cruz Biotechnology, Santa Cruz, USA 
Goat anti-armenian hamster IgG, biotinylated Santa Cruz Biotechnology, Santa Cruz, USA 
Goat anti-rabbit Ig, biotinylated Dako, Hamburg 
pAb to HO-1 (made in rabbit) Alexis, San Diego, USA 
 
3.1.11 Antibodies for flow cytometry 
Alexa Fluor® 647-Conjugated anti-mouseCD4 BD Pharmingen, San Diego, CA, USA 
(L3T4) monoclonal antibody (Clone RM4-5)  
FITC anti-mouse CD4 (Clone GK1.5) BD Pharmingen, San Diego, CA, USA 
PE-Cy5 anti-mouse CD8a (Ly-2) (Clone 53-6.7) BD Pharmingen, San Diego, CA, USA 
PE anti-mouse CD25 (Clone PC61) BD Pharmingen, San Diego, CA, USA 
PE anti-mouse IFN-γ BD Pharmingen, San Diego, CA, USA 
PE anti-mouse IL-10 BD Pharmingen, San Diego, CA, USA 
PE anti-mouse IL-4 BD Pharmingen, San Diego, CA, USA 
PE anti-mouse TNF-α  BD Pharmingen, San Diego, CA, USA 
PE-Cy7-conjugated hamster anti-mouse CD69 BD Pharmingen, San Diego, CA, USA 
Monoclonal antibody (Clone H1.2F3)  
PE-Cy7-conjugated hamster anti-mouse CD95 BD Pharmingen, San Diego, CA, USA 
(Fas) monoclonal antibody (Clone Jo2)  
PerCP anti-mouse CD3e (145-2C11) BD Pharmingen, San Diego, CA, USA 
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3.1.12 Antibodies for cell culture 
Anti-mouse CD3ε NA/LE (Clone 145-2C11) BD Pharmingen, San Diego, CA, USA 
Anti-mouse CD28 NA/LE (Clone 37.51) BD Pharmingen, San Diego, CA, USA 
Anti-mouse IFN-γ NA/LE (Clone XMG1.2) BD Pharmingen, San Diego, CA, USA 
Anti-mouse IL-12 (p40/p70) (Clone C17.8) BD Pharmingen, San Diego, CA, USA 
 
3.1.13 Antibodies for Western Blot 
Anti-β-actin Delta Biolabs, Gilroy, USA 
Anti-Heme Oxygenase-1 Stressgen, Victoria, Canada 
Anti-GAPDH Santa Cruz Biotechnology, Santa Cruz, USA 
Anti-goat IgG, biotinylated Vector Laboratories, Burlingame, UK 
Anti-rabbit IgG, biotinylated Vector Laboratories, Burlingame, UK 
Anti-rabbit IgG, HRP conjugated Santa Cruz Biotechnology, Santa Cruz, USA 
Rabbit anti-prolactin-like protein A Chemicon International, Temecula, USA 
 
3.1.14 Membrane dyes 
5-(and-6)-CFDA-SE  Molecular Probes, Leiden, Holland 
 
3.1.15 Cell lines 
293 cells American Type Culture Collection (ATCC) 
GP+E 86 packaging cell line Dr. A. Flügel, MPI für Neurobiologie, 
Abt. Neuroimmunologie, München 
NIH 3T3, mouse fibroblasts DSMZ, Braunschweig 
Rcho-1 trophoblast cell line Dr. Michael Soares, Department of  
Physiology, University of Kansas Medical 
Center, Kansas City, USA. 
 
3.1.16 Expression vectors 
PLXSN AmpR, NeoR, pBR322ori, Ψ+,PSV40, 
5/3-LTR-Promoter 
Clontech 
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3.1.17 Hormones 
Human chorionic gonadotropin (hCG) Sigma-Aldrich Chemie GmbH, Steinheim 
Pregnant mare serum gonadotropin (PMSG) Sigma-Aldrich Chemie GmbH, Steinheim 
 
3.1.18 Animals 
BALB/c males Harlan Winkelmann, Borchen or  
BgVV, Berlin 
CBA/J females Charles River, Les Oncins, France 
DBA/2J males Charles River, Boston, USA 
 
Hmox-1+/+, Hmox-1+/- and Hmox-1-/- females and males were originally generated by Dr. Yet, 
Harvard Medical School, Boston, USA. The colony of mice used in this work were main-
tained at the Instituto Gulbenkian de Ciencia, Oeiras, Portugal, at the group of  Prof. Miguel 
Soares. After a MTA agreement with Dr. Yet, animals were kindly provided by Prof. Soares 
and the colony is being currently maintained in our group. 
3.1.19 Buffers and Media 
DMEM Invitrogen, Gibco, Karlsruhe 
HBSS  Invitrogen, Gibco, Karlsruhe 
RPMI with L-Glutamin Invitrogen, Gibco, Karlsruhe 
Embryomax Human® Tubal Fluid (HTF) Millipore Corporation, Millerica, MA, USA 
M2 Media Sigma-Aldrich Chemie GmbH, Steinheim 
 
Packaging cell line media: 
1 mM Natriumpiruvat 
2 mM L-Glutamin 
100 U/ml Penicillin 
100 µg/ml Streptomycin 
DMEM with 
10%  Fetal Calf serum 
 +/- 1 mg/ml G-418 
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50 mM Hepes 
10 mM KCl 
12 mM Dextrose 
280 mM NaCl 
2 x HBSP Buffer: 
1,5 mM Na2PO4 x 2 H2O 
 
T-cell media: 
RPMI with 2,05 mM L-Glutamin 
 50 μM β-mercaptoethanol 
 1 mM  Na-Piruvate 
 100 μg/ml Penicillin 
 100 U/ml Streptomycin 
 10% (v/v) Fetal Bovine Serum (Cambrex) 
 
Rcho-1 proliferative cell media: 
RPMI with  2,05 mM L-Glutamin 
 50 μM β-mercaptoethanol 
 1 mM Na-Piruvate 
 100 μg/ml Penicillin 
 100 U/ml Streptomycin 
 20% (v/v) Fetal Bovine Serum (Cambrex) 
 
Rcho-1 differentiation cell media: 
RPMI with 2,05 mM L-Glutamin 
 50 μM β-mercaptoethanol 
 1 mM Na-Piruvate 
 100 μg/ml Penicillin 
 100 U/ml Streptomycin 
 10% (v/v) Horse serum 
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Solutions for flow cytometry 
1% BSA 
0.1% NaN3 
FACS Buffer: 
in PBS  
 
0.1% Saponin  Saponin solution: 
in PBS  
 
1.5 M NH4Cl 
10 mM KHCO3 
100 mM EDTA 
Lysis buffer 
in distilled water  
 
Solutions for magnetic cell isolation 
MACS Buffer 0.5% BSA 
 2mM EDTA 
 in PBS, pH 7,4 
 
Solutions for molecular biology 
3.676 g (tri)-Nacitrat-Dihydrat 
236.32 g Guanidine-Isothiocyanate 
2.5 g N-Lauroylsarcosin 
Solution D: 
ad 500 ml DEPC-H2O, pH 7,0 
 
34 mg Bromophenol blue 
3.4 ml Ficolite-M (δ=1,091) 
Loading buffer 
10.2 ml milli Q water 
 
27 g Trizma®-base 
13.75 g Boric acid 
5x TBE 
10 ml EDTA 0,5 M pH 8 
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Solutions for immunohistochemistry 
Citrate buffer 1.8 mM Citric acid 
 8.2 mM Sodium citrate 
 
Solutions for SDS-PAGE and Western Blot 
Transfer buffer pH 8,3 25 mM Tris-Base 
(for semi-dry blot) 150 mM Glicine 
 10% Methanol 
 in distilled water  
 
Transfer buffer pH 8,3 25 mM Tris-Base 
(for wet blot) 150 mM Glicine 
 20% Methanol 
 in distilled water  
 
Running buffer 25 mM Tris-Base 
 192 mM Glycine 
 0,1% SDS 
 in distilled water  
 
4x sample buffer 1 ml 0,5 Tris/HCl pH 6,8 
 1,6 ml 10% SDS 
 3,7 ml Ficolite-M (=1,091) 
 0,4 ml -mercapthoethanol 
 0,2 ml  bromophenol blue (1% in ethanol) 
 1,2 ml  dist. H2O 
 
10x TBS 200 mM Tris-base 
 80 g/L NaCl 
 10% SDS 
 pH 7,6 in distilled 
water 
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Stacking gel (5%) 1.3 ml 29% acrylamide, 1% bisacrylamide 
 2.5 ml 0,5 M Tris/HCl pH 6,8 
 0.1 ml  10 % SDS 
 6.1 ml  dist. H2O 
 0.01 ml TEMED 
 0.05 ml 10% ammonium persulphate sol. 
 
Running gel (10%) 3.3 ml 29% acrylamide, 1% bisacrylamide 
 2.5 ml  1.5 M Tris/HCl pH 8,8 
 0.1 ml 10 % SDS 
 4.1 ml dist. H2O 
 0.005 ml TEMED 
 0.05 ml 10% ammonium persulphate sol. 
 
3.2 Methods 
3.2.1 Over-expression of HO-1 through adenoviral gene transfer in a mur-
ine model of abortion 
3.2.1.1 Recombinant adenoviruses 
An adenovirus coding for HO-1 and GFP (AdHO-1/GFP) was constructed using the pAdEasy 
and pAdTrack-CMV system in 293 cells. AdHO-1/GFP contains two expression cassettes, one 
for the HO-1 and the other for the GFP, both with the human cytomegalovirus (CMV) pro-
moter, with the human HO-1 cDNA fused to a Flag sequence in its 3´end and a polyA se-
quence. This adenovirus was designed and produced in INSERM (France) and was a kind gift 
of Dr. Ignacio Anegon. The adenovirus containing EGFP, which was used as a control, was a 
kind gift of Dr. Michael Willem (Institute of Neurobiology, Max Planck, Martinsried, Ger-
many). The propagation and purification of both recombinant adenoviruses was performed in 
911 cells as previously described (Fallaux et al., 1996; Ritter et al., 1999). In brief, 911 cells 
were infected at a multiplicity of 5-10 and harvested after 36-48 hrs. The virus was released 
by five freeze-thaw cycles and purified by two CsCl-gradients (Graham and Prevec, 1991). 
The banded virus was recovered, desalted over sephadex columns (Pharmacia, Erlangen, 
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Germany) and kept in virus storage buffer after addition of 10% Glycerol at –80°C. Titration 
of the virus concentration after elution from the column was performed by plaque assay on 
911 cells. The propagation of the adenoviruses as well as the determination of their viral titer 
was routinely performed by Heinz Tanzmann, member of the Institute of Medical Immunol-
ogy. 
 
3.2.1.2 Murine abortion-prone model: animals and treatment 
All animals were maintained in a barrier animal facility with a 12 h light/dark cycle. Animal 
care and experimental procedures were followed according to institutional guidelines and con-
formed to the requirement of the state authority for animal research conduct (LaGeSo Nr. 
0062/03 and 0070/03, Berlin). The previously described immunological murine model of 
abortion was used, in which the mating combination CBA/J x DBA/2J represents the abor-
tion-prone group, being the combination CBA/J x BALB/c the normal pregnancy control. 
Two months old CBA/J females were mated with 2-4 months old BALB/c or DBA/2J males, 
checked twice a day for vaginal plugs and separated from the males if pregnant. The day of 
vaginal plug detection was considered as day 0 of pregnancy. Pregnant females mated with 
BALB/c were considered as group (1) and received PBS intraperitoneally (i.p.) (n=15). 
DBA/2J-mated females were then randomized and divided in the following groups: 
 
2) Abortion-prone group + PBS i.p. (n=11) 
3) Abortion-prone group + 1.105 PFU AdHO-1/GFP in PBS i.p. (n=7) 
4) Abortion-prone group + 1.105 PFU AdEGFP in PBS i.p. (n=7). 
5) Abortion-prone group + 1.108 PFU AdHO-1/GFP in PBS i.p. n=8 ) 
6) Abortion-prone group + 1.108 PFU AdEGFP (n=7 ) 
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Fig. 15 : Experimental setting. 
CBA/J females were mated either with BALB/c males (normal pregnant combination) or with DBA/2J males 
(abortion-prone combination). The day of the plug detection was considered as day 0 of pregnancy. Injections 
were made intraperitoneally (i.p.) on day 5 of pregnancy. 
All injections were made i.p. on day 5 of pregnancy, which is known to be in the implantation 
window (Psychoyos, 1986). A schematic representation of the experimental setting is shown 
in Fig. 15.  
The groups 5 and 6 are not included in the schematic representation, since its data will be 
shown as a table in the appendix. On day 14 of pregnancy, the females were sacrificed, the 
uteri removed and the implantation sites were documented. The abortion sites were identified 
by their small size accompanied by a necrotic, haemorrhagic appearance, compared with 
normal embryos and placentas. 
The percentage of abortion was calculated as the ratio of abortion sites and total implantation 
sites using the following formula: 
 
From each animal, different organs were taken for further analysis. Spleens were kept in cold 
RPMI for flow cytometry until further use. Two small portions of decidua were snap-frozen 
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and kept at -80°C for protein and RNA isolation. The rest of the decidua was used for flow 
cytometry and for that, it was cut in small pieces and kept in HBSS at 4°C until further use.  
Placentas were snap-frozen and kept at -80° until use (for protein and RNA isolation).  
3.2.1.3 Spleen and decidual lymphocytes isolation 
Flow cytometry analysis was performed using decidual and spleen lymphocytes. The isolation 
of mononuclear cells (MC) from decidua was performed as previously described (Zenclussen 
et al., 2003; Zenclussen et al., 2004). Briefly, decidual samples were washed with PBS, cut 
into small pieces, collected in HBSS medium containing 1mM DTT and incubated with agita-
tion for 20 min at 37°C. Thereafter, cells were filtered through a 100 μm net and collected in a 
fresh tube where they were washed with RPMI medium containing 10% FCS. The procedure 
was repeated twice, with HBSS without DTT, all supernatants were collected and washed 
with RPMI medium containing 10% FCS. After that, a Ficolite-M gradient was performed 
following the instructions of the manufacturer (Linaris, Bettingen am Main, Germany).  
Spleen tissues were crushed against a 100 μm net, collected in medium containing 10% FCS 
and the erythrocytes were lysed with lysis buffer containing NH4Cl, KHCO3 and EDTA for 
10 min at RT. After erythrocyte lysis, cells were washed once with RPMI containing 10% 
FBS. 
3.2.1.4 Flow cytometry 
Flow cytometry is a technique that allows the analysis of different cells in a cell mixed popu-
lation, as well as to phenotypically characterize these cells based on their size, granularity and 
cell surface or intracellular expression of different molecules.  
This technique is commonly performed by staining the cells with fluorochrome-labeled anti-
bodies that are specific for molecules expressed in their surface or being produced by them. 
The flow cytometer is an instrument capable of detecting fluorescence on individual cells in a 
suspension and thereby determining the number of cells expressing the molecule labeled with 
the specific fluorochrome-labeled antibody. A representative scheme of the principle of flow 
cytometry is depicted in Fig. 16 (from Abbas and Lichtmann in: Cellular and Molecular Im-
munology).  
Spleen and decidual cells were analyzed in order to determine the systemic (in spleen cells) 
and local (in decidua cells) immune response after the different treatments.   
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Extra- and intracellular staining for tissue samples 
Isolated spleen or decidual lymphocytes were incubated for 1 hour with 50 ng/ml PMA and 
1 μg/ml ionomycin at 37°C with 5% CO2 for stimulation of cytokine secretion. The adition of 
PMA and the ionophore ionomycin is a powerful activating stimulus acting on protein kinase 
C and calcium ion influx, and is used both to induce cytokine expression of cells previously 
activated by physiological stimuli (Pala et al., 2000). After this, 2 μM of monensin, which 
acts by blocking the transport between the endoplasmic reticulum and the Golgi complex 
(Luttmann et al. in: The Experimentator Immunologie), was aggregated and incubated for 
further 3 hours to allow intracellular accumulation of secreted proteins. Cells were further 
washed and antibodies against surface markers were incubated for 10 min at 4°C in darkness. 
For fixation, paraformaldehyde solution (PFA) at a concentration of 1% (p/v) was used, and 
cells were incubated overnight (O.N.) at 4°C. After washing the cells, antibodies for the detec-
tion of intracellular proteins were incubated 20 min at 4°C in darkness, diluted in saponin 
0.1% (p/v), a detergent solution for permeabilization of the cells. After this incubation, cells 
were washed with saponin solution, in order to remove excess of intracellular antibodies. The 
labelled cells were finally resuspended in FACS buffer and analyzed in a FACS Calibur (Bec-
ton Dickinson) cytometer. The lymphocyte population was gated based on size and granular-
ity and used for further analysis. When only analysing extracellular markers, incubation with 
PMA, ionomycin and monensin was avoided. 
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Fig. 16 : Principle of flow cytometry. 
Figure modified from Abbas and Lichtmann, 2003. Briefly, cells pass one at a time through a fluorimeter with a 
laser-generated incident beam and the light that emerges from the sample is analyzed for forward and side scatter 
(size and granularity, respectively) as well as fluorescent light of two or more wavelengths that depend on the 
fluorochrome labels attached to the antibodies. The example represented here is based on a staining of two anti-
genic markers.  
All washing steps were performed using FACS washing buffer (1% bovine albumin serum in 
PBS). Samples were analyzed in a FACS Calibur (Becton Dickinson, Heidelberg, Germany). 
Negative controls were performed by using the respective isotype controls, and cells without 
antibodies were also included as negative controls. 
The extra- and intra-cellular markers analyzed included: 
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Extra-cellular markers: 
CD3: PerCP anti-mouse CD3e (CD3ε chain), diluted 1:100 
CD4: detected with FITC anti-mouse CD4 (L3T4), diluted 1:100 
CD8: detected with PE-Cy5 anti-mouse Cd8a (Ly-2), diluted 1:100 
CD69: detected with PE-Cy7 labeled anti-mouse CD69 (VEA Antigen) (H1.2F3) 
CD95: detected with PE-Cy7 labeled anti-mouse CD95 (Jo2) 
Intra-cellular markers: 
IL-10: detected with PE-rat anti-mouse IL-10, diluted 1:200 
IL-4: detected with PE-rat anti-mouse IL-4, diluted 1:200 
TNF-α: detected with PE labelled anti-mouse TNF-α, diluted 1:200 
IFN-γ: detected with PE anti-mouse IFN-γ, diluted 1:200 
 
3.2.1.5 DNA Isolation 
Placenta, liver and fetuses from animals receiving adenoviruses were snap-frozen in liquid 
nitrogen and kept at –80°C until use. DNA extraction from tissue homogenates was performed 
using the peqGOLD Tissue DNA Mini Kit. For that, livers, fetuses and placentas (30 mg of 
tissue or less) were grinded in a mortar using a pistil under the influence of liquid nitrogen. 
Samples were taken up in TL Buffer, and after adding OBTM protease, samples were incubated 
at 55°C in a shaking water bath for at least three hours. After that, isolation was performed 
following manufacturer´s instructions, using HiBind® DNA columns for the specific binding 
of DNA. After two washing steps, samples were eluted with elution buffer and kept at -20°C 
until further use.  
3.2.1.6 Measurement of adenoviral particles in tissues by Real Time PCR 
SYBR Green chemistry is an alternate method to the method using fluorescent probes used to 
perform real-time PCR analysis. SYBR Green is a dye that binds the Minor Groove of double 
stranded DNA (Applied Biosystems Manual). When SYBR Green dye binds to double 
stranded DNA, the intensity of the fluorescent emission increases. As more double stranded 
amplicons are produced, SYBR Green dye signal will increase. The SYBR Green dye will 
bind to any double stranded DNA molecule, while the 5′ Nuclease assay (explained later) is 
specific to a pre-determined target. For this reason, primers designed for this methodology 
have to be very specific and should not form any dimmers. To analyze whether this occurs, it 
is necessary to perform a melting curve, which plots the fluorescence as a function of the 
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temperature as the thermal cycler heats through the dissociation temperature of the product. 
The shape and position of this melting curve are functions of the GC/AT ratio, length and se-
quence and can be used to differentiate desired and undesired amplification products (Ririe et 
al., 1997).  
In the real time PCR methodology, the reactions are characterized by the time point during 
cycling when amplification of a PCR product is first detected. The higher the starting copy 
number of the nucleic acid target, the sooner a significant increase in the fluorescence is ob-
served. The parameter CT (threshold cycle) is defined as the fractional cycle number at which 
the reporter fluorescence generated by the cleavage of the probe passes a fixed threshold 
above base line. 
Amplifications reactions (13 μl) were performed by mixing 1 μl DNA, 6,25μl Master mix 
(Stratagene, Heidelberg, Germany) containing PCR Buffer, dNTPs, MgCl2, Ampli-Taq DNA 
Polymerase and SYBR-Green, 3 μl of the primer mix and 2,75 μl water. PCR reaction was 
performed as follows: 2 min at 50° C followed by an initial denaturation step of 10 min at 
95°C, followed by 15s at 95°C and 1 min at the appropriate annealing temperature (60°C) for 
40 cycles. The measurement of adenoviral particles was performed by detecting GFP or viral 
constructs. All reactions were performed on the ABI Prism 7700 Sequence Detection System 
(Perkin Elmer Applied Biosystems). As intra-laboratory controls, non-related DNA samples 
were checked for their viral expression showing negative values. The sequences of the prim-
ers used are shown in Table 1.  
Table  1 : Sequences of the primers used for GFP detection by real time PCR 
 Primer sequence (5´Æ3´) 
fw: CGTGGGCTCCAGCATTCTA 
Apob 
rev: TCACCAGTCATTTCTGCCTTTG 
fw: TGCAGTGCTTCAGCCGCTA 
GFP 
rev: AAGATGGTGCGCTCCTGGA 
 
The primers for GFP were used at a concentration of 900 nM for forward and 900 nM for re-
verse primers. The primers for Apob were used at a concentration of 300 nM for forward and 
300 nM for reverse primers. Optimal primer concentrations were determined by titration of 
the primers with DNA samples from a GFP+ animal (titration done by Nadja Ahmad during 
 - 57 -
Materials and Methods 
---------------------------------------------------------------------------------------------------------------------------------------- 
her Diploma Thesis in our laboratory), where the expression of GFP was linked to Apo-b ex-
pression. 
3.2.1.7 Pre-treatment of slides with 3-aminopropyltriethoxysilane (APES) 
Solutions of APES are normally used to treat glass slides. The silane reacts with the –OH 
group of glass, covalently linking aminoalkyl groups to the glass. The resultant surface acts 
“sticky”, promoting the binding of the tissue to the glass. For the treatment of the glass slides, 
they were soaked in a solution of 2% APES in methanol and washed twice with distilled wa-
ter. Slides were dried completely in the oven and were then ready to use for paraffin as well 
for cryosections.  
3.2.1.8 Detection of GFP by fluorescence microscopy 
In order to detect the expression of the green fluorescent protein by fluorescence microscopy, 
placental tissues as well as placental tissue bound to fetuses were cut in cryostat in 8 μm thick 
samples. After fixing the samples for 10 min with PFA 4%, samples were dried and kept at 
-20°C until use. For analysis of GFP expression, samples were mounted with DAPI and ob-
served under fluorescence microscope.  
3.2.1.9 Paraffin embedding of the tissues 
Paraffin embedding of the tissues was performed following a well-established protocol 
(Saint-Marie, 1963).  For doing that, tissues were fixed in 96° ethanol at 4°C for 1-7 days, 
following the proportion of 50 ml alcohol/g tissue. After that, following incubations were per-
formed: 
Dehydratation: -Ethanol 100° at 4°C, 1-2 h, with 4x changes 
 -Xylol at 4°C, 1-2 h, with 2 changes 
 -Xylol at RT, 1-2 h, with 1x change 
Inclusion: -Paraffin at 56°C, 1-2 h 
After inclusion in paraffin, tissues were kept at 4°C. 
For cutting the tissues, a microtome was used, and all tissues were cut in 5 μm thick speci-
mens and placed in slides previously covered with 3-aminopropyltriethoxysilane. Samples 
were allowed to dry at 37°C O.N. and were finally kept at R.T. 
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3.2.1.10 Dewaxing of the tissues 
In order to perform an immunostaining, it is necessary to first remove the paraffin in the cuts. 
For doing that, the following incubations were performed: 
Dewaxation: Xylol, 2 x 20 min 
Fixation/Hydration: Ethanol 100°, 10 min 
 Ethanol 95°, 10 min 
 Ethanol 75°, 10 min 
 Distilled water, 5 min 
 
3.2.1.11 Hematoxilin-Eosin staining 
In order to analyze the morphology of the tissues (placenta, decidua and resorptions), a stain-
ing with Hematoxylin and Eosin, which stain nucleus and cytoplasm of the cells respectively, 
was performed. For doing this, following incubation steps were performed: 
- Distilled water, 5 min 
- Hematoxylin, 2 min 
- Tap water, 5 min 
- Eosin, 10 sec. 
- Ethanol 75°, 10 sec, with agitation 
- Ethanol 95°, 10 sec, with agitation 
- Ethanol 100°, 2 x 10 sec, with agitation 
- Xylol, 2 x 5 min 
After that, slides were mounted with Roti-Histokitt and analyzed under light microscope.  
3.2.1.12 Immunohistochemistry (IHC) 
Immunohistochemistry (IHC) consists in the detection of specific antigens in histologic tissue 
sections by the use of a system consisting in a specific antibody for the antigen of interest. 
This enzyme coupled system allows the conversion of a colorless substrate into a colored in-
soluble substance that precipitates at the site where the antibody an thus the antigen are local-
ized (Abbas and Lichtmann in: Cellular and Molecular Immunology). The specific antibody 
 - 59 -
Materials and Methods 
---------------------------------------------------------------------------------------------------------------------------------------- 
can be directly coupled to the enzyme, or a secondary antibody recognizing the first specific 
antibody can be the one coupled to the enzyme. Another possibility, normally used to amplify 
the signal and thus detect low expressed antigens, is the use of a specific primary antibody, 
which is recognized by a secondary antibody coupled to biotin. This biotin is then recognized 
by avidin coupled to an enzyme, normally horse radish peroxidase (HRP). This methodology 
is normally known as ABC system (Avidin-Biotin-Complex), and was routinely used in the 
experiments done in the course of this doctoral thesis. 
IHC was performed for each molecule of interest on tissue pieces containing placenta and 
decidua. After dewaxation, the sections were washed with Tris buffered saline solution (TBS, 
pH = 7.40) for 10 min and treated with 3% hydrogen peroxide in methanol for 30 min at RT 
to block the endogenous peroxidase activity, which is very high in placental tissue. The tissues 
were then washed and exposed to 5% BSA in TBS for 20 min at RT for protein blocking, 
stained with the primary antibody (Ab) diluted in 5% BSA in TBS, and incubated O.N. at 
4°C. The tissues were then washed and further stained with the secondary Ab diluted in 
5% BSA for 1 h at RT. After washing, the samples were incubated for 30 min with an AB-
Complex/HRP solution. Finally, the sections were developed with AEC+ Substrate Chro-
mogen, counterstained with Hematoxylin and mounted. Negative controls were obtained by 
replacing the first antibody with 5% BSA or 10% rabbit serum. 
The dilutions of the primary and secondary antibody used in each case are indicated in Ta-
ble 2.  
 
Table  2 : Dilutions of the antibodies used for immunohistochemical staining 
Molecule of 
interest 
First antibody Secondary antibody 
HO-1 1:100 1:100 
HO-2 1:500 1:100 
CD3 1:20 1:100 
VEGF 1:100 1:200 
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For the analysis of the results, samples were analyzed under a light microscope, by counting 
the number of positive cells (for VEGF and CD3 staining). In these cases, where only some 
cells were positive for the markers, the number was determined counting the number of cells 
per field. Each field consisted in a 0.25 mm2 square coupled to the ocular of the microscope. 
Using a magnification of 200X (20X objective and 10X ocular magnification), at least 20 rep-
resentative fields per sample were counted, and the results were expressed for each sample as 
the mean of cells per mm2. The analysis was performed without knowing the nature of the 
samples and was confirmed by an independent observer. 
In the case of HO-1 and HO-2 staining, where almost all cells were stained for HO-1 and 
HO-2 expression, the analysis was performed for each cell type independently. The expression 
levels were set by using scores from 0 (no staining) to 6 (very intense staining) for every cell 
type without knowing the nature of the samples, and the results were again confirmed by an 
independent observer. 
3.2.1.13 Protein isolation 
For protein extraction from tissues, frozen specimens were re-suspended in 500 µl Lysis-
buffer containing CHAPS, HEPES and DTT. The buffer used was the one recommended for 
caspase activity measurement (explained later). The samples were homogenized using a glass 
homogenizer. After isolation, homogenates were centrifuged for 10 min at 10.000 g, and the 
supernatant containing the proteins was transferred to a fresh tube. Protein concentration was 
assessed using the BioRad Protein Assay as indicated by the manufacturer. Protein samples 
were kept at -80°C and when working with them, they were always kept on ice. 
For isolation of proteins from cells, 5 x 105 cells were washed with PBS and resuspended in 
50 μl of Lysis Buffer containing Protease Inhibitor and used immediately or kept frozen at 
-70°C until use. For the preparation of the samples, the cell suspension was centrifuged 5 min 
at 15000 g at 4°C and the supernatant containing the proteins was further transferred to a fresh 
tube. 
3.2.1.14 Measurement of Caspase-3 Activity  
The caspase-3 colorimetric assay is based on the hydrolysis of the peptide substrate acetyl-
Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA) by caspase-3, resulting in the release of the 
p-nitroaniline (pNA) moiety by the following reaction: 
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For doing this assay, placentas were snap-frozen in liquid nitrogen and kept in –80°C until 
use. For extracting proteins, a lysis buffer containing 5 mM CHAPS, 50 mM HEPES and 
5 mM DTT was used. It is very important that the proteins are lysed in a buffer without prote-
ase inhibitors, since they can interfere in the reaction, especially cysteine protease inhibitors. 
The determination of total protein concentration was performed using the Bio-Rad Protein 
Assay Dye Reagent with a calibration curve performed with bovine serum albumin standards. 
The determination of the caspase-3 activity was performed in 96-well plates by means of the 
colorimetric Caspase-3 Assay Kit (Sigma) using 50 μg of total protein/sample and following 
manufacturer’s instructions. Three controls were included: an inhibitor-treated lysate control 
for measuring the non-specific hydrolysis of the substrate, a caspase-3 positive control pro-
vided with the kit, and a reagent blank.  Briefly, the following schema was followed (Table 3): 
Table  3 : Scheme of the procedure for the determination of caspase-3 activity. 
 
Cell lysate 
Caspase 3 
2 μg/ml 
1x Assay 
Buffer 
Caspase-3 
Inhibitor 
Caspase-3 
Substrate 
Reagent Blank - - 90 μl - 10 μl 
Sample 5 μl - 85 μl - 10 μl 
Sample + Inhibitor 5 μl - 75 μl 10 μl 10 μl 
Caspase-3  
positive control 
- 5 μl 85 μl - 10 μl 
Caspase-3  
positive control  
+ Inhibitor 
- 5 μl 75 μl 10 μl 10 μl 
For each sample, a control using an inhibitor was used. Positive controls as well as reagent blanks were included 
in each plate assayed.  
The test was performed in 96-well plates. Each setting was made in duplicate for each sample. 
Plates were incubated O.N. at 37°C, and the optical density (O.D.) was finally measured at 
405 nm.  
The calibration curve was made using a p-nitroaniline standard provided by the manufacturer. 
The concentration of the stock solution was determined by measuring the O.D. at 405 nm and 
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calculating it taking into account the εmM of 10.5. In each plate, the calibration curve was 
done in duplicate in serial 1:2 dilutions ranging from 200 μM until 12.5 μm. 
For calculating the Caspase-3 Activity, the following formula was used: 
 
where: 
t= incubation time (min); d= dilution; V= volume of sample in ml 
μmol pNA was calculated for each well using the pNA calibration curve. 
3.2.1.15 In situ cell death detection by TUNEL technology 
The cleavage of genomic DNA during apoptosis may yield double-stranded, low molecular 
weight DNA fragments as well as single strand breaks, or nicks, in high molecular weight 
DNA. Those DNA strand breaks can be identified by labelling free 3’-OH termini with modi-
fied nucleotides in an enzymatic reaction. The In Situ Cell Death Detection Kit labels DNA 
strand breaks by Terminal deoxynucleotidyl transferase (TdT), which catalyses the polimeri-
zation of labeled nucleotides to free 3’-OH DNA ends in a template-independent manner 
(TUNEL reaction). The incorporated fluorescein is detected by anti-fluorescein antibody Fab 
fragments, conjugated with horse-radish peroxidase (POD). After substrate reaction, stained 
cells can be analyzed under light microscope. 
The detection of apoptotic cell death at single cell level was performed in tissues containing 
placenta and decidua following manufacturer’s instructions. However, a modification of the 
temperature of incubation was performed. In the current protocol, the TUNEL reaction mix-
ture and the Converter-POD were incubated at RT instead of 37°C. The modification was per-
formed based on the observation of unspecific staining of the cytoplasm of the cells when 
using the 37°C incubation while establishing the staining. Briefly, paraffin sections were de-
waxed and hydrated as usual, followed by a permeabilization of the samples. For that, slides 
were treated with citrate buffer pH 6 for 5 min at 600 W in a microwave. After cooling of the 
slides, they were washed twice with PBS. The endogenous peroxidase activity of the samples 
was blocked with 3% H2O2 in methanol for 30 min at RT. After washing the slides twice with 
PBS, a protein blocking was performed during 20 min at RT using a buffer containing 
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3% BSA and 20% SFB in Tris-HCl pH 7.5. The TUNEL reaction mixture was added to the 
samples, and incubated in a humified chamber for 60 min at RT. For negative controls, label 
solution instead of TUNEL reaction mixture was added. After the incubation, the samples 
were washed twice with PBS, and a Converter-POD solution was added. After 30 min of in-
cubation at RT, tissues were washed twice with PBS and developed using the AEC+ Substrate 
Chromogen, counterstained with Hematoxylin and mounted with Aquatex. 
For the quantification of the number of apoptotic cells, stained nuclei were identified and 
counted per field. Each field consisted in a 0.25 mm2 square coupled to the ocular of the mi-
croscope. Using a magnification of 200X (20X objective and 10X ocular magnification), at 
least 20 representative fields per sample were counted, and the results were expressed for each 
sample as the mean of cells per mm2. The analysis was performed without knowing the nature 
of the samples and was confirmed by an independent observer. 
3.2.1.16 SDS-Polyacrilamide gel electrophoresis (SDS-PAGE) 
When an electric field is applied to a solution containing protein molecules, these molecules 
migrate in a direction and at a speed that reflects their size and net charge. This is the basis of 
the technique called electrophoresis (Alberts et al. in: Essential Cell Biology, 2004). When 
proteins are mixed with negatively charged molecules of sodium dodecyl sulfate (SDS), the 
negatively charged SDS-protein complex will migrate through a porous polyacrilamide gel to 
the anode. When protein samples are treated like this, they will migrate at a rate that reflects 
only their molecular weight, since they are all be negatively charged by an excess of SDS. A 
reducing agent as like mercaptoethanol is usually added to break any S-S linkage in or be-
tween proteins.  
Proteins isolated from tissues or from cells were mixed with a sample buffer containing SDS, 
β-mercaptoethanol and bromophenol blue and heated for 5 min at 95°C in order to allow the 
complete denaturalisation of the proteins. The same procedure was carried out with the pro-
tein marker. Samples were transferred to an acrylamid/polyacrylamid running gel with a 5% 
stacking gel. Electrophoresis was performed at 150 V until its end. 
3.2.1.17 Western Blot 
Blotting is the technique of transferring electrophoretic products onto other materials prior to 
visualisation. Western Blot, specifically, is the transfer (or blotting) of proteins to a membrane 
(Acquaah in: Understanding Biotechnology, 2004). The membrane is then sequentially ex-
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posed to solutions containing a primary antibody, followed by a secondary antibody to which 
an enzyme or biotin is coupled. Here, after finishing of the SDS-PAGE, proteins were trans-
ferred into a nitrocellulose membrane. For doing this, the following schema was followed: 
 
When using the semi-dry blot method, the protein transfer took place during 30 min at 
250 mA. When using the wet blot method, protein transfer took place during 2 h at 180 mA. 
For verifying the full protein transfer, the nitrocellulose membranes were stained with Pon-
ceau Red for 3 min, and further decoloured using distilled water (dH2O). 
The expression of HO-1 was analyzed (in the membrane) by immunoblot as follows: 
The membrane was blocked with 5% milk powder in TBS for 1h at R.T., and further washed 
with TBST, 3 x 5 min each time. The first antibody (rabbit anti rat-HO-1 polyclonal antibody, 
diluted 1:2000 in 5% milk in TBS) was applied for 2 h at R.T. After washing with TBST, the 
samples were incubated with the secondary antibody (anti-rabbit horseradish peroxidase, di-
luted 1:5000 in 5% milk in TBS) for 1 h at R.T. The membrane was washed again, and the 
reaction was finally developed by using chemoluminiscence (ECL Assay of Amersham) and 
exposed onto Kodak Miomax MR Imaging film. The intensity of the bands was quantified by 
using the Quantity One® Software, Version 4.5.2 from Bio-rad. 
 
3.2.1.18 RNA Isolation 
One placenta and decidua of each animal were snap-frozen in liquid nitrogen and kept in 
-80°C until preparation. RNA extraction was performed using Trizol Reagent, which is a mo-
nophasic solution of phenol and guanidine isothiocyanate, and represents an improvement to 
the single step RNA isolation method developed by Chomczynski and Sacchi (1987). Briefly, 
tissues were homogenized in Trizol using an Ultra-Turrax T25 homogenizer. After adding 
chloroform and vortexing for 2 min at RT, samples were centrifuged at 10.000 g for 10 min at 
4°C. The upper phase obtained after the centrifugation was then transferred to a new tube, and 
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ice-cold ethanol was added. After an incubation of 10 min at -20°C, samples were centrifuged 
for 10 min at 10.000 g at 4°C. The pellet obtained after this centrifugation was then washed 
three times with ethanol 80°, in order to remove the rest of Trizol reagent. Between each wash 
step, cells were centrifuged for 10 min at 10.000 g and 4°C. After the last wash, the pellet was 
allowed to dry and it then was resuspended with RNase free water. In case that the pellet was 
not immediately resuspended, samples were kept at 4°C to allow pellet resuspension. RNA 
concentration was determined by measuring the O.D. at 260 nm and at 280 nm. To calculate 
the RNA concentration, the following formula was used: 
 
3.2.1.19 cDNA Synthesis 
Samples containing 2 μg of total RNA were placed for 2 min on ice and added with dNTPs 
(2,5 mM), Amersham Pharmacia), DNase I (2U/μl, Stratagene) and RNase-Inhibitor (40 U/μl) 
mixed in reaction buffer. The mix was incubated for 30 min at 37°C and further heated to 
75°C for 5 min. The addition of the reverse transcriptase (200 U/μl) and RNase-inhibitor in 
distilled water started the reverse transcription. This reaction mixture was incubated at 42°C 
for 60 min followed by incubation at 94° C for 5 min.  
As negative controls, we performed a so called RT- control, which consists in the same mix-
ture, but avoiding the aggregate of Reverse Transcriptase. This control was done in order to 
check the samples for contamination with genomic DNA.  
Once the cDNA synthesis was completed, the samples were immediately used or kept at 
-20°C. 
3.2.1.20 TaqManTMPCR 
The Real-Time TaqManTM PCR is a sensitive, reproducible and specific method for the quan-
tification of mRNA. Together with the specific primers for the gene of interest, an oligonu-
cleotid fluorescence probe is used. The probe is marked at the 5´end with a fluorescent re-
porter-dye (6-Carboxyfluorescein, FAM) and at the 3´end with a quencher-dye (6-carboxy-
tetramethyl-rodhamin, TAMRA). While the probe is intact, the proximity of the quencher re-
duces the fluorescence emitted by the fluorescent dye. During the PCR, if the target sequence 
is present, the probe anneals downstream from one of the primer sites and is cleaved by the 
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5´-exonuclease activity of Taq polymerase as the primer is extended. Then, the cleavage of the 
probe separates the reporter dye from the quencher, increasing the reporter dye signal. Addi-
tional reporter dye molecules are cleaved with each cycle, which produces an exponential 
increase in the fluorescence intensity that is proportional to the amount of the amplicon pro-
duced (Fig. 17). 
In the real time PCR methodology, the reactions are characterized by the time point during 
cycling when amplification of a PCR product is first detected. The higher the starting copy 
number of the nucleic acid target, the sooner a significant increase in the fluorescence is ob-
served. The parameter CT (threshold cycle) is defined as the fractional cycle number at which 
the reporter fluorescence generated by the cleavage of the probe passes a fixed threshold 
above base line. 
 
 
Fig. 17 : Principle of the TaqManTM PCR Reaction (Figure taken from the Applied Biosystems´s user 
manual) 
A) The 5´nuclease assay 
B) Polymerase collides with TaqMan® probe 
C) Cleavage of the TaqMan® probe 
 
The PCR reaction was developed using the ABI PRISMTM 7700 Sequence Detection Systems, 
which detects the fluorescence intensity. 
The primers and probes were designed using the Primer Express Software. The establishment 
of the primers, their titration and their efficiency determination through standard curves were 
performed at the Institute of Medical Immunology (Charité, Berlin) by Katrin Vogt, a member 
of the Institute. The sequences for primers and probes are detailed in Table 4. 
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For each sample, 1 μl of template was used together with 6 μl primer mix and 1 μl probe. The 
final volume of 25 μl was reached aggregating 12.5 μl Mastermix and 4.5 μl distilled water. 
For the PCR, the following cycle conditions were applied: 
50°C 2:00 min 
95°C 10:00 min 
95°C 0:15 min 
60°C 1:00 min 
40 cycles for each determination were performed. 
 
Table  4 : Sequences of primers and probes 
 Primer (5´Æ3´) Probe (5´Æ3´) 
Fw: GCTTCTTTGCAGCTCCTTCGTT β-actin 
rev: GTTGTCGACGACCAGCGC 
CAGCCTTCCTTCTTGGGTATGGAATCCT 
fw:GCTAACCACCTGCAAGAATTGAAT 
Bag-1 
rev: GTTTGCAGAGAGCCTCCGC 
TTCTGACATCCAGCAGGGTTTTCTGGC 
fw: TGAACCGGCATCTGCACA 
Bcl-2 
rev: CAGAGGTCGCATGCTGGG 
AACGGAGGCTGGGATGCCTTTGTG 
Fw: GGTGAGTCGGATTGCAAGTTG 
Bcl-xl 
r:GTAGAGATCCACAAAAGTGTCCCAG 
CCTGAATGACCACCTAGAGCCTTGGATCC 
fw: GGCTACCATGCCAACTTCTGTCT 
HO-1 
Rev: CCGGGTTGTGTTGGTTGTAGA 
CACACAGTACAGCAAGGTCCTTGCCCT 
fw:ATTGCGGGACAGGATGGAG 
CD3 
rev:CTTGGAGATGGCTGTACTGGTCA 
TCGCCAGTCAAGAGCTTCAGACAACGA 
Fw: CCCAGGAAAGACAGCAACCTT 
FoxP3 
Rev: TTCTCACAACCAGGCCACTTG 
ATCCTACCCACTGCTGGCAAATGGAGTC 
fw: GGCTACCATGCCAACTTCTGTCT 
TGF-β 
Rev: CCGGGTTGTGTTGGTTGTAGA 
CACACAGTACAGCAAGGTCCTTGCCCT 
Sequences are indicated in a 5´Æ3´direction 
3.2.1.21 Relative RNA Quantification 
A relative quantification of the mRNA expression is possible because of the use of a “house 
keeping gene”, which is constitutively expressed in all cell types. In all cases, β-actin was 
used as house keeping gene after confirming its constitutive expression in the analyzed tissues 
(decidua and placenta). 
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The determination of the ΔCT value is made using the formula: 
ΔCT= CT (gene of interest) – CT (“house keeping gene”) 
Due to the inverse proportional relationship between the Ct and the original gene expression 
level, and the doubling of the amount of the product with every cycle, the original expression 
level for each gene of interest is expressed as following: 
 
3.2.2 Studies using HO-1 over-expressing primary T cells 
3.2.2.1 Culture of primary T lymphocytes 
Spleen and lymph nodes were isolated from CBA/J females. Cells from spleen and lymph 
nodes were separately isolated. For spleen cells isolation, spleen tissues were crushed against 
a 100 μm net, collected in medium containing 10% FCS and the erythrocytes were lysed with 
lysis buffer containing NH4Cl, KHCO3 and EDTA for 10 min at R.T. After centrifugation, 
cells were washed once with complete medium and finally resuspended in RPMI containing 
10% FBS, Na-Piruvate, Penicillin, Streptomycin and β-mercaptoethanol and kept on ice until 
use. For lymph node cell isolation, lymph nodes were crushed against a 100 μm net, washed 
with complete medium, and after centrifugation resuspended in RPMI containing 10% FBS, 
Penicillin, Streptomycin, Na-Piruvate and β-mercaptoethanol. 
Different culture conditions were tested: a) stimulation of the cells with irradiated APCs from 
the male (DBA/2J) or b) polyclonal stimulation with anti-CD3 and anti-CD28. For stimula-
tion with male antigens, spleen and lymph node cells from DBA/2J were irradiated at 30 Gy, 
and immediately used. The cell amount was always the same as the one from the CBA/J fe-
male cells.  For polyclonal stimulation, 1μg/ml anti-CD3 and 0.1 μg/ml anti-CD28 were used. 
In both cases, 10 ng/ml of recombinant murine IL-2 (rmIL-2) were added to the culture (final 
concentration). Cells were routinely maintained at 37°C in a humified incubator with 5% 
CO2. When necessary, medium was changed for fresh medium containing rmIL-2 (normally at 
a 2-3 days interval). After one week in culture, cells were restimulated with either APC or 
anti-CD3/anti-CD28. The optimal cell amount was tested and 1.5 x 106 cells/ml were finally 
used.  
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The effect of antibodies against Th1 phenotype was also tested in our culture at a concentra-
tion of 5 μg/ml anti-IFN-γ and 5 μg/ml anti-TNF-α. In another setting, IL-4 was added to the 
cultures at a 10% of the final volume. IL-4 was obtained as a supernatant of the 3T3 BMG 
IL-4 cell line (kind gift of Prof. Werner Müller, Braunschweig). This was done in order to 
obtain majority of Th2 cells. 
3.2.2.2 Generation of retroviral vectors expressing HO-1 
Two different retroviral vectors expressing HO-1 were generated. Both retroviral vectors en-
code for the rat HO-1 gene, while the second construct express in addition the EGFP gene for 
tracing the transduced cells. The generation of these constructs was done according to stan-
dard procedures. Briefly, the rat HO-1 cDNA was used as template for PCR-amplification 
with specific primers introducing Xho-1 restriction sites on both ends of the PCR product. 
The resulting PCR-fragment was subsequently cloned into the pdrive cloning vector (Qiagen) 
to allow DNA-sequencing. Then, the HO-1 fragment was excised from pdrive and cloned into 
the pLXSN retroviral vector (Clontech). The correct orientation of the HO-1 transgene was 
confirmed both by restriction analysis and DNA-sequencing. For the generation of the bicis-
tronic retrovirus expressing both HO-1 and EGFP, a pLXSN-based construct containing an 
internal ribozyme binding site (IRES) followed by the EGFP-gene (kind gift of Dr. A. Flügel, 
Max-Planck-Institute of Neurobiology, Martinsried) was employed. A similar strategy as de-
scribed for the generation of pLXSNHO-1 was performed to obtain the bi-cistronic construct. 
The generation of both vectors was performed previously to the beginning of this thesis by 
Katrin Vogt, member of the Institute of Medical Immunology. 
3.2.2.3 Establishment of the packaging cell lines 
The retroviral gene transfer system needs basically two components: the packaging cell line 
and the retroviral vector. The retroviral vector is modified, being the genes gag, pol and env 
deleted. It contains the packaging signal Ψ+, and the 5 - and 3 –LTRs (Long Terminal Re-
peats), which flank the transgen and a selection marker. The packaging cell line contains the 
genes gag, env and pol. Once the packaging cell line is transfected with the retroviral vector, 
it is able to produce retroviral particles which are able to infect other cells, but are unable to 
replicate by themselves. 
The packaging cell line used was one derived from the NIH/3T3, called GP+E 86 (Dr. Flügel, 
Neurobiology, Munich). It was cultured under normal conditions, in T75 cm2 flasks, using 
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DMEM with 10% FCS, penicillin, streptomycin and glutamine, in an incubator with 5% CO2 
at 37°C. Routine passaging of the cells was performed using brief exposure to a trypsin-EDTA 
solution followed by vigorous agitation of the culture flask. The cells were frozen employing 
a solution containing 90% FCS and 10% DMSO. 
3.2.2.4 Transfection using calcium phosphate 
24 h before transfection, 2.2x106 GP+E 86 cells were seeded in 60 mm (21,5 cm2) dishes in 
DMEM with 10% FCS, in order to allow about 60-70% confluence on the next day. From two 
to four hours before the transfection, culture medium was replaced by 5 ml of fresh medium. 
The preparation of the phosphate-DNA suspension was made using 15 μg Plasmid DNA, 
31 μl 2M CaCl2, ad 250 μl distillate water and 250 μl 2x HBSP-Buffer. After 15 min at R.T., 
the suspension was mixed and dispensed drop by drop onto the cells. 12-24 h after the trans-
fection, medium was replaced for one containing 1 mg/ml G-418 in order to select the G-418 
resistant cells. 
Two different constructs, the pLXSN-HO-1, and the pLXSN-HO-1iresEGFP, were used. The 
efficient transfection and the over-expression of HO-1 in the both cell lines were verified by 
Western Blot analysis. Cells transfected with the HO-1iresEGFP vector were routinely 
checked for their EGFP expression under fluorescence microscope. 
3.2.2.5 Limiting dilution 
After verifying the HO-1 transgene expression through Western Blot, a limiting dilution 
method was used to obtain monoclonal cell lines from the polyclonal packaging cell line. This 
approach offers the possibility of select those clones with an optimal viral titer and transgene 
expression. To perform this, the following schemas followed: 
1 x 96 plates with 5 cells/well 
2 x 96 plates with 1 cells/well 
1 x 96 plates with 0.3 cells/well 
 
After 4 weeks under selection, the positive clones were tested again through Western Blot for 
the transgene expression, and those ones with the higher HO-1 expression were selected and 
further analyzed for their viral titer. 
 - 71 -
Materials and Methods 
---------------------------------------------------------------------------------------------------------------------------------------- 
3.2.2.6 Viral titer determination 
The viral titer determination was analyzed following the protocol proposed by the manufac-
turer (Clontech). In brief, 5 x 105 GP+E 86 cells were harvested two days before of the begin-
ning of the viral titer determination in a 25 cm2 flask. One day before transfection, NIH 3T3 
cells were plated at a density of 1.105 cells/well with 2 ml medium/well in 6-well plates. 
Lastly, for viral titer determination, the supernatants of the packaging cell lines were filtered 
through 0.45 μm cellulose acetate filters. Serial dilutions of the supernatant were made, from 
1.10-1 until 1.10-8, and the NIH 3T3 cells were infected by adding 1 ml of the diluted virus 
medium (day 0). The dilution medium contained polybrene (final concentration = 8 μg/ml). 
The selection with G-418 began 24 h after the infection, followed by a medium change, on 
day 6. On day 12 after infection, the colonies were counted under the microscope, and the 
viral titer corresponded to the number of colonies present at the highest dilution which con-
tains colonies, multiplied by the dilution factor. 
3.2.2.7 Concentration of viral supernatants by means of centrifugation 
Since the titer of retroviral particles was not always sufficient to achieve good percentages of 
transduction, a concentration of the viral particles was aimed by means of centrifugation of 
the supernatant containing the viral particles. For that, supernatants from the packaging cell 
lines were collected and filtered through 0.45 μm filters to remove possible dead cells o cell 
debris present in the supernatant. Filtered supernatants (15 ml) containing the retroviruses 
were transferred into Vivaspin 20 tubes with a 100000 MWCO PES membrane and centri-
fuged for 30 min at 3300 r.p.m. at 4°C. After this first centrifugation, 15 ml of filtered super-
natant were further added and centrifuged for 45 min at 3300 r.p.m. Concentrated super-
natants were immediately used. 
3.2.2.8 Isolation and culture of cells from CBA/J females  
T cells were isolated from spleen and lymph nodes from CBA/J females, and treated for 10 
min at RT with lysis buffer containing ammonium chloride, potassium hydrogen carbonate 
and EDTA, and further washed twice with medium containing 10% FBS. These cells were 
then cultured under the presence of antigen presenting cells (APCs) from a DBA/2J male iso-
lated similarly from spleen and lymph nodes and treated with lysis buffer. These APCs were 
irradiated at 30 Gray (Gy) and co-cultured with the CBA/J cells, putting the same cell number 
of CBA/J and irradiated DBA/2J cells. 
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After observing that these cells were poorly stimulated with DBA/2J cells, other stimulation 
condition was tested, namely stimulation with anti-CD3 and anti-CD28 antibodies. For that, 
cells were cultured in the presence of 1 μg/ml anti-CD3 and 10 ng/ml anti-CD28 and in the 
presence of 10 ng/ml rmIL-2. For maintenance of the culture, medium was changed every two 
days, and rmIL-2 concentration was maintained at the same concentration, but no further anti-
CD3 or anti-CD28 was added to the culture. Although a cell suspension containing different 
type of cells was isolated, the stimulation protocols tested were aimed to stimulate only T 
cells to proliferate.  
3.2.2.8.1 CD4+ T cell isolation 
CD4+ T cells were isolated from lymph nodes of CBA/J females using the MACS CD4+ T cell 
negative selection kit following the manufacturer´s instructions. Briefly, a cell suspension 
from lymph nodes was stained with a cocktail of streptavidin conjugated antibodies against all 
cells except CD4+ T cells. Subsequently, cells were incubated with biotin conjugated ferro-
magnetic microbeads. The suspension was passed through a magnetic column, allowing the 
CD4+ T cells to be collected as a negative fraction. After centrifugation of the cells, the cell 
pellet was resuspended in T-cell media and cells were counted. A representative fraction of the 
sample was taken in order to analyze the purity of the isolated cells by flow cytometry. 
CD4+ T cells were then cultured at a concentration of 1.5 x 106 cells/ml in 12 well plates with 
1.5 ml/well. Polyclonal stimulation was performed as previously described and cells were 
routinely maintained in medium containing 10 ng/ml rmIL-2. 
3.2.2.8.2 CD4+CD25+ regulatory T cells isolation (Treg) 
CD4+CD25+ T cells (known as Treg) and CD4+CD25- T cells (reportedly T-effector cells) 
were isolated from thymus using the MACS CD4+CD25+ regulatory T cell isolation kit fol-
lowing manufacturer´s instructions. Briefly, cells were resuspended in MACS Buffer, fol-
lowed by addition of Biotin-Antibody Cocktail. After 10 min of incubation at 4°C, MACS 
buffer, biotin microbeads and CD25-PE antibody were added. Cells were additionally incu-
bated for 15 min at 4°C and the reaction was stopped by adding MACS buffer. Cells were 
centrifuged at 300 g for 10 min, and the cell pellet was resuspended in MACS Buffer. Non-
CD4+ T cells were depleted by using a LD Column, which allows the CD4+ T cells to pass 
through as a negative fraction. After centrifugation of the isolated CD4+ T cell fraction, the 
magnetic labelling of CD25+ cells was performed. For doing this, cells were resuspended in 
MACS buffer, and anti-PE microbeads were added. Cells were incubated in darkness for 
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15 min at 4°C, and the reaction was stopped by adding MACS buffer and centrifuging at 
300 g for 10 min. Cells were resuspended in MACS buffer and the magnetic separation was 
performed in a MS column. CD4+CD25- cells were allowed to pass through the magnetic col-
umn and collected in a tube, and after removing the column from the magnetic field, 
CD4+CD25+ cells were flushed out by adding MACS buffer. Both fractions were centrifuged 
at 300 g for 10 min, resuspended in T cell media and counted. Representative samples of each 
fraction were taken in order to analyze the purity of the isolated cells by flow cytometry. 
3.2.2.9 Retroviral transduction of mouse T lymphocytes  
The aim of this part of the study was to obtain T lymphocytes over-expressing HO-1. Since 
retroviral vectors are able to permanently transduce cells, different conditions were tested in 
order to obtain enough number of T cells over-expressing HO-1.  
The following conditions were tested: co-culture of packaging cell line and T-lymphocytes, 
culture of T-lymphocytes with supernatant containing the retroviruses, and culture of the cells 
with a concentrated supernatant. Every condition is described below: 
3.2.2.9.1 Co-culture of packaging cell line and T-lymphocytes 
This co-culture was performed in order to have the packaging cell line constantly producing 
retroviral particles during the proliferation process of the T cells under stimulation with anti-
gen presenting cells (APCs) or under the stimulation with anti-CD3 and anti-CD28 antibodies 
in the presence of rmIL-2.  For that, cells from the packaging cell line were cultured O.N. in 
96-well plated with U-bottom in a concentration from 1x103 to 1x105 (different conditions 
tested). Once adhered to the plate, the supernatant was taken and CBA/J cells (cultured under 
the conditions explained in 3.2.2.8) were added, at a concentration from 1.103 to 1x105 (dif-
ferent conditions tested). After 48 h of co-culture in the presence of polybren (tested at 4, 6 
and 8 μg/ml), supernatant containing cells in suspension was taken, aiming to let the packag-
ing cells adhered to the plate. Cells previously obtained from CBA/J females were further 
cultured and analyzed for transduction efficiency. 
3.2.2.9.2 Culture of T-lymphocytes with supernatant containing the retro-
viruses 
In order to avoid contamination of the T-lymphocyte culture with cells from the packaging 
cell line, transduction was attempted by means of the supernatant containing the retroviral 
particles, following a protocol described by Hori et al. (Hori et al., 2003). For that, 2.5 x 105 T 
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cells from a CBA/J female were cultured in the presence of 5 x 106 APCs from the male 
(DBA/2J), previously irradiated at 30 Gy in a 24 well plate, and after 24 h of culture half of 
the volume was replaced by virus supernatant, previously filtered through 0.45 μm filters and 
containing polybren (at a final concentration of 4, 6 or 8 μg/ml). This procedure was also 
tested stimulating cells with anti-CD3 and anti-CD28 as previously described (3.2.2.8), as 
well as in 12 and 96 well plates.  
3.2.2.9.3 Culture of T-lymphocytes with concentrated supernatant contain-
ing the retroviruses 
Since the transduction of total cells from CBA/J using the previous conditions was not suc-
cessful, a new protocol was tested using CD4+ T cells previously isolated using magnetic cell 
separation (as explained in 3.2.2.8.1). In brief, cells from CBA/J females were cultured for 24 
h using anti-CD3/anti-CD28 stimulation in the presence of rmIL-2 in 12-well plates with a 
total volume of 1.5 ml/well with 1.5 x 106 cells/ml. 1 ml of cell supernatant was carefully re-
moved, and 500 μl of concentrated retroviral supernatant as well as 500 μl of media contain-
ing rmIL-2, anti-CD3 and polybren were added. The final concentration of polybren in the 
culture was 4 μg/ml. The transduction took place for 24 h, and 1 ml of media of the cells was 
replaced for fresh medium containing anti-CD3 and rmIL-2. Cells were further incubated at 
37°C and were eventually measured for HO-1iresEGFP expression by flow cytometry.  
3.2.2.10 Protein Transfection 
The protein transfection was performed by using ChariotTM, which forms a non-covalent 
compound with the protein of interest, in our case HO-1. This complex bypasses the transcrip-
tion-translation process associated with gene expression. The complex formed stabilizes the 
protein, and helps to protect it from degradation during the transfection process. Upon inter-
nalisation, the complex dissociates and the macromolecule is free to proceed to its target or-
ganelle.  
No protocol was available for the transfection of primary lymphocytes, therefore various con-
ditions were tested in this work and the protocol was adapted for CD4+ lymphocytes in cul-
ture. Briefly, for each well to be transfected, 3.5 μl of Chariot were dissolved in 100 μl of ster-
ile water, and 2 μg of the protein of interest (HO-1, Stressgen) was dissolved in 100 μl of 
PBS. These two solutions were mixed up carefully and incubated at RT for 30 min. During 
this incubation time, a specific number of cells (2 x 106 per well) were washed twice with 
PBS and further centrifuged. After incubation, the pellet of washed cells was resuspended in 
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200 μl of the Chariot-protein complex, and placed in a 12-well plate. After adding 150 μl of 
RPMI without serum, cells were incubated for 30 min at 37°C in a CO2 incubator, and 1 ml of 
RPMI with serum was added to stop the protein transfection and to avoid the damage of the 
cells. Cells were further incubated for 30 min-1h and used.  
Protein transfection using β-galactosidase (provided by the manufacturer of the transfection 
kit) was used as a positive control to determine the percentage of transfection. Although it has 
to be considered that both proteins differ in structure and the transfection may not be the 
same, it was used as an internal control to verify whether the transfection has worked, since it 
was no colorimetric method available to analyze whether HO-1 has entered the cells. In addi-
tion, for HO-1, the transfection efficiency was checked by analysing the HO-1 protein content 
by Western Blot.  
3.2.2.11 Measurement of β-galactosidase activity by hydrolysis of fluorescein 
di-β-D-galactosidase (FDG) 
The principle of the measurement of the β-galactosidase activity is based in the stepwise hy-
drolysis of fluorescein-di-β-galactosidase (FDG) by β-galactosidase (Huang, 1991), which is 
measured by flow cytometry. The measurement of the activity of the β-galactosidase was per-
formed following a protocol described by Nolan et al., 1988. The reaction was performed at 
37°C. Briefly, up to 1 x 106 cells were resuspended in 100 μl pre-warmed media and placed in 
pre-warmed tubes. After that, 100 μl of a pre-warmed 2mM solution of FDG was added, and 
the reaction took place for 1 min 30 sec at 37°C. The reaction was stopped by adding 1.8 ml 
of ice cold medium and vortexing. After incubation of the cells for 1 h on ice protected from 
light, cells were placed in 5 ml Falcon tubes and washed with FACS Buffer. After centrifuga-
tion of the cells, they were fixed with 1% PFA O.N. After washing the cells, they were meas-
ured on a flow cytometer, being FDG detectable on FL-1H. 
3.2.2.12 Mixed leukocyte culture (MLC) 
The mixed leukocyte culture (MLC) test (Bain et al., 1964, Bach and Hirschhorn, 1964) is 
widely used in the transplantation field in order to study the histocompatibility and cellular 
mechanisms of graft rejection. As pregnancy involves antigens from two genetically different 
organisms, MLC reactions are a useful tool to study the histocompatibility and the cellular 
mechanisms involved when cells from both organisms are put in contact with each other. 
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For this study, cells obtained from pregnant DBA/2J-mated CBA/J females (day 5 of preg-
nancy) were put in contact with mitomycin-treated DBA/2J cells. In this assay, CD4+ T cells 
over-expressing HO-1 were also added in order to analyze the effect of HO-1 over-expressing 
lymphocytes on this in vitro setting. CD4+ T cells receiving the same transfection procedure 
but without HO-1 were used as control. The study involved the following steps: 
3.2.2.12.1 Treatment of stimulator cells with mitomycin C 
Treatment of mitomycin C is known to arrest the cell cycle in the stimulating cells, so that 
they remain viable but are unable to proliferate or divide (Malinowski et al., 1992). Mitomy-
cin C crosslinks with DNA and selectively inhibits DNA synthesis; RNA and protein synthe-
sis are less affected, with a slowing in progress of the cells through the S and into the G2 
phase (Anderson and Williams, 1977). 
DBA/2J male cells were used as stimulator cells and were therefore treated with mitomycin C. 
Spleen and lymph node from DBA/2J males were crushed against at 100 μm net and collected 
in RPMI. After lysis of erythrocytes with a lysis buffer containing NH4Cl, KHCO3 and EDTA, 
the cells were finally re-suspended in RPMI containing 10% FBS. For treatment of the cells 
with mitomycin C, they were washed twice with RPMI without FBS, and finally resuspended 
in RPMI without FBS containing 50 μg/ml of mitomycin C, at a ratio of 1.107 cells/ml. Cells 
were incubated for 30 min at 37°C with 5 % CO2. The reaction was stopped by washing the 
cells three times with medium containing 10% FBS. 
3.2.2.12.2 Staining of responder cells with CFDA-SE 
In order to measure the proliferation of responder cells by flow cytometry, cells were first 
stained with CFDA-SE, which is a dye known to intercalate in the membrane of the cells. 
Spleen and lymph node cells were isolated as previously described from DBA/2J-mated 
CBA/J females (day 5 of pregnancy). CD4+CD25- and CD4+CD25+ cells were isolated from 
thymus of these animals as previously described (3.2.2.8.2).  All these cells were stained as 
followed: after washing the cells twice with PBS to remove rest of FBS from the medium, 
cells were resuspended in medium containing 1 μM of CFDA-SE in PBS, at a ratio of 1.107 
cells/ml. Cells were incubated for 1 min 30 sec and the reaction was stopped by adding RPMI 
containing 10% FBS. After two washes with RPMI with FBS the, cells were re-suspended in 
the same medium. The number of viable cells was assessed by means of trypan blue as it is 
known that many cells die during the procedure. 
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3.2.2.12.3 Protein transfection of CD4+ T cells from CBA/J females 
The protein transfection was performed as mentioned above. CD4+ T cells were transfected 
with HO-1 protein and these cells will be mentioned as HO-1 over-expressing CD4+ T cells in 
the following sections. CD4+ T cells that were treated with the protein transfection reagent but 
with PBS instead of HO-1 will be referred from now on as CD4+ control T cells. For this 
study, purified CD4+ T cells that were already at least one week in culture were used. 
3.2.2.12.4 Mixed leukocyte reaction (MLC) 
3.105 CFSE-responder CBA/J cells (HO-1+ or control cells) were put in contact with 3.105 
mitomycin-treated stimulator DBA/2J cells in RPMI containing 10% FBS, in a total volume 
of 100 μl. CD4+ T cells over-expressing HO-1 or CD4+ control T cells were added at a con-
centration of 1.105 cells per well. The schema indicated in Table 5 was followed. 
 
Table  5 : Scheme of reaction in 96 well plates 
 CFSE+ CBA/J 
♀ cells 
DBA/2J 
♂cells HO-1
+ CD4+ Tcells CD4+ control Tcells 
1.105 1.105 - - 
1.105 1.105 1.105 - Spleen cells 
1.105 1.105 - 1.105 
1.105 1.105 - - 
1.105 1.105 1.105 - Lymph node cells 
1.105 1.105 - 1.105 
1.105 1.105 - - 
1.105 1.105 1.105 - CD4
+CD25+ 
cells 
1.105 1.105 - 1.105 
1.105 1.105 - - 
1.105 1.105 1.105 - CD4
+CD25- 
cells 
1.105 1.105 - 1.105 
Cells were cultured in a final volume of 100 μl/well in RPMI containing 10% FBS. 
The cells were cultured for 48 h in 96-well plates, at 37°C in humified incubator with 5% CO2 
atmosphere. Each experiment setting was performed in triplicate, and the proliferation of 
CFSE+ cells was analyzed by flow cytometry at two time points, namely 0 h and 48 h. 
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3.2.2.13 Measurement of lymphocyte proliferation by means of CFDA-SE 
Since the CFSE membrane fluorescence dye is transferred to daughter cells in the same pro-
portion, a decrease in fluorescence intensity can be followed (as cells multiply). CFSE is 
therefore widely used as an indirect proliferation marker. Unstained cells were used as con-
trols. 
3.2.3 Studies using the Rcho-1 trophoblast cell line 
3.2.3.1 Cell culture of the Rcho-1 trophoblast cell line 
Rcho-1 trophoblast cells represent a stem cell population capable of differentiation along the 
trophoblast giant cell lineage (Faria and Soares, 1991). The cells can be manipulated to prolif-
erate or differentiate depending upon culture conditions (Peters et al. in: Methods in Molecu-
lar Biology, 2000). This cell line was a kind gift of Dr. Michael Soares, and was first estab-
lished in his laboratory from a rat choriocarcinoma.  
Cells were cultured in proliferation medium consisting of RPMI containing L-glutamine sup-
plemented with 20% FBS (Cambrex), 1 mM sodium piruvate, 100 μg/ml penicillin, 
100 μg/ml streptomycin and 50 μM β-mercaptoethanol. Cells were grown at a density of 
1-2.106 cells/T 75 cm2 flask. Cells were routinely maintained at subconfluent conditions and 
fed at a 2-day interval. It is very important to maintain the cells at subconfluent conditions, 
since high cell density facilitate trophoblast giant cell formation.  
For differentiation of the Rcho-1 trophoblast stem cells into trophoblast giant cells, FBS was 
replaced by horse serum. Since a 1 to 10% of horse serum was mentioned in the literature, 
different concentrations of horse serum were tested. Finally, cells were differentiated using 
10% of horse serum since it showed the best differentiation. The differentiation process takes 
normally place during 7 days, period after which the cells are fully differentiated. 
 
3.2.3.2 Treatment of the Rcho-1 cells with CoPPIX and ZnPPIX 
In order to determine the best concentration of protoporphyrin necessary to cause a diminu-
tion or augmentation of HO-1 protein expression in Rcho-1 cells, different concentrations of 
CoPPIX and ZnPPIX were tested, namely 25, 50, 100 and 200 μM. It was found that 50 and 
100 μM of ZnPPIX were able to down-regulate the expression of HO-1, as measured by 
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Western Blot. CoPPIX did not induce a down- or up-regulation of HO-1 in these cells. Never-
theless, CoPPIX was used as a control for the use of ZnPPIX, at the same concentrations in 
order to assess whether the effects of ZnPPIX observed in the cells is due to the down-
regulation of HO-1 or to the toxic effect of the porphyrin.  
Two approaches using CoPPIX and ZnPPIX were performed. First, the porphyrins were em-
ployed to test the effect of a down-regulation of HO-1 in undifferentiated stem cells. In this 
case, cell viability was assessed by trypan blue staining.  
In a second approach, CoPPIX or ZnPPIX were used during the whole differentiation process 
of the cells, changing the media when necessary (normally every two days) in order to inves-
tigate the influence of HO-1 down- or up-regulation in the differentiation from stem cells into 
giant cells.  A control of differentiation using differentiation media without CoPPIX or 
ZnPPIX was always included.  
3.2.3.2.1 Protein isolation and Western blot analysis 
For protein isolation, cells were trypsinized as usual and then washed with PBS. For protein 
isolation, cells were lysed in a protein isolation buffer containing HEPES, CHAPS and DTT. 
After isolation, homogenates were centrifuged for 10 min at 10.000 g, and the supernatant 
containing the proteins was transferred to a fresh tube. Protein concentration was assessed 
using the BioRad Protein Assay as indicated by the manufacturer. Protein samples were kept 
at -80°C and when working with them, they were always kept on ice. 
For Western Blot analysis, 15 μg of protein were transferred into a 10% polyacrilamide gel 
and a SDS-PAGE in denaturizing conditions was performed at 120V using a Mini-Protean 3 
electrophoresis gel system. Then, proteins were transferred into a nitrocellulose membrane 
using a Mini-trans-Blot system for 1h at 180 mA. After the transfer, efficient protein transfer 
was assessed by staining of the membrane of Ponceau Red. The expression of HO-1 was ana-
lyzed (in the membrane) by immunoblot as follows: the membrane was blocked with 5% milk 
powder in TBS O.N. at 4°C, and further washed with TBST, 3 x 5 min each time. The first 
antibody (rabbit anti-HO-1 polyclonal antibody, diluted 1:500 in 5% milk in TBS) was ap-
plied for 2 h at R.T. After washing with TBST, the samples were incubated with the secondary 
antibody (anti-rabbit horseradish peroxidase, diluted 1:1000 in 5% milk in TBS) for 1 h at RT. 
The membrane was washed again, and the reaction was finally developed by using chemolu-
miniscence (ECL Assay of Amersham) and exposed onto Kodak Miomax MR Imaging film. 
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The intensity of the bands was quantified by using the Quantity One® Software, Version 4.5.2 
from Bio-Rad. 
3.2.3.2.2 Treatment of glass slides with poly-L-lysine 
In order to be able to analyze the phenotype of Rcho-1 cells by immunohistology, the cells 
were grown on glass slides previously treated with poly-L-lysine (Sigma). Poly-Lysine en-
hances electrostatic interaction between negatively-charged ions of the cell membrane and 
positively-charged surface ions of attachment factors on the culture surface. When adsorbed 
to the culture surface, it increases the number of positively charged sites available for cell 
binding. Briefly, slides were incubated in sterility for 5 min with a 0.01% solution of 
poly-L-lysine at RT, then washed with sterile distilled water and allowed to dry for at least 2 
hours. Covered slides were kept under sterility until use, and the cells have shown normal 
growth patterns on these slides. 
3.2.4 Studies using mice deficient in Hmox-1 
The fact that a homozygous mating of Hmox1 deficient mice does not yield progeny (Poss and 
Tonegawa, 1997; Yet et al., 1999), and that the mating of heterozygous mice does not yield 
the expected Mendelian rate suggests that HO-1 plays a very important role in pregnancy. For 
this part of the work, animals partially or totally deficient in Hmox1 in a BALB/c genetic 
background- first established in the lab of Dr. Lee by Shaw-Fang Yet (Yet et al., 1999) were 
used as a part of a cooperation project with Prof. Miguel Soares, from the Instituto Gulben-
kian de Ciencia in Oeiras, Portugal, who provided us with the mice, after MTA agreement 
with Dr. Yet from Harvard. This part of the work was divided in different parts, which are 
explained below. 
3.2.4.1 Influence of the partial or total loss of Hmox1 in the pregnancy outcome 
For this, different mating combinations of females and males partially or totally deficient in 
Hmox1, as well as of wild type mice were performed. A schematic representation of these 
mating combinations is shown in Fig. 18.  
This was performed in a syngeneic (BALB/c x BALB/c) and allogeneic (C57/BL6 x BALB/c) 
background. A schematic representation of the groups analyzed is shown in Fig. 18.  
Part of the mating combinations as well as the analysis of the abortion rates and collection of 
the samples of some of the animals was performed by Ivonne Wollenberg and Prof. Dr. Ana 
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Claudia Zenclussen from our group at the Instituto Gulbenkian de Ciencia. This work was 
continued in our laboratories by me and the Hmox1-/- colony is currently being maintained at 
the animal facility of Virchow Klinikum, Charité.  
3.2.4.1.1 DNA isolation from fetuses and resorptions 
The isolation of DNA from the fetuses and resorptions was performed using the peqGOLD 
Tissue DNA Mini Kit. For that, fetuses and resorptions were previously washed with PBS in 
order to remove the rests of blood from the mother, and the samples were grinded in a mortar 
using a pistil under the influence of liquid nitrogen. The samples were taken up in TL Buffer, 
and after adding OBTM protease and were further incubated at 55°C in a shaking water bath 
for at least three hours. After that, isolation was performed following manufacturer´s instruc-
tions, using HiBind® DNA columns for the specific bindng of DNA. After two washing steps, 
samples were eluted with elution buffer and kept at -20°C until further use. 
 
 
Fig. 18 : Experimental setting. 
Heterozygous females for Hmox1 as well as wild type females were mated with knockout, heterozygous or wild 
type BALB/c males. For the syngeneic combination, BALB/c females were mated to BALB/c males, whereas 
for the allogeneic combination C57BL/6 wild type females were mated with BALB/c males knockout or wild 
type for Hmox1. 
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3.2.4.1.2 Genotyping of the fetuses and resorptions 
The fundament for the PCR reaction used for genotyping of the fetuses and resorptions is 
based in the way that the knockouts were generated, which is schematized in Fig. 19. The 
mutated gene lacks the E3 region of the Hmox1 gene, and possesses a Neo resistance gene 
instead. As it can be deduced from this Fig. 19, knockout fetuses show amplification only 
with the HO/E4-Neo1 primers which amplifies a 400-bp fragment of the mutated allele, 
whereas wild type fetuses will show amplification only with the HO/E3-HO/I3R set of prim-
ers, which amplifies a 456-bp fragment of the wild type allele. Accordingly, heterozygous 
fetuses show amplification with both set of primers. Table 6 shows the sequences of the prim-
ers used for the PCR reaction.  
 
Fig. 19 : Deletion in the Hmox1 gene for the generation of the knockout colony (by Yet et al., 1999). 
The mutated gene lacks the E3 region and possesses a gene of resistance to Neomycin (Neo). 
 
Fetuses and resorptions were genotyped using the standard procedure used for genotype the 
colony. This was done by means of traditional PCR, which was optimized for the GoTaq® 
DNA Polymerase (Promega) using 2.5 units of polymerase with Green GoTaq® Buffer con-
taining 1.5 mM MgCl2 (final concentration). This buffer allows the direct transfer of the sam-
ple into agarose gel for visualization with ethidium bromide. The reaction mixture was com-
pleted with 25 pmol of each primer (forward and reverse) and completed with water to a final 
volume of 50 μl.  
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The PCRs for the HO/E3-HO/I3R and for the Neo1-HO/E4 set of primers were performed in 
different tubes, making duplicates for each sample. Every time that PCR was performed, wild 
type, knockout and heterozygous controls were included. The PCR was performed by 3 cycles 
of 5 min at 94°C followed by 30 s at 58°C and 30 s at 72°C. This was followed by 25 cycles 
at 94°C, 58°C and 72°C, for 30 s each, followed by a final elongation step of 7 min at 72°C. 
Samples were transferred into an agarose gel and visualized using ethidium bromide. 
Table  6 : Sequences of the primers used for genotyping of fetuses and resorptions 
Primer Sequence 
Neo1 5´-TCT TGA CGA GTT CTT CTG AG-3´ 
HO/E4 5´-ACG AAG TGA CGC CAT CTG T-3´ 
HO/E3 5´-GGT GAC AGA AGA GGC TAA G-3´ 
HO/I3R 5´-CTG TAA CTC CAC CTC CAA C-3´ 
The Neo1-HO/E4 set of primers amplifies a 400-bp fragment of the mutated allele, whereas the HO/E3-HO/I3R 
set amplifies a 456-bp fragment from the wild type allele (primer sequences first described in Fujita et al., 2001). 
 
3.2.4.2 In vitro fertilization 
In vitro fertilization (IVF) was carried out during my research period at the Instituto Gulben-
kian de Ciencia, Oeiras, Portugal, according to the host laboratory´s procedure and with the 
assistance of Sofia Rebelo, an expert in the field. It included the following steps: induction of 
superovulation by hormonal treatment, preparation of the dishes for IVF, sperm collection, 
collection of the oviducts, fertilization, washing of the oocytes, and assessment of the fertili-
zation rates, which will be briefly described below: 
 
3.2.4.2.1 Superovulation 
For superovulation, 2-3 months old females were intraperitoneally injected with 5.0 IU of 
PMSG (Pregnant Mare Serum Gonadotropin), followed by an injection of 5.0 IU of hCG 
(human chorionic gonadotropin) 48 h later.  
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3.2.4.2.2 Preparation of the dishes for IVF 
A small Petri dish with one drop (500 μl) of HTF medium in the middle of the dish was pre-
pared (“sperm dish”). This drop was covered with oil and placed O.N. at 37°C. The “fertiliza-
tion dish” (1 per three females) consisted in a 60 mm Petri dish with 500 μl of HTF medium 
covered with oil. This dish was also incubated O.N. at 37°C. One “wash dish” per each fertili-
zation dish was prepared using 4 drops x 125 μl of HTF in a small Petri dish, covered with 
oil, which was also incubated O.N. at 37°C.  
 
3.2.4.2.3 Sperm collection 
For sperm collection, males were sacrificed by cervical dislocation 12 h after hCG was in-
jected to the females. The cauda epididymides and vasa deferentia were dissected out and 
placed in the sperm dish, inside the medium drop. The cauda epididymis was dissected out 
making 5 slashes with a 30-gauge needle on a syringe and the sperm was gently squeezed out 
from the vasa deferentia by using forceps. Sperm was collected 15 to 45 min before the fe-
males reach 13 h post hCG injection. After 10 min-1 h incubation of the sperm in a 37° C in-
cubator in a dish containing HTF medium, 10 μl of sperm was transferred into each fertiliza-
tion dish. 
 
3.2.4.2.4 Collection of the oviducts and fertilization 
For collection of the oocytes, females were sacrificed 13 to 14 h after hCG injection by cervi-
cal dislocation and oviducts were taken as shown in Fig. 20. The oocytes were collected from 
the swollen ampulla (Fig. 21) and were found in a cloud together with cumulus cells. This 
“cloud” was taken to the drop and put in contact with the sperm. This procedure had to be 
very quick and not to take more than 5 minutes per plate.  
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Fig. 20 : Dissection of the oviduct  
Figure taken from Nagy et al. in: Manipulating the mouse embryo, 2003. A) The ovary, oviduct and the end of 
the uterus are separated from the mesometrium. B) A cut is made between the oviduct and the ovary. A second 
cut separated the oviduct from the uterus. 
 
 
Fig. 21 : Isolation of oocytes from dissected oviduct 
When the oviduct is removed soon after hormonal treatment, the oocytes surrounded by cumulus cells in the 
upper part of the oviduct (ampulla), and can be released by tearing the ampulla with fine forceps. 
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3.2.4.2.5 Washing of the oocytes 
The manipulation of the oocytes was always carried out with a mouth pipette assembly, con-
sisting of an aspirator mouthpiece, tubing, and a glass Pasteur pipette previously pulled on a 
flame (to create a narrow opening). Oocytes were placed in the fertilization drop, which al-
ready contained the sperm. After 4 to 6 h of incubation, oocytes were washed in order to re-
move the excess of sperm, and further incubated O.N. at 37°C.  In this step, the number of 
total oocytes was counted and will be referred as one-cell stage. 
3.2.4.3 Assessment of the fertilization rate 
Two-cell stage was evaluated in order to address fertilization efficiency.  The number of cells 
in two cell stage was determined under the microscope, and the fertilization rate was calcu-
lated according to the formula: 
 
 Two-cell stage embryos were washed in M2 Medium, in order to remove the excess of HTF 
Medium. 
3.2.4.4 Male vasectomisation 
For the vasectomisation procedure, males were anesthetized and both testes were pushed 
down into the scrotal sac by applying pressure to the abdomen. A small incision was made 
through the skin along the midline of the scrotal sac. Testes were taken out one at a time, and 
the membrane of the testis suffered a small incision close to the vas deferens. The vas defer-
ens was identified as a bright white tubule with a single blood vessel. Using forceps, both the 
vas deferens and the blood vessels were hold and cauterized in two positions with red hot tips, 
taking out a small portion of the vas deferens. Testes were put back in place, and the skin was 
clipped together. Males were kept on a heating pad until they recovered from the injected an-
esthetic, and were mated with the females after at least one week. 
Vasectomized males (BALB/c background) were bred with females to produce pseudopreg-
nant recipients for oviduct and uterine transfer.  
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3.2.4.5 Embryo transfer 
The surgical procedure of embryo transfer was performed by Sofia Rebelo, member of the 
Instituto Gulbenkian de Ciencia, an expert on the field. Two-cell stage embryos were trans-
ferred into female recipient mice that have been previously mated with vasectomized males 
and which exhibited plug in the morning of the transfer. In order to assure that females will 
show plug, recipient females were injected with hormones and mated with the males immedi-
ately after HCG injection. After mating with the vasectomised (sterile) male, the female´s 
reproductive tract is supposed to become receptive for transferred embryos, even though their 
own unfertilized oocytes degenerate. The day of the embryo transfer was considered as day 0 
of pregnancy. 
The transfer was performed anesthetizing the female and making a small incision in the skin 
along the dorsal midline, at the level below the last rib. As shown in Fig.22, the ovarian fat 
pad, attached to the ovary, oviduct and uterus was pulled out in order to make the transfer into 
the oviduct (infundibulum). Embryos in two-cell stage in M2 Medium were transferred into 
the oviduct using a transfer pipette (mouth-pipetting device). Once transferred in both ovi-
ducts, the uterus, oviducts and ovaries were put back inside the body cavity and the skin was 
closed with wound clips. Each side of the uterus received 10 embryos in two-cell stage. 
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Fig. 22 : Embryo transfer into the oviduct 
Fig. taken from Nagy et al. in: Manipulating the mouse embryo, 2003.  
 
3.2.4.5.1 Assessment of the pregnancy success 
On day 14 of pregnancy, females were sacrificed, the uteri removed, and the implantation 
sites were documented. Resorptions were kept for further analysis, as well as spleen, liver, 
thymus, ovaries and decidua. Abortion rates were calculated as the ratio of abortion sites to 
total implantation sites as previously described. 
3.2.4.6 Analysis of ovarian follicle development 
Ovaries from Hmox-1+/+ and Hmox-1-/- females used as donors were embedded in paraffin as 
previously described in 4.2.1.9. Samples were cut in 5 μm slides and stained with Hematox-
ilin and Eosin as previously described in 4.2.1.11. The analysis of the follicles was carried out 
under light microscope, counting the follicles in each stage of maturation (primordial, pri-
mary, secondary and mature) using a 20X magnification. Both ovaries of each animal were 
analyzed, counting at least three slides per ovary.  
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3.2.5 Data analysis and statistics 
Most of the data presented in this thesis is represented by boxplots. This type of graphic was 
chosen since it is the best way to present data that is analyzed by non-parametric tests.  
An example of a boxplot representation is shown in Fig. 23. The boxes show the lower quar-
tile (25th percentile), the median and the upper quartile (75th percentile). The difference be-
tween the upper and lower quartiles is the inter-quartile range (IQR) and it contains 50% of 
the sample. The smallest and largest values are indicated by the small horizontal bars at the 
end of the whiskers. Outliers (defined as 1.5-fold the IQR, Henderson, 2006) are normally 
shown as circles and/or asterisks below or above boxplots. 
 
Fig. 23 : Representation of the data with boxplots 
Boxplots were used as a representation for non-parametric data, showing between the maximal and minimal 
value the 100% of the data obtained. 
 
Data from the study using the murine model of abortion are presented as medians or medians 
± 75% quartiles. Analysis and graphics were made with the SPSS 11.5 software. When appro-
priate, statistical analysis of the data was performed using the non-parametric Kruskal-Wallis 
test followed by Mann-Whitney U-test. In all cases, p<0.05 was considered a statistically sig-
nificant difference. 
Data obtained using the Hmox1 deficient mice are presented as mean ± SD when analyzing 
the in vitro fertilization results. The statistical analysis of the in vitro fertilization was per-
formed with the total number of oocytes, fertilized and unfertilized, using the Fisher´s exact 
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test. The graphics and statistics of this part of the work were obtained with the GraphPad 
Prism 4 Software. The data regarding follicle development is shown as median ± interquartile 
range and were analyzed by the Mann-Whitney U-test.  
Results 
---------------------------------------------------------------------------------------------------------------------------------------- 
4 Results 
4.1 Morphology of murine implantations (healthy fetuses and re-
sorptions) 
Immunological rejection during pregnancy is characterized in the mouse by necrotic tissue 
and infiltration of immune cells at the site of implantation. This site is usually called “resorp-
tion” and resembles human abortion (or miscarriage). Fig. 24 depicts a typical abortion event, 
near to a healthy fetus at its implantation site. As seen in the picture, resorptions are hemor-
rhagic necrotic areas of the tissue that are considerable smaller than the normal placentas and 
their fetuses.  
 
Fig. 24 : Representative picture of the feto-maternal interface in a murine pregnancy 
Resorptions and healthy fetuses can be clearly differentiated from each other due to the hemorrhagic and ne-
crotic appearance of the resorption, as well as due to its smaller size as compared to the healthy implantation site. 
 
Hematoxilin-Eosin staining of healthy placental tissue made it possible to identify the differ-
ent cell types present in a murine placenta on day 14 of gestation. Fig. 25 shows a typical pla-
centa, staining in which all types of cells can be appreciated.  
The outer layer of the placenta, even after dissection from the uterus, is contaminated with 
maternal decidual cells which usually appear as a thin layer of small cells (Nagy et al. in: Ma-
nipulating the mouse embryo, 2003). In the mature placenta, the spongiotrophoblast forms the 
middle layer of the placenta between the outermost giant cells and the innermost labyrinth. 
Finally, the last type of cells found in the placenta are the glycogen cells, which appear within 
the trophoblast layer (reviewed in Cross, 2005). 
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Fig. 25 : Representative HE staining showing the different cell types in a murine placenta 
 
4.2 In vivo application of AdHO-1/GFP in a murine model of 
abortion 
4.2.1 Effect on the pregnancy outcome 
The application of an adenoviral vector containing HO-1 was employed in order to analyze 
the effect of a specific up-regulation of HO-1 on the pregnancy outcome of mice undergoing 
spontaneous immunological abortion.  
As expected (Chaouat et al., 1995; Clark et al., 1997), DBA/2J-mated CBA/J mice presented 
significantly higher abortion rates when compared to the normal pregnant combination 
CBA/J x BALB/c. Interestingly, abortion-prone mice receiving 1.105 PFU AdHO-1/GFP 
showed a significant diminution in the abortion rate as compared to PBS-treated abortion-
prone mice (p<0.05) or mice receiving 1.105 AdEGFP (p<0.05), pointing out a beneficial ef-
fect of HO-1 on pregnancy outcome (Fig. 26). Since mice receiving the adenoviral construct 
without HO-1 showed similar abortion rates as the abortion-prone group, it is to speculate that 
the injection of sole adenoviral particles -known to be immunogenic- did not significantly 
affect the pregnancy outcome (Fig. 26). However, a small augmentation in the abortion rate 
was observed in the group receiving the AdEGFP vector, indicating that injection of AdHO-1 
had a beneficial effect despite the immunological response that the injection of adenoviruses 
implied. 
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Fig. 26 : Specific up-regulation of HO-1 improves pregnancy outcome in a murine model of abortion 
Data are represented by medians ± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. Circles 
and/or asterisks above box plots indicate outliers. Significant differences between groups are indicated as aster-
isks above lines. *p≤ 0.05, **p≤ 0.01 and *** p≤ 0.001, as analyzed by the Kruskall-Wallis non-parametric test 
between all groups, followed by the Mann-Whitney U-test for two particular groups. 
 
Interestingly, abortion-prone mice receiving 1.108 PFU AdHO-1/GFP presented a slight and 
not significant diminution in the abortion rate (n = 8) when compared to mice receiving 1.108 
AdEGFP (n = 7), suggesting that a too high HO-1 concentration is not pregnancy-protective. 
This data is shown as Table 14 in the appendix. These two groups will not be taken into ac-
count for the graphics, since its application did not show any effect on the pregnancy out-
come. Nevertheless, the data regarding these two groups are shown in the appendix as Table 
14.  
Since the percentage of abortion rate depends on the number of implantations, the number of 
implantations was calculated for every group. As it can be observed in Fig. 27, the number of 
implantations was comparable between all groups (Fig. 27). Considering this, it can be stated 
that the up-regulation of HO-1 has beneficial effect of pregnancy outcome. 
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Fig. 27 : The number of implantation sites was similar between all experimental groups 
Data are represented by medians ± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion; Circles 
below box plots indicate outliers. No significant differences were found between the groups as analyzed by the 
Kruskall-Wallis non-parametric test between all groups, followed by the Mann-Whitney U-test for two particular 
groups. 
 
4.2.2 Heme Oxygenase-1 expression at the feto-maternal interface 
In order to analyze whether the effect of HO-1 up-regulation is noticeable in the levels of 
HO-1 at the feto-maternal interface 9 days after treatment, the expression of HO-1 was meas-
ured at mRNA and protein levels in placental tissue. Table 7 shows the mRNA levels of 
mouse HO-1 in all groups, where a slight augmentation of mouse HO-1 mRNA can be seen in 
the group receiving AdHO-1/GFP. However, this augmentation is not statistically significant. 
HO-1 mRNA levels where significantly augmented in placentas of mice receiving the higher 
doses of AdHO-1/GFP in comparison with mice receiving low doses (Table 17, Appendix). 
By measuring mRNA of human HO-1, the one coded in the adenovirus used for the in vivo 
experiment, only few samples showed amplification curves and most of them did not show 
any amplification after 40 cycles. This may be due to the fact that the mice were killed on day 
14 of pregnancy, 9 days after injection of the adenoviruses. This makes sense as it is reported 
that adenoviruses remain between 5 and 20 days post-infection (Dai et al., 1995).  
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Table  7 : No significant differences in the placental HO-1 mRNA levels between the groups 
 N.P (n=5) 
S.A. 
(n=8) 
S.A. + 
AdHO-1/GFP 
(n=5) 
S.A. + 
AdEGFP 
(n=7) 
Mean 0.05076 0.03590 0.04565 0.05047 
SD 0.04651 0.01383 0.02169 0.01575 
Median 0.02906 0.02967 0.04404 0.04443 
mRNA levels of HO-1 normalized to b-actin. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. No signifi-
cant differences were found between the groups as analyzed by the Kruskall-Wallis non-parametric test between 
all groups, followed by the Mann-Whitney U-test for two particular groups. 
 
Protein levels of HO-1 were analysed by Western Blot using homogenates of whole placental 
tissues using b-actin as protein reference. Intensity of the bands was analyzed using the Quan-
tity One Software (BioRad), and a HO-1/β-actin ratio was calculated for each sample. Fig. 28 
shows an example of the β-actin and HO-1 Western Blot bands obtained.  
 
Fig. 28 : Example of the Western Blot from placental samples 
1 and 5) CBA/J x BALB/c placentas 
2 and 6) CBA/J x DBA/2J placentas 
3 and 7) CBA/J x DBA/2J + AdHO-1/GFP placentas 
4 and 8) CBA/J x DBA/2J + AdEGFP placentas 
Bands were analyzed using a densitometer being the densitometric units for HO-1 normalized 
to those of b-actin. The results are showed in Table 8, showing mean, standard deviation and 
median for each analyzed group. No differences were obtained in HO-1 protein levels be-
tween the groups, as analyzed by the Kruskall Wallis test between all groups, as well as no 
differences between the groups, as analyzed by the Mann Whitney test.  A trend towards a 
diminution of HO-1 expression in the abortion prone-group when compared to the normal 
pregnant group could be observed (Table 8), in accordance with previous results from our 
group (Zenclussen et al., 2005).  A tendency towards an augmentation was observed in the 
group receiving AdHO-1/GFP as well as in the group receiving AdEGFP (Table 8). 
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Table  8 : Placental protein levels of HO-1 were similar between all groups at the analyzed time point 
 N.P. (n=5) 
S.A. 
(n=5) 
S.A. + 
AdHO-1/GFP 
(n=4) 
S.A. + 
AdEGFP 
(n=3) 
Mean 0.3188 0.1370 0.3924 0.3681 
SD 0.2296 0.1524 0.2978 0.2267 
Median 0.3165 0.05028 0.2772 0.4157 
Protein levels of HO-1 as normalized to β-actin, N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. No 
significant differences were found between the groups as analyzed by the Kruskall-Wallis non-parametric test 
between all groups. 
 
 
Fig. 29 : HO-1 is highly expressed in all murine placental cell types as well as in the decidua as analyzed 
by immuno-histochemistry in paraffin-embedded tissues.  
Immunohistochemical analysis of HO-1 in paraffin-embebbed tissues. A) shows intense HO-1 staining on giant 
cells; B) depicts HO-1 expression on spongiotrophoblasts. C) HO-1 expression was also found on decidual cells. 
D) represents the negative control of the staining. All pictures were taken using a 20X magnification of the ob-
jective lens. 
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Protein levels of HO-1 were also measured by immunohistochemistry in order to analyze the 
HO-1 expression in each different cell type and have more detailed information regarding 
local HO-1 expression. HO-2 expression was as well analyzed by immunohistochemistry.  
Again, no differences were observed between the groups for murine HO-1, and also no differ-
ences were found for HO-2 expression. Representative pictures for HO-1 staining are shown 
in Figures 29A-C, were it can be seen that HO-1 is highly expressed throughout the placenta 
as well as in decidua, with its highest expression in giant cells. Since giant cells are very im-
portant for the onset of placentation, it is tempting to assume that HO-1 may play an impor-
tant role in placentation. Fig. 29D shows the negative control of the staining. HO-2 expression 
was found throughout the whole placenta, with similar patterns of expression as for HO-1. 
4.2.3 Detection of adenoviral particles in placental and fetal tissue 
Although no differences were observed in the levels of HO-1 between the groups, it was pos-
sible to detect human HO-1 mRNA (derived from the vector) in some placenta samples from 
animals treated with Ad-HO-1. This suggests that the adenovirus reached the feto-maternal 
interface. The use of a therapeutic vector containing GFP made possible the analysis of the 
presence of the construct in the reproductive tract to confirm that the applied adenoviruses 
reached the feto-maternal interface. GFP expression was analyzed by fluorescence micros-
copy as well as by real-time PCR.  
 
Fig. 30 : GFP+ cells were found in the placenta and not in the fetus when analyzed by fluorescence micros-
copy 
A) shows GFP+cells at the feto-maternal interface from abortion-prone mice receiving 1 x 105 PFU AdHO-
1/GFP; GCs = giant cells; B) depicts GFP+ cells in decidual and placental cells but not in the fetus after the 
transfer of 1 x 105 PFU AdEGFP. Pictures were taken in a 20X magnification of the objective lens.  
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GFP protein was in fact expressed at the feto-maternal interface in decidual cells as well as in 
giant cells, i.e. in the outer layer of the fetal-maternal interface as analyzed by fluorescent 
microscopy. Figure 30A shows a representative field of GFP+ cells found in cryo-sections of 
placental tissue. Figure 30B shows positive GFP expression in decidual and placental tissue, 
while no expression could be observed in fetal tissue. 
Further, a semi-quantitative measurement of adenoviral particles for GFP was performed by 
real time PCR in liver and placental tissues as well as in fetus homogenates in order to deter-
mine the tissue distribution of the adenoviral particles after injection. The higher GFP expres-
sion was found in maternal liver, which was expected considering the high hepatic tropism of 
adenovirus if applied intra-peritoneally (Huard et al., 1995). A lower adenovirus expression 
was found in placental tissue, which confirms the GFP detection by fluorescent microscopy, 
and also very low levels of adenoviral particles could be found in fetus homogenates (Fig.31). 
Low adenovirus expression in fetuses after gene therapy was already described by other au-
thors (Senoo et al., 2000). Because we homogenized fetal tissues using liquid N2, the quanti-
fied virus may represent only the virus present in the fetal skin as already reported by other 
groups (Senoo et al., 2000), since effective gene transfer into the fetal organs e.g. liver or kid-
ney is only possible when applying the vector into the umbilical vein (Senoo et al., 2000). 
However, this GFP may be not expressed at the fetal tissue, as no GFP expression could be 
observed in the fetuses by fluorescence microscopy.  
 
Fig. 31 : GFP DNA was mostly found in maternal liver after i.p. injection of AdEGFP as measured by real 
time PCR 
GFP expression (relative to ApoB) measured with real time PCR in mice receiving 1x105 PFU AdEGFP. The 
highest GFP expression was found in the maternal liver. Placentas and fetuses showed very low GFP expression.  
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4.2.4 Ex-vivo intracellular cytokine production by spleen and decidual 
lymphocytes as measured by flow cytometry 
As HO-1 was previously described to affect the cytokine balance in transplantation models 
(reviewed in Katori et al., 2002) and considering that a proper Th1/Th2 balance is important 
for successful pregnancy, systemic and local cytokine expression by T cells was measured by 
flow cytometry. Spleen and decidual cells were stimulated by PMA/Ionomycin, process which 
is known to stimulate mainly memory T cells.  
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Fig. 32 : HO-1 up-regulation could significantly diminish the IL-4/IFN-γ ratio in spleen and decidual lym-
phocytes as analyzed by flow cytometry 
Th1/Th2 ratios in spleen (A) or decidual lymphocytes (B) measured by the production of IFN-γ and IL-4 by flow 
cytometry after PMA/Ionomycin incubation in the presence of monensin. Data are represented by medians ± 
75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion; Circles and/or asterisks above box plots 
indicate outliers. Significant differences between groups are indicated as asterisks above lines. *p≤ 0.05, 
**p≤ 0.01 and *** p≤ 0.001, as analyzed by the Kruskall-Wallis non-parametric test between all groups, fol-
lowed by the Mann-Whitney U-test for two particular groups. 
 
T cells were gated according to their size and granularity, and the ability of Th2 (IL-4 and 
IL-10) and Th1 (IFN-γ and TNF-α) production was analyzed by flow cytometry. The results 
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were expressed as IL-4/IFN-γ or IL-10/TNF-α ratio, as it can be observed in Fig 32 for spleen 
(A) and decidual (B) lymphocytes.  
Interestingly, a diminution in the IL-4/IFN-γ ratio could be observed in both, spleen and de-
cidual lymphocytes from abortion mice when compared to normal pregnant mice, nicely sup-
porting the Th1/Th2 paradigm (Fig. 32 A and B). Results are shown in Fig.32A and B, for 
spleen and decidual lymphocytes, respectively. Very interestingly, only mice treated with 
1x105 PFU but not with 1x108 PFU AdHO-1/GFP showed a significant augmentation in the 
IL-4/IFN-γ cytokines ratio in both, spleen and decidual lymphocytes. Moreover, the 
IL-4/IFN-γ levels in this group were comparable to those obtained in the normal pregnancy 
group. High doses of HO-1 were not able to up regulate the IL-4/IFN-γ ratio, suggesting again 
that too much HO-1 is not pregnancy compatible. 
 
Fig. 33 : IL-10/TNF-α ratio in spleen and decidual lymphocytes as analyzed by flow cytometry 
Th1/Th2 ratios in spleen (A) or decidual lymphocytes (B) measured by the production of TNF-α and IL-10 by 
flow cytometry after PMA/Ionomycin incubation in the presence of monensin. Data are represented by medians 
± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion; Circles and/or asterisks above box plots 
indicate outliers. No significant differences were obtained between groups as analyzed by the Kruskall-Wallis 
non-parametric test between all groups. 
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As depicted in Fig. 33A, a diminution in the IL-10/TNF-α ratio in spleen cells was found in 
abortion-prone animals compared to normal pregnant animals. HO-1 treatment up-regulated 
IL-10/TNF-α ratio when compared to abortion-prone mice. Nevertheless, this difference was 
not significant. Surprisingly, the levels of IL-10/TNF-α in decidual cells were augmented in 
abortion-prone mice when compared to normal-pregnant mice. Mice receiving AdHO-1/GFP 
as well as mice receiving AdEGFP showed similar IL-10/TNF-α levels as those obtained for 
the normal pregnant combination. Kruskall-Wallis analysis between all groups show no sig-
nificant differences between all groups analysed (Fig.33B).  
Medians of the cytokine levels for each measured cytokine are shown as a Table in the Ap-
pendix (Tables 15 and 16). 
4.2.5 Lymphocyte infiltration at the feto-maternal interface 
Since a Th2 shift in the cytokine production was observed in the AdHO-1/GFP treated group, 
it was interesting to analyze whether this treatment also provokes an augmentation in the 
number of lymphocytes reaching the feto-maternal interface. The marker CD3, expressed in 
all T cells, was analyzed at mRNA and protein levels.  
Levels of CD3 mRNA were measured by real time RT-PCR in placentas (tissue of fetal ori-
gin) as well as in decidua (maternal tissue). As can be observed in Table 9, the CD3 mRNA 
levels were very low, confirming low amounts of the immune cells at the placenta. Besides, 
no major differences were obtained regarding CD3 expression in placental tissue between the 
groups. This suggests that the lymphocytes present in the placenta are prone to produce more 
Th2 and less Th1 cytokines after HO-1 treatment. 
In decidual tissue (of maternal origin) CD3 expression was augmented in animals receiving 
AdHO-1/GFP. As can be seen in Fig. 34, the expression of CD3 mRNA in HO-1 treated ani-
mals was significantly augmented when compared to normal pregnant animals. It is tempting 
to speculate that this augmentation is due to a migration of lymphocytes into the feto-maternal 
interface. As we could observe higher Th2 than Th1 levels it is then postulated that more Th2 
lymphocytes generated in the periphery (Fig. 33A and 34A) reach the feto-maternal interface 
(Fig. 33B). 
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Table  9 : similar levels of CD3 mRNA in placental tissues between all groups as measured by real time 
RT-PCR 
 N.P (n=3) 
S.A. 
(n=5) 
S.A. + 
AdHO1/GFP 
(n=5) 
S.A. + 
AdEGFP 
(n=4) 
Mean 0.0003161 0.0002290 0.0003148 0.001146 
SD 0.0005072 0.0002357 0.0003607 0.001094 
Median 0.0000277 0.0001757 0.0002286 0.0007203 
N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. No significant differences were found between the 
groups as analyzed by the Kruskall-Wallis non-parametric test between all groups. 
 
 
Fig. 34 : The systemic application of AdHO-1/GFP led to an augmentation of CD3 mRNA in the decidua as 
analyzed by real time PCR normalized to β-actin. 
Decidual expression of CD3 mRNA as analyzed by real time PCR normalized to b-actin. Data are represented by 
medians ± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. Significant differences be-
tween groups are indicated as asterisks above lines. *p≤ 0.05, as analyzed by the Kruskall-Wallis non-parametric 
test between all groups, followed by the Mann-Whitney U-test for two particular groups. 
 
CD3 expression at protein level was analyzed in placental tissue by immunohistochemistry. 
Unfortunately, CD3+ cells were rare to found. Since in many samples no cells could be found, 
it was not feasible to quantify the number of CD3+ cells. Nevertheless, samples of animals 
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receiving AdHO-1/GFP did not show massive infiltration of CD3+ lymphocytes, supporting 
the RT-PCR data with no differences in CD3 expression in placental tissue between the 
groups.  
4.2.6 Levels of FoxP3 and TGF-β mRNA as measured by real time RT-PCR 
Many authors have proposed a link between HO-1 and regulatory T cells (Treg) (Pae et al., 
2003; Choi et al., 2005), although this is still controversial. In order to clarify whether in our 
animal model HO-1 was able to up-regulate the number of Treg at the feto-maternal interface, 
the markers TGF-β and FoxP3 were analyzed by real time RT-PCR in placental tissue. FoxP3 
is considered to be a specific marker that indicates the presence of Treg as it is constitutively 
expressed in Treg but not in effector T cells. TGF-β is normally secreted by certain types of 
Treg and augmented levels of any of these markers or of both markers together may indicate 
the presence of Treg. As shown in Table 10 no augmentation of TGF-β mRNA was observed 
when injecting AdHO-1/GFP, but there was an augmentation in the levels of TGF-β in the 
group receiving AdEGFP when compared with the group receiving AdHO-1/GFP. Although 
these results were not expected as it would mean that the sole injection of an adenovirus is 
protective, one have to keep in mind that TGF-β is mainly regulated post-transcriptionally, 
and mRNA levels may not reflect protein levels, hence may not count for the in vivo situation. 
Unfortunately, it was impossible to measure protein levels by IHC or Western Blot.  
 
Table  10 : No differences in the mRNA levels of TGF-β in placental tissue between the groups as meaured 
by real time RT-PCR 
  
N.P 
(n=5) 
S.A. 
(n=6) 
S.A. + 
AdHO1/GFP 
(n=5) 
S.A. + AdEFP 
(n=5) 
Mean 0.1278 0.1041 0.05937 0.1624 
SD 0.1106 0.06807 0.05241 0.02397 TGF-β 
Median 0.1344 0.08931 0.04123 0.1560* 
N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. *p≤0.05 as analyzed by the Kruskall-Wallis non-
parametric test between all groups, followed by the Mann-Whitney U-test for two particular groups. Differences 
were found between the group receiving AdEGFP and the group receiving AdHO-1/GFP. 
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Levels of FoxP3 mRNA were found to be comparable between all groups analyzed (Table 
11). No relationship could be found between the application of the adenoviral vector contain-
ing HO-1 and Treg. However, more studies should be carried out before excluding a connec-
tion between these two systems in this particular model.  
 
Table  11 : No differences in the mRNa levels of FoxP3 in decidual tissue between the groups 
 
 
 
N.P 
(n=3)§ 
S.A. 
(n=2) § 
S.A. + 
AdHO-1/GFP 
(n=3) § 
S.A. + 
AdEGFP 
(n=3) § 
Mean 4.00 x 10-5 1.24 x 10-4 1.23 x 10-4 9.59 x 10-5 
SD 2.88 x 10-5 1.91 x 10-5 6.35 x 10-5 4.29 x 10-5 FoxP3 
Median 2.43 x 10-5 1.24 x 10-4 9.06 x 10-5 9.61 x 10-5 
N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. No significant differences were found between the 
groups as analyzed by the Kruskall-Wallis non-parametric test between all group. §Only samples with detectable 
levels of FoxP3 were included. 
  
4.2.7 Measurement of apoptosis at the feto-maternal interface 
HO-1 and its products are known to exert anti-apoptotic effects in many different models. In 
order to see if HO-1 also has an anti-apoptotic effect at the feto-maternal interface, apoptosis 
was measured by two different methods, namely caspase-3 activity in tissue homogenates and 
TUNEL staining in tissue slides. The measurement of Caspase-3 activity of whole placental 
homogenates showed a slight augmentation in the caspase-3 activity, thus in apoptosis, in pla-
centas from abortion-prone animals when compared to placentas from normal pregnant mice. 
The caspase-3 activity could be diminished after injection of AdHO-1/GFP, suggesting an 
anti-apoptotic effect of the HO-1 therapy that may involve a caspase-3 dependent pathway. 
The levels of caspase-3 activity were also diminished when compared to the levels measured 
in mice receiving an AdEGFP control vector. Besides, the placental homogenates from ani-
mals receiving the AdEGFP control vector showed even a slight augmentation when com-
pared to the abortion-prone group. Results for caspase-3 activity are shown in Fig. 35. The 
measurement of caspase-3 activity gives an idea of the rate of apoptosis in the tissue that oc-
curred in a caspase-3 dependent way. However, other mechanisms of apoptosis may occur, 
and this was the reason why apoptosis was also measured by TUNEL technology. 
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Fig. 35 : Diminished caspase-3 activity in placental tissue of animals receiving the AdHO-1/GFP vector 
 Data are represented by medians ± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion; Cir-
cles and/or asterisks above box plots indicate outliers. No significant differences were found as analyzed by the 
Kruskall-Wallis non-parametric test between all groups. 
 
By using the TUNEL technology, the number of apoptotic cells/mm2 in the placenta could be 
determined by light microscopy based on the morphology of the stained nuclei of the cells, 
and results are depicted in Fig.36. Placentas from abortion-prone mice presented significant 
higher number of apoptotic cells when compared to placentas from normal pregnant animals.  
The application of AdHO-1/GFP led to a significant diminution of the number of apoptotic 
cells when comparing to placentas from abortion-prone mice receiving PBS or AdEGFP, rein-
forcing the hypothesis of an anti-apoptotic effect of the HO-1 therapy.  The fact that a big 
diminution in the number of apoptotic cells was found in the group receiving AdHO-1/GFP, 
whereas the difference obtained in the caspase-3 activity was only slight and not significant 
may suggest that the AdHO-1/GFP could have acted also in a caspase-3 independent pathway. 
A representative picture of the TUNEL staining in placental tissue is shown in Fig. 37A. Fig. 
37B shows the negative control of the staining. 
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Fig. 36 : The up-regulation of HO-1 led to a significant diminution in the number of apoptotic cells in the 
placenta as measured by TUNEL 
Number of apoptotic cells/mm2. For each section, positive cells were counted in at least 20 fields using a 200x 
magnification (20x objective and 10x ocular). Data are represented by medians ± 75% quartiles. N.P.= Normal 
Pregnancy; S.A.= Spontaneous abortion. Significant differences between groups are indicated as asterisks above 
lines. *p≤ 0.05  as analyzed by the Kruskall-Wallis non-parametric test between all groups, followed by the 
Mann-Whitney U-test for two particular groups. 
 
 
 
Fig. 37 : Representative example of the TUNEL staining in placental tissue 
A) sample containing apoptotic cells;  
B) negative control; pictures taken at 20X objective and 10X ocular amplification. 
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4.2.8 Measurement of mRNA of pro- and anti-apoptotic molecules by real 
time RT-PCR 
Since mice receiving AdHO-1/GFP presented diminished apoptosis, it was interesting to go 
into a deeper analysis and try to elucidate by which mechanism this prevention of apoptosis 
occurred. For that, mRNA levels of Bag-1 and further anti-apoptotic molecules such as Bcl-xl 
and Bcl-2 in decidual and placental samples were analysed by real time RT-PCR. As depicted 
in Fig. 38, Bag-1 mRNA levels were slightly diminished in decidual tissues from the abortion-
prone group when compared to the normal pregnancy group. Interestingly, AdHO-1/GFP 
treatment could revert the Bag-1 down-regulation (p<0.05), confirming an anti-apoptotic ef-
fect of the HO-1 therapy. Levels of mRNA for Bcl-xl and Bcl-2 molecules were not affected 
by the AdHO-1/GFP treatment and no differences between the groups were found (data not 
shown). 
 
 
Fig. 38 : Up-regulation of HO-1 led to a significant augmentation of the mRNA levels of the anti-apoptotic 
molecule Bag-1 as measured by real time RT-PCR. 
Data are represented by medians ± 75% quartiles. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. Sig-
nificant differences between groups are indicated as asterisks above lines. *p≤ 0.05  as analyzed by the Kruskall-
Wallis non-parametric test between all groups, followed by the Mann-Whitney U-test for two particular groups. 
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4.2.9 Vascular endothelial growth factor (VEGF) 
The HO-1 molecule is known to be related to angiogenesis. In this regard, it has been shown 
by others (reviewed in Dulak et al., 2004) that an up-regulation of HO-1 leads to an augmen-
tation of the angiogenic factor VEGF and viceversa (Bussolati et al., 2004). In order to ana-
lyze whether the beneficial effect obtained by the up-regulation of HO-1 was related to angio-
genesis, the expression of VEGF was measured at a single cell level in placental tissue by 
immunhistochemistry. The results obtained with this method are shown in Fig. 39, where it 
can be seen that animals receiving low doses of AdHO-1/GFP showed a slight augmentation 
in the number of cells expressing VEGF, when compared to all other groups, suggesting that 
HO-1 may have also angiogenic effects in this particular model.  
 
 
Fig. 39 : Slight augmentation in the number of VEGF+ cells in placentas of animales treated with AdHO-
1/GFP as analyzed at single cell level by IHC. 
Number of VEGF+ cells/mm2. For each section, positive cells were counted in at least 20 fields using a 200x 
magnification (20x objective and 10x ocular). Data are represented by medians ± 75% quartiles. N.P.= Normal 
Pregnancy; S.A.= Spontaneous abortion. No significant differences were found between groups as analyzed by 
the Kruskall-Wallis non-parametric test between all groups. 
 
An example of the immunohistochemical staining for VEGF is shown in Fig. 40, where a 
sample containing VEGF+ cells (A) is depicted next to the negative control of the staining 
(B).   
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Fig. 40 : Representative example of the VEGF expression in placental tissue as measured by immunohisto-
chemistry in paraffin-embedded tissue.  
A) sample containing VEGF positive cells; B) negative control of the staining. Pictures taken at 20X objective 
and 10X ocular amplification. 
 
4.3 In vitro studies using the Rcho-1 trophoblast cell line 
4.3.1 Effect of CoPPIX and ZnPPIX on the viability of trophoblast precur-
sor cells 
The Rcho-1 cell line is a trophoblastic stem cell line that differentiates into giant cell line 
upon different culture conditions. This cell line is useful to study whether HO-1 is necessary 
for these cells to survive and differentiate into giant cells in the context of this thesis. For this 
purpose, the effect of CoPPIX and ZnPPIX was analyzed in the culture of undifferentiated 
Rcho-1 cells. ZnPPIX is known to down-regulate HO-1 in vivo as well as in vitro. CoPPIX is 
known to up-regulate HO-1 in vivo, whereas in vitro is controversial if this up-regulation 
takes place (reviewed in Ryter et al., 2006). Since no reports of the effect of CoPPIX or 
ZnPPIX on trophoblast cells were found in the literature, different conditions were tested in 
order to use the optimal concentration of ZnPPIX and CoPPIX for these cells. The results on 
HO-1 expression using the different concentrations and incubation time are shown in Fig. 41.  
As it can be observed in the western blot example (Fig 41), Rcho-1 cells express very high 
basal levels of HO-1. A down-regulation of HO-1 can be observed already with 50 mM 
ZnPPIX at 24h. Unlike ZnPPIX, CoPPIX had no effect on HO-1 levels in these cells as HO-1 
expression remained at basal levels. Cells treated with CoPPIX were used then as a control for 
the assay, in order to analyze whether the effects observed with ZnPPIX are due to the down-
regulation of HO-1 or to a putative toxic effect of the porphyrin. 
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Fig. 41 : Example of the Western Blot analysis of Rcho-1 cells treated with CoPPIX or ZnPPIX 
A to D: 12 h after ZnPPIX treatment (0, 25, 50 and 100 μM respectively). 
E to H: 24 h after ZnPPIX treatment (0, 25, 50 and 100 μM respectively) 
I to L: 12 h after CoPPIX treatment (0, 25, 50 and 100 μM respectively). 
M to P: 24 h after CoPPIX treatment (0, 25, 50 and 100 μM respectively). 
It is unknown the reason why the antibody against HO-1 gave two bands in these samples. Nevertheless, the 
upper band (corresponding to 32 kDa) was taken into consideration. 
 
In a first assay, cell viability of the trophoblast stem cell was analyzed after 48 h of treatment 
with medium, ZnPPIX or CoPPIX by tryphan blue exclusion.  
 
Fig. 42 : HO-1 down-regulation leads to diminished viability of the trophoblast stem cells as measured by 
trypan blue exclusion. 
Data are represented by median & range. Significant differences between groups are indicated as asterisks above 
lines. *p≤ 0.05 as analyzed by the Kruskall-Wallis non-parametric test between all groups, followed by the 
Dunn´s Multiple Comparison Test for two particular groups. 
As it can be observed in Fig. 42, a significant diminution in the viability of the cells was ob-
tained 48 h after cells were treated with 50 μM or 100 μM ZnPPIX.  This effect cannot be due 
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to the toxic effect of the porphyrin, since cells treated with CoPPIX did not show a significant 
diminution in the cell viability. Since ZnPPIX is known to block the expression of HO-1, it 
can be assumed that HO-1 is necessary for the survival of trophoblast precursor cells. 
4.3.2 Effect of CoPPIX and ZnPPIX on the differentiation of trophoblast 
precursor cells into giant cells 
The effect of CoPPIX and ZnPPIX in the differentiation of Rcho-1 cells into giant cells was 
analysed applying CoPPIX or ZNPPIX during the differentiation process. Differentiated cells 
show a characteristic morphology, and they can be well recognized from undifferentiated 
cells. Differentiated cells (giant cells) are considerably bigger that undifferentiated cells, and 
they are normally multinucleated or bear a big nucleus. Differentiation of these cells is nor-
mally obtained after 1 week of culture in medium containing 10% horse serum.  
 
Fig. 43 : Stem cells treated with ZnPPIX were unable to differentiate into giant trophoblast cells as ana-
lyzed by light microscopy. 
Pictures taken after 72 h, 5 days and 7 days of culture under differentiation media. Cells treated with normal 
media as well as cells treated with CoPPIX are able to differentiate into giant cells, whereas cells treated with 
ZnPPIX are unable to differentiate into a mature state. 
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As observed in Fig. 43, the morphology of the cells start changing already at 72 h of culture 
and the differentiation is complete at 7 days of culture with medium including horse serum. 
When applying CoPPIX (Fig. 43), no significant changes in the morphology of the cells are 
observed when compared to cells treated with only differentiation medium. However, when 
applying ZnPPIX (Fig 43), which blocked HO-1, the cells are unable to differentiate into gi-
ant cells, pointing out that HO-1 is indispensable for trophoblast precursor cells to differenti-
ate into a mature phenotype. This effect could be due to the toxic effects of ZnPPIX, but this 
is not rather the case, since cells receiving CoPPIX, where the same toxic effect is applied, did 
not show alterations in their differentiation capacity.  
4.4 In vitro studies using mouse T cells over-expressing HO-1 
4.4.1 Generation of the packaging cell lines 
With the aim to transduce lymphocytes with HO-1 for testing their in vitro or in vivo ability to 
suppress maternal T cell responses, we proceed to first generate packaging cell lines express-
ing HO-1. Since retroviral vectors are suited for transduction of T cells, two different packag-
ing cell lines overexpressing the HO-1 transgene were obtained. These cell lines showed the 
following viral titers: 
GP+E HO-1: 6.106 cfu/ml. 
GP+E HO-1iresEGFP: 4.106 cfu/ml. 
After limiting dilution, 14 clones of the packaging cell line HO-1 and 9 clones of the 
HO-1iresEGFP packaging cell line were selected. The selection criterion was based on the 
Western Blot intensity of HO-1 observed for each sample. Representative examples of differ-
ent HO-1 protein expression patterns are shown in Fig.44. In A) it can be observed the differ-
ence in the HO-1 expression between the packaging cell line without the HO-1 transgene, and 
both packaging cell lines obtained. These packaging cell lines were further cloned, and exam-
ples of the different HO-1 expression in the clones are illustrated in B). 
After selecting the highest producer clones, the viral titers were determined as already de-
scribed and the results are summarized in the following table (Table 12). 
Since there is not always a correlation between the transgene expression and the viral titer, it 
was necessary to select those clones that show not only a high expression of the transgene but 
also have a high viral titer. 
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Fig. 44 : Cells from the packaging cell line were efficiently transfected to produce high amounts of HO-1 
as observed by Western Blot analysis. 
A) HO-1 expression in the packaging cell lines prior and after transfection. B) HO-1 expression in the different 
clones from the HO-1 and the HO-1iresEGFP packaging cell lines. 
 
Table  12 : Viral titers of the different clones of the HO-1 over-expressing packaging cell lines 
Clone Viral titer (cfu/ml) Clone Viral titer (cfu/ml) 
1D10 3.107 1H7 4.105 
1E12 3.106 2A10 2.107 
1H12 3.105 2D1 6.106 
2A11 2.107 2D7 1.108 
2C11 3.105 2G2 1.106 
2C3 7.106 3B3 1.108 
2D12 1.106 3E1 1.107 
2E8 9.106 3E10 8.107 
3A2 1.107 3G8 8.107 
3B10 1.106   
3B6 2.107   
3B7 4.107   
3D8 1.107   
A 
3H1 1.107 
B
  
A) Clones from the HO-1 packaging cell line; B) Clones from the HO-1iresEGFP packaging cell line 
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After careful analysis of the results from Western Blots and viral titers determination, the 
clone 3B3 was selected as an appropriate one to be used in the transduction of the 
T-lymphocytes with the HO-1iresEGFP, since it shows a high expression of the protein, and 
an excellent viral titer. In addition, it harbours the advantage of the EGFP as a reporter gene to 
control the transduction efficiency. From the HO-1 packaging cell line, the clone 3D8 was 
selected. 
4.4.2 Transduction of mouse T cells 
Many conditions for mouse T cell transduction with the retroviral particles were tested. The 
highest transduction efficiency (7.91%) was obtained when CD4+ T cells were transduced 
with 500 ml of virus concentrate, in a final volume of 1.5 ml in a 12-well plate. The virus 
concentrate was obtained by means of centrifugation in a Vivaspin column. An example of the 
efficiency of virus transduction, as measured by flow cytometry, is shown in Fig. 45. All other 
conditions tested (explained in materials and methods) were unsuccessful or led to even lower 
transduction efficiency (around 2%).  
 
Fig. 45 : The highest transduction efficiency was obtained by using a virus concentrate as analyzed by flow 
cytometry 
FL-1H measures the cells that are positive for HO-1iresEGFP (transduced cells). In this example, 7.49% of the 
total cells were efficiently transduced. 
 
These transduced cells could theoretically be selected by G-418. Although the selection 
seemed to work, the number of cells remaining alive was to low to be maintained in culture, 
and the cells died after few days. This was repeatedly observed in several approaches. Since 
the G-418 selection was not feasible, the obtainment of a sufficient amount of transduced cells 
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would have required the sacrifice of more than one animal in order to obtain a sufficient ini-
tial amount of cells. Additionally, an excessive production of virus supernatant would have 
been necessary in order to obtain enough amount of virus concentrate. All these inconvenient 
led us to conclude that the transduction of mouse T cells with a retroviral vector was not a 
feasible for our proposed experimental settings, at least using this retroviral vector. We de-
cided then to try alternative methods, like protein transfection, in order to obtain T cells over-
expressing HO-1. 
4.4.3 Protein Transfection 
Protein transfection is still not described in the literature for mouse primary T cells as it is for 
other cells like murine and human fibroblasts. In order to establish the better condition for 
transfection, a positive control using β-galactosidase was used (suggested by the manufacturer 
of the protein transfection reagent). As mentioned in Materials and Methods, different cell 
number, protein content and incubation times were analyzed. Fig.46 depicts the different re-
sults obtained.  
 
0,5 μg protein, 2h incubation
Negative control
1 μg protein, 2h incubation
0,5 μg protein, 30 min incubation
1 μg protein, 30 min incubation
0,5 μg protein, 2h incubation
Negative control
1 μg protein, 2h incubation
0,5 μg protein, 30 min incubation
1 μg protein, 30 min incubation
A B1.105 cells/well 3.105 cells/well
 
Fig. 46 : Up to 80% of the cells were efficiently transfected with the b-gal protein using the protein trans-
fection technology as analyzed by flow cytometry. 
Data are shown by histogram. FL1-Height measures the cells that show b-galactosidase activity. Fig. A shows the 
different conditions tested for 1x105cells/well, whereas Fig. B shows the conditions tested for 3x105cells/well. 
Up to 80.95% of the cells (purple line, diagram B) were efficiently transfected. 
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As mentioned in Materials and Methods, the condition mentioned in 2.2.2.10 was selected as 
optimal for protein transfection. Transfection with HO-1 protein could unfortunately not be 
measured by flow cytometry, and the optimal protein amount was determined by western blot. 
As can be seen in Fig. 47, transfected cells showed higher expression of HO-1 protein when 
compared to untransfected cells, and the amount of 2 μg of protein was selected as optimal for 
the further experiments.  
 
 
Fig. 47 : HO-1 protein was efficiently transfected into CD4+ cells as determined by Western Blot analysis 
1) Untransfected CD4+ T cells 
2) CD4+ T cells transfected with 1 μg of HO-1 protein 
3) CD4+ T cells transfected with 2 μg of HO-1 protein 
 
4.4.4 In vitro analysis of the effect of HO-1+ T cells on the proliferation of 
T cells 
The idea to use cells over-expressing a given molecule as therapy for transplantation (Ham-
mer et al., 2000) gave us the idea of using CD4+ T cells in an abortion-prone setting. For that 
reason, the effect of CD4+ T cells over-expressing HO-1 on cells from an abortion-prone fe-
male was analyzed. Since HO-1 has been described as having anti-proliferative effects, the 
proliferation of these cells (called from now on “control cells”) was analyzed by flow cytome-
try using the CFSE membrane dye. For doing this, cells from a CBA/J female previously 
mated with a DBA/2J male were isolated from lymph nodes, spleen, and thymus and stained 
with CFSE. From the thymus, CD4+CD25+ and CD4+CD25- were isolated and separately 
tested. As previously mentioned, the female was pregnant on day 5 from a DBA/2J male, 
meaning that cells from this female have already encountered male antigens and are supposed 
to generate an antigen specific reaction. In order to stimulate the culture and to simulate the 
continuous encounter with male antigens, DBA/2J cells previously treated with mitomycin C 
were used as stimulators. 
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As depicted in Fig 48, and contrary to our expectations, no differences in the proliferation of 
control cells could be found when CD4+ T cells over-expressing HO-1 were put in contact 
with cells from lymph nodes, spleen or thymus of a CBA/J pregnant female. A significant 
difference was observed in the proliferation of spleen cells, but this diminution was also ob-
served when TMOCK cells were used. The presence of these cells (both THO-1+ or TMOCK cells) 
did also not influence the expression of different markers as CD69 or CD25 (data not shown). 
 
 
Fig. 48 : No effect of CD4+ T cells overexpressing HO-1 on the proliferation of control T cells as measured 
in a MLC. 
Data are represented by mean ± SD. Significant differences between groups are indicated as asterisks above 
lines. *p≤ 0.05 and ***p≤0.001 as analyzed by the Kruskall-Wallis non-parametric test between all groups, fol-
lowed by the Dunn´s Multiple Comparison Test for two particular groups. 
 
The effect of these cells was also tested in vivo. For this purpose, DBA/2J-mated CBA/J fe-
males were intravenously injected with CD4+ T cells over-expressing HO-1 or with TMOCK 
cells in day 5 of pregnancy. Also in vivo, no effect of these cells could be observed, since the 
abortion rates remained similar between the groups.  
From this part of the study, it can be concluded that in this particular model, a cell therapy 
with lymphocytes over-expressing HO-1 was not adequate for the purpose of reducing the 
abortion rate. However, one has to keep in mind that even when HO-1 was expressed in the T 
cells, the transfected protein may not have been active. Unfortunately we were not able to 
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measure HO-1 activity in these cells to confirm our hypothesis. Other possibility is that T 
cells are not the right target for over-expressing HO-1. Dendritic cells would be a rather better 
choice since it is known that HO-1 is expressed in them and that an up-regulation of HO-1 in 
these cells is capable of maintaining them in an immature state (Chauveau et al., 2005). 
4.5 Studies using heme oxygenase-1 deficient mice 
4.5.1 Analysis of the progeny of different mating combinations of mice 
partially or totally deficient on heme oxygenase-1 
The use of transgenic animals lacking a given molecule represents a useful tool to analyze the 
effect that this produces in the organism. In pregnancy, it was essential for the purpose of this 
thesis to analyze the effect of the lack of HO-1 on different stages of pregnancy. 
As already mentioned in the literature, breeding between homozygous Hmox1 deficient mice 
does not yield progeny (Poss and Tonegawa, 1997), and mice genetically deficient in Heme 
Oxygenase-1 (Hmox1 deficient mice, or Hmox1-/- mice) are partially embryonic lethal (Yet et 
al., 1999), suggesting a key role of HO-1 in the onset of pregnancy. Additionally, when het-
erozygous mice (Hmox1+/-) are mated for maintaining the colony, very low percentage of 
knockout animals (Hmox1-/-) are usually born, usually between 5 and 10%, according to the 
literature and to personal communication of Prof. Soares. This unexpected variation from the 
25% expected Mendelian rate may be due to different reasons:  
 
1) The Hmox1-/- fetuses are rejected 
2) The Hmox1-/- blastocyst present implantation impairments 
3) Oocytes lacking Hmox1 are not as easily fertilized as oocytes expressing Hmox1. 
4) Sperm lacking Hmox1 does not fertilize as easily as sperm expressing Hmox1. 
 
For the purpose of analyzing if the Hmox1-/- fetuses are rejected and to know if there is a dif-
ference in the number of implantations or in the abortion rates regarding the different expres-
sion of Hmox1, the outcome of different combinations of Hmox1-/-, Hmox1+/- and Hmox1+/+ 
mice was analyzed. This was tested in a syngeneic as well as in an allogeneic context, 
whereas the female was from a different genotype, namely C57/BL6. Unfortunately, for this 
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combination it was only possible to use wild type females (Hmox1+/+) as no knockout in 
C57/BL6 background were available at the moment of performing the experiments. The re-
sults obtained are shown in Table 13. 
It has been described previously (Poss and Tonegawa, 1997; Yet et al., 1999) that no progeny 
can be achieved when mating Hmox1-/- mice. However, these studies did not analyze whether 
this phenomenon is due to no implantation or due to complete rejection of the implanted em-
bryos. Due to the difficulties in the obtainment of Hmox1-/- animals, we did not perform 
groups using Hmox1-/- females.  
 
Table  13 : Hmox1 partial or total deficiency in the female or the male resulted in implantation failure or 
higher abortion rates. 
Mating genotype 
(female x male) 
Number of con-
cepti 
(number of ani-
mals) 
Abortion rate 
(median) only in 
those animals 
with visible im-
plantations on day 
12-14 
Mean of  
Implantation 
sites 
(plugged fe-
males) 
Number of ani-
mals with  
visible cocepti 
(plugged female) 
Syngeneic (BALB/c x BALB/c) 
Hmox1+/- x Hmox1-/- 44 (11) 38.7 % 4 (11) 4 (11), 36.4 % 
Hmox1+/- x Hmox1+/- 82 (7) 22.2 % 11.7 (7) 7 (7), 100 % 
Hmox1+/- x Hmox1+/+ 46 (6) 18.4 % 7.7 (6) 4 (6), 66.7 % 
Hmox1+/+ x Hmox1-/- 32 (5) 9.4 % 6.4 (5) 3 (5), 60 % 
Hmox1+/+ x Hmox1+/- 42 (5) 11.1 % 8.4 (5) 5 (5), 100 % 
Hmox1+/+ x Hmox1+/+ 43 (8) 0 % 5.45 (8) 5 (8), 62.5% 
Allogeneic (C57/BL6 x BALB/c) 
Hmox1+/+ x Hmox1-/- 58 (8) 8,6 % 7.25 (8) 7 (8), 87.5% 
Hmox1+/+ x Hmox1+/+ 43 (8) 0 % 5.40 (8) 5 (8), 62.5% 
Abortion rates and implantation sites resulting from the mating of mice with different genotypes for Hmox-1. In 
the second row, the total number of concepti is depicted, with the total number of females shown between brack-
ets.  In the third and fourth row, the number of plugged females is indicated between brackets.   
 
When females partially deficient in Hmox-1 (Hmox1+/-) are mated with Hmox1-/- males, 4 out 
of 11 females that showed insemination plug were indeed pregnant, and showed an abortion 
rate of 38.7%. The fact that only 4 out of 11 females were pregnant suggests that Hmox1-/- 
male may present fertilization problems. Similarly, when Hmox1+/+ females were mated with 
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Hmox1-/-, 3 out of 5 females mated were pregnant, suggesting here that Hmox1-/- males may 
have fertilization problems. However, Hmox1+/+ males also showed fertilization problems 
when fertilizing Hmox1+/- or Hmox1+/+ females, since not all females showing insemination 
plug were pregnant. This suggests that these fertilization problems may not be exclusively 
associated with the lack of Hmox1 in the male. 
When analyzing the abortion rates from the heterozygous females, an interesting result is ob-
served, namely that the abortion rate is higher when less HO-1 is present in the mating com-
binations. When these females were mated with Hmox1+/+ males, they presented an abortion 
rate of 18.4 %, with Hmox1+/- males the abortion rate was of 22.4 %, whereas with Hmox1-/- 
males the abortion rate was of 38.7 %.  Although these differences are not significant, a ten-
dency towards an augmentation on the abortion rate with the diminution of HO-1 in the sys-
tem can be appreciated.  
When Hmox1+/+ females were mated with all three types of males, they showed very similar 
abortion rates in all three types of combinations, and the abortion rate was normal for synge-
neic combinations (between 0 and 10% of abortion). This data strongly suggests that HO-1 is 
very important in the maternal site for a successful pregnancy, whereas its absence in the pa-
ternal site may not be as important as like in the maternal site. 
When doing an allogeneic combination using Hmox1+/+ C57/BL6 females mated either with 
Hmox1-/- or Hmox1+/+ BALB/c males, most of the females presenting insemination plug were 
pregnant. When the male was deficient in Hmox1, an 8.6% of abortion was observed, against 
0% of abortion obtained with the Hmox1+/+ males, confirming again that the absence of HO-1 
on the paternal side may not be as important as it is in the maternal site. 
Analysis of the genotype of the fetuses and resorptions were performed in the groups of het-
erozygous females mated either with knockout or heterozygous males. Some of the fetuses 
from the other groups were randomly analysed and confirmed to be heterozygous, as ex-
pected. An example of the genotyping analysis performed by PCR is shown in Fig. 49.  
The results of the analysis are shown in Fig. 50 for the Hmox1+/- x Hmox1-/- combination, and 
in Fig. 51 for the Hmox1+/- x Hmox1+/- mating combination. 
Surprisingly, the mating of Hmox1+/- females with Hmox1-/- males lead only to heterozygous 
offspring. These results may suggest that Hmox1-/- blastocysts were unable to implant, since 
fetuses as well as resorptions were heterozygous. The fact that in this group only 4 out of 11 
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females showing insemination plug were pregnant suggests that Hmox1-/- sperm may present 
fertilization problems. 
 
 
Fig. 49 : Example of amplification bands obtained in the genotyping of fetuses as analyzed in an Ethidium 
Bromide-stained gel after electrophoresis. 
Amplification products of the PCR reactions for the E3/EI3 fragment (present in the wild type gene) and the 
Neo-1/E4 fragment (present in the modified gene) as analyzed in a 1% agarose gel containing ethidium bromide 
under ultraviolet transillumination.  
A) Wild type control F), G) Heterozygous fetus (duplicate) 
B) Hmox1-/- control  H), I) Hmox1-/- fetus (duplicate) 
C) Heterozygous control  J), K) Wild type fetus (duplicate) 
D), E) Non Template Control (duplicate)  
 
 
 
Fig. 50 : all fetuses and resorptions from the Hmox1+/- x Hmox1-/- combinations were heterozygous. 
In the Hmox1+/- x Hmox1-/- combination, fetuses and resorptions from 2 pregnant females were genotyped. 
 
On the other side, the mating of Hmox1+/- females with Hmox1+/- males led to the typical per-
centage of knockouts obtained from these matings, and this percentage is lower as the ex-
pected Mendelian rate of 25%. According to personal communication from Prof. Soares and 
to personal observation from the maintenance of the colony, this percentage is always be-
tween 3 and 10%. This reinforces the idea of inability of knockout embryos to implant, or 
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inability of females lacking partially HO-1 of providing essential conditions for fetuses to 
implant. 
 
Fig. 51 : All resorptions from the Hmox1+/- x Hmox1+/- combination were heterozygous 
In the Hmox1+/- x Hmox1+/- combination, fetuses and resorptions from 3 females were genotyped. 
 
Interestingly, the resorptions were again heterozygous (Fig 51) suggesting that the lower per-
centage of Hmox1-/- fetuses obtained from the Hmox1+/- x Hmox1+/- mating is due to the lack 
of implantation of the Hmox1-/- blastocysts rather than to rejection of these fetuses.  
4.5.2 Assessment of fertility of the Hmox1-/- females  
4.5.2.1 Number of oocytes after hormonal stimulation 
In the former experiment it could be observed that HO-1 is very important especially in the 
mother, for successful pregnancy to occur. This does still not explain why the mating of het-
erozygous mice does not give the expected Mendelian rate, since the fetuses that were re-
jected were heterozygous and not homozygous as expected, and does also not explain why 
homozygous mice do not give viable progeny. In order to assess if this can be due to sterility 
problems of the homozygous mice or to a defect or delayed ovulation, Hmox1-/- and Hmox1+/+ 
females were first stimulated with hormones in order to see if they are able to produce viable 
oocytes. As described in 3.2.4.2.4, females were sacrificed 13-14 h after hCG injection. Oo-
cytes from 8 females were placed in two or three fertilization plates. This procedure was car-
ried out for wild type females, here referred as Hmox1+/+ (n = 8) and for knockout (Hmox1-/-) 
females (n = 8). Interestingly, the number of oocytes obtained differed greatly between the 
Hmox1+/+ and Hmox1-/- females, although they were treated under the same conditions and 
injected with the same lot of hormones. Age differences between the animals can not play a 
role since the animals used were age-mated. The total number of oocytes obtained from the 
wild type females (n=8) was 208, while the number obtained from the Hmox1-/- females (n=8) 
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was 137. This difference is depicted in Fig. 52A. A similar graphic was obtained when calcu-
lating the number of oocytes per female (calculated taking into account the average of oo-
cytes/female in each plate), as can be seen in Fig. 52B.  
 
Fig. 52 : Hmox1-/- females produce less oocytes than Hmox1+/+ after hormonal stimulation. 
A) Total number of oocytes (n=8 wild type females; n=8 Hmox1-/- females); B) Number of oocytes per female. 
 
Since the procedure of oocyte collection from the oviduct has to be performed very quickly 
and in a very short period of time (less than 5 minutes per female), and considering that newly 
ovulated oocytes are surrounded by cumulus cells, it was not possible to count the number of 
oocytes obtained per female as they were retreated from the oviducts. Once the oocytes were 
washed and liberated from cumulus cells, it was possible to determine the exact number of 
oocytes per fertilization plate. As the number of oocytes obtained from the Hmox1-/- females 
was less than the ones from the Hmox1+/+ females, their fertilization was performed only in 
two fertilization plates instead of three. For this reason, it was not possible to determine of the 
difference in the number of oocytes was statistically significant. 
4.5.2.2 Analysis of the follicle development in the ovaries from Hmox1-/- and 
Hmox1+/+ females 
In order to analyze the origin of the difference observed in the oocyte number between 
Hmox1+/+ and Hmox1-/- females, the ovaries of the females used as oocytes donors Hmox1+/+ 
and Hmox1-/-) where analyzed histologically. Differences in the ovaries due to different sexual 
maturity between Hmox1-/- and Hmox1+/+ can be discarded since, as mentioned before, the 
animals used for this study were age-mated. 
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Histological analysis of the ovaries of females from both groups showed that, even though 
ovaries from both types of females showed similar morphology, they presented differences 
regarding their follicle development. In order to quantify these observations, the number of 
follicles in different stages of maturation was analyzed under the microscope in all samples 
obtained (in both ovaries from each animal, counting at least three slides per ovary). As de-
picted in Fig. 53, the total number of oocytes per ovary is similar between both types of fe-
males.  
 
 
Fig. 53 : Ovaries from Hmox1+/+ and Hmox1-/- females present the same total number of follicles as ana-
lyzed under light microscope. 
Data are represented by medians ± 75% quartiles. No significant differences were found between the groups 
Mann-Whitney U-test between both groups.  
 
However, when analyzing the number of follicles in the different maturation stages (Fig 55), 
some differences were found. Fig 54 is showing an example of follicles in different matura-
tion stages. As it can be observed in Fig. 55,  Hmox1-/- ovaries show similar number of secon-
dary follicles as Hmox1+/+ ovaries. The number of primordial, primary and mature follicles 
differs slightly between both groups, but these differences were not significant. However, 
when analyzing the number of corpus luteum between both groups, Hmox1-/- ovaries showed 
a significant diminution when compared to Hmox1+/+ ovaries. It is important to mention that 
the total number of follicle per ovaries does not differ between the groups (Fig. 54), pointing 
out that the difference in the number of corpus luteum account are compensated by a slight 
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augmentation in the number of primordial and secondary follicles in Hmox1-/- ovaries when 
compared to Hmox1+/+ ovaries.  
 
 
Fig. 54 : Representative pictures of HE staining showing the different stages of follicle maturation as seen 
under light microscope. 
Pictures were taken with a 20X magnification. The differences in the size of the follicles showed in these pic-
tures are in accordance with the difference in sizes observed in the samples. 
A) Primordial follicle 
B) Primary follicle 
C) Secondary follicle 
D) Mature follicle 
E) Corpus luteum 
 
The significant diminution in the number of corpus luteum as shown in Fig. 55 is also in ac-
cordance with the fact that Hmox1-/- females produced less oocytes than Hmox1+/+ females 
(Fig. 52), because the corpus luteum is the structure remaining after the release of the oocyte. 
Taken all these data together, it is tempting to speculate that Hmox1-/- females react differently 
than Hmox1+/+ females to hormones, since the follicle development of the ovaries from both 
differ greatly, even though both groups showed similar number of oocytes in the ovaries. This 
difference in the response to hormonal treatment may also account for the difference found in 
the number of oocytes secreted by Hmox1-/- and Hmox1+/+ females. Since the difference in the 
number of corpus luteum between both groups is significant, it is tempting to speculate that 
the difference in the number of oocytes showed in Fig. 52 may also be significant. 
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Fig. 55 : Different follicle development in ovaries from Hmox1+/+ and Hmox1-/- females after hormone 
stimulation as analyzed by light microscopy. 
Data are represented by median & interquartile range. Significant differences between groups are indicated as 
asterisks above lines. *p≤ 0.05 as analyzed by the Mann-Whitney U-test between both groups. For each animal, 
the mean value of follicles in different stages was calculated analyzing at least 3 slides for each ovary and used 
as number of follicles per ovary. For each group, 8 animals were analyzed. 
 
4.5.2.3 Assessment of the fertilization rate after In Vitro Fertilization (IVF) 
Since Hmox1-/- do not yield progeny, it was imperative to determine whether this problem 
could be due to an impaired fertilization. Briefly, Hmox1-/- oocytes were in vitro fertilized 
with Hmox1-/- sperm whereas Hmox1+/+ oocytes were in vitro fertilized with Hmox1+/+ sperm. 
The fertilization rate was assessed by counting the number of oocytes in two-cell stage, and 
the percentage of fertilization was calculated taking into account the initial number of oo-
cytes. As can be observed in Fig. 56, a statistically significant difference in the fertilization 
rate of Hmox1+/+ and Hmox1-/- oocytes was obtained.  
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Fig. 56: Hmox1-/- oocytes are poorly fertilized with Hmox1-/- sperm when compared to Hmox1+/+ oocytes 
with Hmox1+/+ sperm compared to Hmox1+/+ oocytes by counting the number of oocytes in two 
cell stage. 
Percentages of fertilization rate of Hmox1+/+ and Hmox-/- oocytes. The results are expressed as the mean of the 
fertilization rate obtained in each fertilization plate. ***p≤ 0.0001 as analyzed by the Fisher´s exact test between 
both groups comparing the total number of fertilized and unfertilized oocytes. 
 
A high percentage (61.70%) of the Hmox1+/+ oocytes were successfully fertilized in vitro, 
whereas only 19.78% of the Hmox1-/- oocytes could be fertilized using the exact same condi-
tions (Fig. 56).  
The percentage of fertilization obtained for Hmox1+/+ oocytes was in accordance with the 
percentages normally obtained using this methodology. The percentage of fertilization of 
Hmox1-/- was extremely low, even though the conditions of fertilization were identical in both 
cases. The statistically significant difference obtained in the fertilization rates between 
Hmox1+/+ and Hmox1-/- oocytes is outstanding, since works claiming the importance of other 
molecules in fertilization present a difference in percentage of 14.1% between wild type and 
knockout oocytes (Hefler and Gregg, 2002), whereas in this work the difference was as big as 
41.92%. The data obtained here clearly shows that deficiency in Hmox1 has a strong effect in 
fertilization and opens up an unexpected role of HO-1 in the reproductive field. 
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4.5.3 Assessment of the implantation capability after embryo transfer 
Another possible explanation for the lack of progeny of Hmox1-/- could be related to implanta-
tion problems beside the impaired fertilization ability of the oocytes and sperm. In order to 
test this hypothesis, the embryos in two-cell stage obtained by in vitro fertilization were trans-
ferred into recipient females. The recipient females were hormonally treated and mated with 
vasectomised males in order to assure that they were in a receptive phase. Only females show-
ing plug with the vasectomised males on the day of the transfer were used for this part of the 
study.  
In order to test whether Hmox1 is necessary in the mother, in the fetus or in both for implanta-
tion to occur, Hmox1-/- oocytes were transferred to a Hmox1+/+ as well as to a Hmox1-/- recipi-
ent female. Additionally, Hmox1+/+ oocytes were transferred either to a Hmox-/- or to a 
Hmox1+/+ female. In this context, it was also interesting to analyze the participation of T cells 
in HO-1-dependent impaired pregnancies. As we know from a personal communication, the 
mating of Hmox1+/- SCID animals gives more Hmox1-/- progeny mice than the mating of 
Hmox1+/- immune competent animals (personal communication of Prof. Soares). Therefore, 
we also tested whether Hmox1+/+ are able to implant in SCID Hmox1-/- recipient females.  
Results for the transfer of Hmox1+/+ oocytes are schematized in Fig. 57 and in Fig. 58 for the 
transfer of Hmox1-/- oocytes.  
Two Hmox-1-/- females and two SCID/Hmox1-/- females received 10 two-cell stage Hmox1+/+ 
embryos in each uterine horn. One Hmox1+/+ female and one SCID Hmox1+/+ female received 
as well 10 two-cell stage embryo in each uterine horn.  
Unfortunately, one of the Hmox1-/- females died two days after the embryo transfer due to 
unknown reasons. The other Hmox1-/- female was sacrificed on day 14 of pregnancy, and 
showed no sign of embryo implantation. The uterus was neither swallowed nor was it differ-
ent from the uterus of a virgin female.  
One of SCID Hmox1-/- females showed no visible implantations after transfer of Hmox1+/+ 
oocytes, but inflamed uterus. However, the other SCID Hmox1-/- female presented two im-
plantations after the transfer of Hmox1+/+ oocytes. It is possible that the first recipient female 
rejected the embryos after implantation, therefore the inflamed uterus. Unfortunately, the 
SCID Hmox1+/+ female, which was supposed to serve as a control, showed no sign of visible 
implantations. 
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Hmox1+/+ oocytes 
 
Fig. 57 : Hmox1+/+ embryos were not able to implant in Hmox1-/- uteruses 
Implantation success was assessed 14 days after embryo transfer. 
 
The Hmox1+/+ female showed 2 implantations after transfer of Hmox1+/+ oocytes.  
These results suggest that in immune competent animals, the lack of Hmox1 can lead to im-
plantation failure, as Hmox1+/+ oocytes were not able to implant in Hmox1-/- uterus while 
these oocytes were able to implant in Hmox1+/+ uterus. The fact that these embryos were able 
to implant in SCID animals lacking Hmox1 suggests that in immune competent animals, 
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HO-1 is necessary to counteract the inflammation in the uterus due to the presence of immune 
cells of maternal origin, which may attack paternal antigens. 
 
Hmox1-/- oocytes 
 
Fig. 58 : Hmox1-/- embryos are able to implant in Hmox1+/+ uterus 
Implantation success was assessed 14 days after embryo transfer. 
 
Due to the low number of Hmox1-/- fertilized oocytes, the transfer could be only performed 
into two females (one Hmox1+/+ and one Hmox1-/-).  
The Hmox1+/+ female implanted three Hmox1-/- embryos, showing that Hmox1-/- can normally 
implant if the uterus express HO-1. However, the Hmox1-/- female showed no implantation. 
The uterus was nor inflamed or different from the uterus of a virgin female. This suggests 
again need of uterine HO-1 expression for implantation to occur. 
All these data together suggest that HO-1 is essential in the female uterus for implantation to 
occur beside the already analyzed role of HO-1 in prevention of rejection. 
Summary 
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5 Discussion 
Mammalian pregnancy is a parabiotic union of two genetically different individuals, the fetus 
and the mother. At the feto-maternal interface, inflammatory processes can occur due to the 
invasion of microorganisms, but also due to an immune reaction against alloantigens on the 
fetus or trophoblast. Many studies in animals and humans indicate that some degree of sys-
temic or uterine inflammation is necessary for both normal implantation and pregnancy, but if 
this inflammation becomes too excessive it can cause pregnancy complications such as abor-
tion (reviewed in Christiansen et al., 2006). Many changes in uterine physiology that occur 
following the implantation of the blastocyst resemble classical inflammation at the mucosal 
surfaces of the female reproductive tract (Mellor and Munn, 2000). One of the first works 
showing the similarity between implantation of the blastocyst and inflammation was the dem-
onstration in rats by Psychoyos (Psychoyos, 1976) that areas of the uterus containing implant-
ing blastocysts stained blue following the intravenous injection of Pontamine Sky Blue. This 
demonstrated increased blood flow and permeability of the vessels supplying implantation 
sites, a response known to be the basis of the main early stages of inflammation (Finn, 1986). 
As pointed out in previous reports, heme oxygenase-1 (HO-1) plays a key role in inflamma-
tory processes (rewieved in Ryter et al., 2006). Viewing pregnancy mainly as an inflammatory 
process had led us to the idea that HO-1 may play an important role in pregnancy. Previous 
works from our group and from others have shown that HO-1 as well as HO-2 are expressed 
in different trophoblast cells (Lyall et al., 2000; Barber et al., 2001; Zenclussen et al., 2002b 
and 2003b), and diminished levels of both can be found in immunological pregnancy compli-
cations in humans as well as in animals models (Zenclussen et al., 2002b and 2003b). This 
suggests that the heme oxygenase system is necessary at the feto-maternal interface, and that 
its degree of expression may be related to the success or failure of pregnancy.  
Pregnancy is viewed by many from a histoincompatibility point of view. Many propose the 
histoincompatibility between maternal and paternal antigens that provokes a semi-allogeneic 
fetus as one of the main causes for fetal acceptance or rejection. In this regard, it is thought 
that an exacerbated immunological reaction towards the fetus may provoke an immunological 
misbalance that would lead to fetal rejection. According to this, fetal rejection mechanisms 
would resemble the mechanisms involved in the rejection of an allograft. In the transplanta-
tion field, HO-1 has also been shown by others to play an important role and to have benefi-
cial effects when up-regulated (Soares et al., 1998; Coito et al., 2002; Tullius et al., 2002).  
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Considering the important role of HO-1 in inflammatory processes as well as in transplanta-
tion, and regarding the resemblance of both entities to different stages of pregnancy, the main 
aim of this work was to analyze the role of HO-1 in the different processes related to preg-
nancy by means of functional studies employing in vivo as well as in vitro models. In the first 
part of the work we aimed to clarify whether a specific up-regulation of HO-1 may be able to 
rescue mice from spontaneous abortion using a well established abortion model. The HO-1 
up-regulation was performed by applying an adenoviral vector containing HO-1. We further 
aimed to obtain T cells over-expressing HO-1 as a therapeutic tool. In the second part of this 
thesis, considering that trophoblasts are important sources of HO-1, we aimed to clarify 
whether HO-1 is indispensable in the process of trophoblast survival and differentiation into 
giant cells. For this, we used a trophoblast stem cell line which differentiates into trophoblast 
giant cells in order to in vitro resemble the process of placentation.  In the last part of this 
work, mice deficient in Hmox1 were used for clarifying the role of HO-1 in earlier stages of 
pregnancy, namely fertilization and ovarian follicle development. Besides, different mating 
combinations of mice partially or totally deficient in Hmox1 were used to analyze the preg-
nancy outcome, to try to clarify if HO-1 is necessary in the female, in the male or in both for 
successful pregnancy to occur. All these points are discussed below. 
 
Role of HO-1 in immunological spontaneous abortion 
 
Previous studies from our group and from others support the concept that, during pregnancy, 
different types of trophoblast cells are important sources of HOs (Ihara et al., 1998; Barber et 
al., 2001; Zenclussen et al., 2003; Zenclussen et al., 2005) and would participate in the ca-
tabolism of the heme protein, avoiding accumulation or recirculation of free heme, which 
could be extremely toxic for the mother and for the fetus. HO-1 and HO-2 down-regulation 
has a high potential to be harmful at the feto-maternal interface, since high amounts of free 
heme readily incorporate into endothelial cells, leading to oxidative injury and enhanced ad-
hesion molecule expression (Balla et al., 1991; Wagener et al., 1997; Vachharajani et al., 
2000), allowing the migration of inflammatory lymphocytes into the feto-maternal interface. 
Interestingly, previous works have reported down-regulated HO-1 and HO-2 levels at the feto-
maternal interface from mice undergoing abortion (Zenclussen et al., 2005). Accordingly, low 
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HO-1 and HO-2 levels were found in placental tissues from patients undergoing abortion 
when compared to normal pregnant patients (Zenclussen et al., 2003). 
Although the presence and the putative protective role of HO-1 during pregnancy have been 
previously reported (Ihara et al., 1998; Barber et al., 2001; Zenclussen et al., 2003; Zenclus-
sen et al., 2005c), it was still unknown if an up-regulation of HO-1 around implantation win-
dow would have beneficial effects on pregnancy outcome. During the preparation of this the-
sis, it was shown by another work from our group that an up-regulation of HO-1 through 
chemical induction by means of CoPPIX can diminish the abortion rate (Sollwedel et al., 
2005). Most interestingly, the down-regulation of HO-1 through ZnPPIX during implantation 
boosted abortion up to 60%, suggesting that HO-1 plays an important role in avoiding fetal 
rejection (Sollwedel et al., 2005). However, the mechanisms by which HO-1 exerted its action 
were not clear in the employed onset, since many of the effects observed can be accounted to 
secundary effects of the chemical compound CoPPIX and in many cases were similar to the 
effects observed by ZnPPIX application.  
In the first part of the present work, the CBA/J x DBA/2J combination, an established mouse 
model to investigate immunological pathways leading to spontaneous abortion was employed 
(Chaouat et al., 1988), to analyze the effect of HO-1 up-regulation on pregnancy outcome. 
Pregnant mice were injected with an adenovirus coding for HO-1 and the reporter gene GFP. 
As indicated by similar abortion rates to the PBS-treated abortion-prone animals, the injection 
of a vector containing EGFP alone did not provoke any deleterious effects in the pregnancy 
outcome. We could show that the application of viral vectors containing putative protective 
genes provides a useful and valid system to glance at their effects on pregnancy outcome in 
this experimental model.  
Here, it could be shown for the first time that a specific increase in the systemic HO-1 expres-
sion following gene transfer of 1.105 PFU AdHO-1/GFP improves pregnancy outcome in a 
murine model of abortion by diminishing fetal rejection rate. The avoidance of accumulated 
free heme might be one main reason for the success of the therapy, since an excess of free 
heme can cause cell damage and conduce to tissue injuries by the formation of reactive oxy-
gen species (Vercellotti et al., 1994). Nevertheless, mice receiving 1.108 PFU AdHO-1/GFP 
showed no significant diminution in the abortion rate. One has to keep in mind that all the 
heme-degradation products are potentially toxic, depending on the generated amounts and the 
microenvironment (Wagener et al., 2003). Too high HO-1 expression may cause tissue injury 
by generating high levels of iron or resulting in bilirubinemia (Suttner and Dennery, 1999; 
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Tyrrell, 1999). Interestingly, mice receiving high doses of the AdHO-1/GFP vector showed 
icteric sera and amniotic liquid, suggesting a too high HO-1 expression and subsequently hy-
perbilirubinemia and toxicity against the fetus. 
The fact that no significant differences regarding HO-1 levels were found at mRNA or protein 
levels after AdHO-1/GFP treatment may be related to the time point chosen for analysis (9 
days after adenovirus injection). It is known that adenoviruses are cleared between 5 and 20 
days post-infection (Dai et al., 1995), due to the strong immune that they generate in the host. 
Having sacrificed the animals 9 days after the injection implies the possibility that most of the 
transduced cells were already cleared and therefore no major differences regarding HO-1 ex-
pression could be found. It would have been interesting to sacrifice the animals 2 or 3 days 
after injection of the adenovirus to analyze the pattern of HO-1 expression in different organs. 
However, if that would have been the case, it would have been impossible to analyze the 
pregnancy outcome, since at day 8 of pregnancy it is still impossible to differentiate between 
a healthy fetus and a resorption. However, some transduced cells were found in some of the 
treated animals. As it was shown by fluorescence microscopy, trophoblast cells were effi-
ciently transduced by the adenovirus, whereas no GFP expression was found in fetal tissue. 
This is in accordance with previous reports pointing out that fetal membranes may act as a 
barrier, which may naturally prevent adenoviral particles from passing between embryonic 
cavities (Laurema et al. 2004). On the other side, when analyzing GFP expression by PCR, 
most of the GFP expression was found in the maternal liver. This is due to the fact that the 
liver sequesters the majority of systemically administered Ad particles via hepatic macro-
phages (Kupffer cells) (Glasgow et al., 2006) and is in accordance with the already described 
hepatic tropism of adenoviruses. However, it was surprising to find comparable levels of GFP 
DNA expression in the fetuses and placentas. The fact that no GFP expression was observed 
by fluorescence microscopy in the fetuses may suggest that adenoviral vectors may have been 
able to infect some cells of the fetus, but the protein was not expressed. Interestingly, a report 
by Everett et al. analyzing the persistence of adenoviral vectors in different strains of animals 
have shown that despite the persistence of the vector genome in the liver, a precipitous loss of 
LacZ protein expression was found. One of their explanations was that the differential elimi-
nation of transgene expression may have been due to a strain-specific differential down-
regulation of the CMV enhancer/promoter element utilized to drive the LacZ gene in their Ad 
vector (Everett et al., 2004). One alternative speculation for the promoter shutdown was a 
differential rate of down-regulation of transcriptional factors induced by adenoviral infection. 
It is tempting to speculate that in the work presented in this thesis, a differential down-
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regulation of the CMV-promoter took place in the fetuses, making the GFP protein not ex-
pressed in this tissue. The GFP expression found by PCR can also arise from fetal skin, since 
Senoo and co-workers have also been able to find low adenoviral expression in fetal skin 
(Senoo et al., 2000). 
Regarding the mechanisms by which the adenoviral vector containing HO-1 is pregnancy-
protective in this model, one of them seems to be a Th2 polarization. In this work, augmented 
levels of IL-4 as well as diminished levels of IFN-γ were found systemically and locally after 
application of AdHO-1/GFP. The “Th1/Th2/Th3 paradigm” proposes that a balance between 
Th1 and Th2/Th3 cytokines is critical for pregnancy development. Th2 and Th3 type cyto-
kines such as IL-4, IL-10 (Th2) and TGF-β (Th3) were proposed to favour the maintenance of 
mammalian pregnancy (Lin et al., 1993; Chaouat et al., 1995), whereas the excessive produc-
tion of Th1 cytokines (IL-2, IFN-γ, TNF-α) would mediate the rejection of the fetus at the 
feto-maternal interface (Lin et al., 1993; Raghupathy, 1997). Down-regulated HO levels were 
related with increased Th1 levels in transplantation immunology (Woo et al., 2000) and the 
up-regulation of HO-1 by CoPPIX diminished Th1-cytokines levels while being successful in 
allowing graft acceptance (Woo et al., 2000). Here, we found diminished IL-4/IFN-γ 
(Th2/Th1) ratio at the fetal-maternal interface from abortion-prone mice, confirming previous 
results of the group (Zenclussen et al., 2005c). Treatment of mice undergoing abortion and 
presenting elevated Th1 levels with 1.105 PFU AdHO-1/GFP provoked an augmentation in 
Th2 secretion accompanied by a diminution in the Th1 production, as shown by an augmented 
IL-4/IFN-γ ratio when compared to animals treated with PBS or the control vector. Here, en-
hanced Th2/Th1 ratio was found in spleen as well as in decidual lymphocytes from mice in 
which the therapy was successful in avoiding fetal rejection, suggesting a local and systemic 
effect of the therapy on the Th2/Th1 secretion. It is tempting to speculate that the up-
regulation of HO-1 protects the tissues by stimulating cells to shift their cytokine production 
to a Th2 profile. Regarding the expression of IL-10 and TNF-α, a tendency towards an aug-
mentation of the IL-10/TNF-α ratio was found in spleen lymphocytes from mice treated with 
AdHO-1/GFP. In decidual lymphocytes, however, normal pregnant mice presented a dimin-
ished IL-10/TNF-α ratio when compared to the abortion prone-group. In accordance with the 
levels found in normal pregnant mice, decidual lymphocytes from mice receiving AdHO-
1/GFP presented a diminished IL-10/TNF-α ratio when compared to the abortion-prone mice 
group. Nevertheless the differences were not significant for any of the cases (spleen and de-
cidual lymphocytes). Even though the results were not as expected, the IL-10/TNF-α levels in 
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decidual cells of the group receiving the AdHO-1/GFP behaved in the same way as the de-
cidual cells from normal pregnant animals. Our data on the influence of HO-1 on the Th1/Th2 
ratio are in agreement with data by Woo and co-workers showing that an up-regulation of 
HO-1 by CoPPIX diminished the IFN-γ production in a graft-versus-host disease model (Woo 
et al., 2000).  
To analyze whether the Th2 augmentation responds to a major number of Th2 lymphocytes 
migrating to the fetal-maternal interface or to a polarization of lymphocytes to Th2, lympho-
cyte infiltration was measured in placental and decidual tissue. In placental tissue, no differ-
ences were found between the groups, suggesting that HO-1 application did not lead to an 
augmented lymphocyte infiltration into the fetal component of the feto-maternal interface. In 
decidual tissue, however, a significant augmentation of the CD3 mRNA expression was found 
in the group of mice receiving the AdHO-1/GFP vector. This suggests an augmented infiltra-
tion into the maternal part of the feto-maternal interface. Considering the already mentioned 
Th2 shift, it is tempting to speculate that these lymphocytes were Th2.  
We next analyzed whether HO-1 application has any effect on a specific lymphocyte sub-
population, namely regulatory T cells (Treg) as Treg were proposed to be important for preg-
nancy maintenance (Zenclussen, 2005; Saito et al., 2005). Interestingly, it has been proposed 
that it may be a relationship between Treg and HO-1 (Pae et al., 2003; Choi et al., 2005), 
whereas others do not find any relation (Zelenay et al., 2007). We have shown that mice that 
were rescued from abortion by the adoptive transfer of Treg presented augmented levels of 
HO-1 at the feto-maternal interface (Zenclussen et al., 2006). This suggests that Treg are able 
to induce HO-1 expression at the feto-maternal interface. On the other hand, we could also 
show that HO-1 up-regulation by means of CoPPIX augmented the levels of the Treg marker 
Neuropilin-1 (Sollwedel et al., 2005), suggesting a bi-directional relationship between HO-1 
and Tregs in pregnancy. In this work, no relation could be found between HO-1 and Treg as 
the application of an adenoviral vector containing HO-1 did not modify the levels of the 
markers analyzed (Foxp3 and TGF-β).  
Since HO-1 is known to have anti-apoptotic properties (Soares et al., 1998), the possible in-
fluence of HO-1 up regulation on apoptosis-related events at the fetal-maternal interface was 
investigated. AdHO-1 treatment could slightly down-regulate the placental caspase-3 activity 
when compared to abortion-prone mice treated with PBS or with a control vector, suggesting 
diminished apoptotic activity at the feto-maternal interface. Moreover, the TUNEL staining 
allowed us to confirm a significant diminution in the number of apoptotic cells in placenta 
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from mice receiving low doses of AdHO-1/GFP when compared to PBS- or EGFP-treated 
abortion-prone mice, confirming therefore the anti-apoptotic effect of the HO-1-therapy at the 
feto-maternal interface. Since the caspase-3 activity was not statistically diminished after 
AdHO-1 therapy, while the number of apoptotic cells was, it is tempting to speculate that 
apoptosis in this system is not caspase-3 dependent. Other works have already pointed out that 
the anti-apoptotic effects of HO-1 may act through a caspase-3 independent pathway (Lang et 
al., 2005).  The anti-apoptotic effect observed in our model is also in accordance with anti-
apoptotic effects of HO-1 observed in transplantation (Coito et al., 2002; Braudeau et al., 
2004). Interestingly, a work of Redaelli and co-workers in transplantation showed like we did 
that HO-1 had anti-apoptotic effects in a model of liver graft, and this was associated with 
significantly lower number of apoptotic cells (detected by TUNEL) and slightly diminished 
levels of caspase-3 (Redaelli et al., 2002). The work of Coito and co-workers also suggest that 
HO-1 may also act by up-regulating anti-apoptotic molecules like Bcl-2 and Bag-1 (Coito et 
al., 2002). Accordingly, we found augmented mRNA levels of the anti-apoptotic molecule 
Bag-1 which reinforces an anti-apoptotic/cytoprotection hypothesis. This data strongly sug-
gest that Bag-1 over expression following HO-1 treatment is directly implied in the avoidance 
of abortion. As Bag-1 mRNA is not significantly down-regulated in the abortion-prone com-
bination compared to the normal one, the finding that AdHO-1 induces Bag-1 expression may 
be specific to gene over-expression. In fact, Bag-1 was already described to be augmented 
after up-regulation of HO-1 by gene therapy in tolerant grafts (Coito et al., 2002). Since the 
first demonstration of Bag-1 as an anti-apoptotic molecule (Takayama et al., 1995), Bag-1 
over-expression has been shown to inhibit apoptosis induced by a wide range of inducers in 
various cell types (reviewed in Townsed et al., 2003). The mechanisms accounting for the 
effects of Bag-1 on apoptosis induced by several stimuli are not fully characterized yet. One 
potential target is the Bcl-2 protein, a Bag-1 interaction partner (Townsed et al., 2003). Thus, 
it is possible that the broad effects of Bag-1 derive from its targeting of this key Bcl-2-
regulated mitochondrial apoptosis checkpoint. Further, Bag-1 interacts with the HSC70 and 
HSP70 heat shock proteins and promotes cell survival by coordinating the function of these 
chaperones with the proteasome to facilitate protein degradation (Townsed et al., 2004). Inter-
estingly, Townsend et al. have demonstrated that Bag-1 has a novel cytoprotective function, 
e.g. protecting cardiac myocytes from apoptosis induced by simulated ischemia/reperfusion, 
mediated via association with HSC70/HSP70, which is critical upon cytoplasmic localization 
but independent of the BAG-1 ubiquitin-like domain (Townsed et al., 2004). Accordingly to 
our data, we speculate that Bag-1 is mediating fetal tissue protection. This data is in accor-
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dance with other data from our group, where the protective effect of HO-1 through CoPPIX 
application was also related to augmented levels of Bag-1 at the feto-maternal interface 
(Sollwedel et al., 2005).  
Heme oxygenase-1 has also been described to be involved in angiogenesis. In this regard, 
Dulak and co-workers have shown that these angiogenic effects are related to the modulation 
of vascular endothelial growth factor (VEGF) synthesis by HO-1 activity (Dulak et al., 2002). 
In pregnancy, the endometrium, decidua and placenta are sources rich if angiogenic growth 
factors (Zygmunt et al., 2003), and VEGF production by the trophoblasts during pregnancy 
has paracrine effects on maternal endothelial cells resulting in vascular remodelling and/or 
permeability within the microcirculation. Besides, trophoblast derived VEGF acts by increas-
ing the efficiency of vascular-mediated exchange between the mother and the fetus. In this 
work, an up-regulation of HO-1 led to a slight augmentation in the number of VEGF positive 
cells in placental tissue, suggesting that HO-1 may have had angiogenic effects in this model. 
Knowing the relationship between VEGF and HO-1 expression, it is tempting to speculate 
that HO-1 up-regulation during implantation may have augmented VEGF expression within 
the feto-maternal interface, favouring a proper vasculogenesis and angiogenesis that would 
lead to a proper implantation of the fetuses and consequently to an avoidance of fetal rejec-
tion. 
The protective effect of up-regulated HO-1 levels in our treatment could be also related to 
increased carbon monoxide (CO) production (Sato et al., 2001). Although CO was considered 
for years a very dangerous gas (Johnson et al., 1999), it is now clear that CO can reduce in-
flammatory responses by inhibiting pro-inflammatory genes and by augmenting 
anti-inflammatory cytokine production (Otterbein and Choi, 2000; Sarady et al., 2002; Song 
et al., 2003). Interestingly, inhibition of HO-1 by SnPPIX did not conduce to graft rejection if 
the mice were simultaneously exposed to CO. Besides, both, gene transfer of HO-1 or CO 
application inhibited chronic graft rejection (Chauveau et al., 2002). These data indicate a 
crucial role for CO in transplant acceptance and suggest that the HO-1-related beneficial ef-
fects are related to CO production. Data obtained in our group by Ivonne Wollenberg (Di-
ploma thesis), showed that exposure to 250 p.p.m. of CO during implantation (days 4 and 5 of 
pregnancy) could completely avoid abortion in the CBA/J x DBA/2J model, indicating a 
beneficial effect of CO during pregnancy. However, CO inhalation during the whole experi-
ment (days 0-13 of pregnancy) led to detrimental effects on the fetuses and the mother, and 
even to unsuccesful pregnancies (no viable litters). This indicates that CO in specific amounts 
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and in specific time points of pregnancy can be protective, and that may also suggest that the 
effects seen in this approach may be due to the effects of CO. If biliverdin/bilirubin or free 
iron were involved in the protective effect of our work is unclear. However, it has been shown 
in other models that biliverdin can imitate the effects of HO-1 by inducing tolerance to car-
diac allografts (Yamashita et al., 2004), suggesting that some of the effects seen by the 
up-regulation of HO-1 can be explained by augmented biliverdin levels. The third by-product 
of the HO-1 enzymatic reaction, free iron, is potentially toxic but can give antioxidant protec-
tion when coupled with proteins that promote their sequestration or export of the liberated 
iron. In this regard, ferritin has been also proposed as a cytoprotective molecule and as a con-
tributory mechanism underlying HO-dependent protection (reviewed in Ryter, 2006). It was 
not found in the literature if an up-regulation of biliverdin or ferritin can be protective in 
models of pregnancy complications, and it is unknown if in our model the up-regulation of 
HO-1 acted through its compounds. 
Summarizing, the use of an adenoviral vector containing HO-1 allowed us to glance at the 
mechanisms by which HO-1 would have a protective role during pregnancy. Taken together, 
our findings point out a protective effect of systemic HO-1 up regulation on pregnancy out-
come. A complex picture of regulatory interactions between the HO system and apoptotic and 
cytokine networks is suggested. These data could further open new opportunities finding 
novel therapeutic directions in immunological pregnancy failure. 
The use of an adenoviral vector over-expressing HO-1 was used in order to elucidate the im-
portant role of HO-1 in avoiding fetal rejection, and not intended to be proposed as a therapy. 
A more therapeutical approach was intended to do using T cells over-expressing HO-1. The 
use of retroviral vectors, reported by others as being a successful method for the transduction 
of T cells (Hammer et al., 2002; Hori et al., 2003), was in our hands not successful enough. 
One of the reasons why this approach could not be established may be that cells from CBA/J 
females were poorly stimulated with paternal antigens, since retroviral vectors are known to 
transduce only dividing cells (Somia and Verma, 2000). The attempt of stimulating cells with 
anti-CD3 and anti-CD28 did improve the proliferation of these cells, but the transduction effi-
ciency was not significantly improved. The other possibility for the lack of success of this 
approach may be the vector (pLXSN), since works from our group (Paul Wafula, ongoing 
PhD thesis) using other retroviral vector (MIGR-1) are currently being successful in transduc-
ing CBA/J cells stimulated with anti-CD3 and anti-CD28 (but not stimulated with paternal 
antigens). Since the maximal transduction efficiency obtained in this approach was less than 
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8%, it was not feasible to obtain enough amounts of cells to be transferred in sufficient num-
ber of animals. For this reason, the approach using protein transfection was performed.  
The protein transfection has been used to transfect mainly adherent cells (Morris et al., 2001) 
and has even been used in vivo (Aoshiba et al., 2003). However, no report has been found to 
date about the transfection of murine primary T cells. In the context of this PhD work, a suc-
cessful transfection has been achieved in CD4+ T cells. The practical convenience of this 
method relies on the time that is saved when compared to retroviral transduction, and the per-
centage of efficiency obtained. CD4+ cells have been efficiently transfected using the positive 
control (80% of transfection), and have been also efficiently transfected with HO-1. When 
used in vitro, however, these cells were not showing any particular effect on the proliferation 
of cells from a CBA/J female. The effects observed were always comparable to those ob-
served with cells treated with the transfection agent alone (TMOCK). In vivo (data not shown) 
these cells were also not effective, reason why the experiment was not fully completed. One 
possible explanation for this may be that the protein transfected into the cells is not active. 
The HO-1 protein used for this approach was commercially available, and the company was 
not able to inform us whether the protein is active or not. The other possibility may be that 
CD4+ T cells are not the right target for the transfection of HO-1. Alternative targets for the 
HO-1 transfection could be dendritic cells, since HO-1 is known to act on dendritic cells by 
keeping them in an immature state (Chauveau et al., 2005).  
 
Role of HO-1 in trophoblast survival and differentiation 
 
After implantation, the trophectoderm surrounding the blastocyst goes on to differentiate into 
a variety of trophoblast cell subtypes with different functions. Trophoblast stem cells emerge 
from the polar trophectoderm that overlies the inner cell mass of the blastocyst, and they pro-
liferate in response to close contact to the inner cell mass (Cross, 2005). From the different 
types of trophoblasts in the mouse, the giant cells are the first to arise, already at the blasto-
cyst stage. These cells exit the mitotic cell cycle and stop dividing, enlarge, and they undergo 
endoreduplication to become polyploid (MacCauley et al., 1998). The function of trophoblast 
giant cells is to first mediate the process of implantation and invasion of the conceptus into 
the uterus. Later they produce several hormones and cytokines to promote local and systemic 
physiological adaptations in the mother including the regulation of maternal blood flow to the 
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implantation site, and production of progesterone from the ovary (reviewed in Cross, 2005). 
Due to the vital importance of the giant cells in the formation of the placenta and in the estab-
lishment of a successful pregnancy, the main aim of this part of the study was to analyze in 
vitro whether HO-1 is necessary for trophoblast stem cell differentiation into giant cells.  
The Rcho-1 cell line is usually used as an in vitro model for studying trophoblast cell differen-
tiation (Faria and Soares, 1991). These cells can be manipulated to proliferate or differentiate 
into trophoblast giant cells by altering culture conditions. Rcho-1 trophoblast stem cell differ-
entiation recapitulates in vivo trophoblast giant cell development, and is a valuable in vitro 
tool for studying the process of trophoblast cell differentiation (Sahgal et al., 2005). So far, 
HO-1 was reported to be expressed in different trophoblast cells of human and murine placen-
tas (Ihara et al., 1998; Barber et al., 2001; Zenclussen et al., 2003b; and 2005b), and its ex-
pression in the murine placenta is normally the highest in giant cells (personal observation). 
However, no report was found in the literature showing that HO-1 is necessary during the 
differentiation process of trophoblasts. In the experiment showed in this thesis, the main aim 
was to analyze whether a down-regulation of HO-1 renders these cells unable to proliferate 
into giant cells. This would help us understand if HO-1 is really necessary for the differentia-
tion of trophoblast stem cells, and therefore to the proper formation of a placenta when trans-
lated into an in vivo situation.  
Interestingly, the down-regulation of HO-1 expression by ZnPPIX led already to a signifi-
cantly diminished viability of precursor stem cells, suggesting that HO-1 is necessary even for 
the survival of trophoblast stem cells. The application of CoPPIX did not lead to significant 
changes in the viability of Rcho-1 cells, suggesting that the effect seen with ZnPPIX may not 
be due to the toxic effect of the porphyrin per se. When analyzing the ability of these cells to 
differentiate into giant cells, the application of ZnPPIX led them unable to transform into gi-
ant cells, whereas cells treated with CoPPIX did not show any problem in the differentiation 
process. These results suggest that HO-1 may play an important role in the differentiation 
process of trophoblast cells. No results have been found in the literature on this regard, mak-
ing this a novel discovery in the role of HO-1 in formation of placenta.  
The fact that mice lacking Hmox1 do not get pregnant also suggests that without HO-1 no 
placentation is able to occur.  
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Role of partial or total loss of HO-1 on the outcome of pregnancy 
 
As already described by others (Poss and Tonegawa, 1997, Yet et al., 1999) and as mentioned 
before, no progeny can be achieved when mating Hmox1-/- mice. Interestingly, the mating of 
heterozygous females and males leads to only 3-10% of knockout progeny, instead of the 25% 
expected Mendelian rate. Both facts suggest that Hmox1 plays a very important role in preg-
nancy, but so far no explanation for this problem in the maintenance of the colony was found 
in the literature. For this reason, we aimed to analyze the origin of this problem by analyzing 
if the low progeny of the heterozygous combination is due to rejection of the fetuses or to 
other reasons. Besides, different combinations of wild type, heterozygous and knockout ani-
mals were performed in order to assess whether the problem resides in the females, in the 
males, or in both.  
When females partially deficient in Hmox-1 (Hmox1+/-) were mated with Hmox1-/- males, 
only 4 out of 11 females that showed insemination plug were indeed pregnant, and showed an 
abortion rate of 38.7 %. The fact that only 4 out of 11 females were pregnant suggests that 
Hmox1-/- males may present fertilization problems. Similarly, when Hmox1+/+ females were 
mated with Hmox1-/- males, 3 out of 5 females mated were pregnant, suggesting here that 
Hmox1-/- males may have fertilization problems. However, Hmox1+/+ males also showed fer-
tilization problems when fertilizing Hmox1+/- or Hmox1+/+ females, since not all females 
showing insemination plug were pregnant. This suggests that these fertilization problems may 
not be exclusively associated with the lack of Hmox1 in the male.  
Analyzing the situation from the female site, an interesting result when using the heterozy-
gous females was observed, namely that the abortion rate is higher when less HO-1 is present 
in the male, thus leading to less HO-1 in the F1 tissue (placenta). This was as follows: when 
heterozygous females were mated with Hmox1+/+ males, they presented an abortion rate of 
18.4 %, with Hmox1+/- males the abortion rate was of 22.4 %, whereas with Hmox1-/- males 
the abortion rate increased to 38.7%. This clearly shows a trend towards an augmentation on 
the abortion rate with a diminution of HO-1 in the system. When Hmox1+/+ females were 
mated with all three types of males, they showed very similar abortion rates in all three types 
of combinations. All these data together shows that, when the female present normal HO-1 
levels, the male HO-1 contribution is not relevant for the success of pregnancy. However, 
when the female is already partially lacking HO-1, the less HO-1 the males are contributing 
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the more abortion can be observed. This data strongly suggests that HO-1 is very important in 
the maternal site for a successful pregnancy, whereas its absence in the paternal site may not 
be as important as like in the maternal site. 
No references in the literature were found regarding the necessity of HO-1 in the oocytes or 
sperm for reproductive processes. For HO-1-related molecules, however, interesting informa-
tion has been published. It has been pointed out that a low concentration of nitric oxide may 
have some physiological role in fertilization through the enhancement of sperm´s capacity to 
bind to the zona pellucida of the oocyte (Kazuo et al., 1998). On the other hand, mice defi-
cient in Cox-2, a molecule related to HO-1, are known to have multiple reproduction failures 
including problems in ovulation, fertilization, implantation and decidualization (Lim et al., 
1997). Interestingly, mice deficient in Cox-2 showed a blunted and delayed induction of HO-1 
in a model of endotoxemia (Ejima and Perrella, 2004), suggesting altered HO-1 expression in 
these animals. It is not mentioned in the literature whether HO-1 is involved in the process of 
fertilization, but considering the relationship of HO-1 with the nitric oxide system and with 
Cox-2, it is tempting to speculate that the lack of HO-1 leads to impaired or altered expression 
of NO and/or Cox-2, which in turn leads to infertility. We did not address this point in the 
present work and this may lead to interesting results and merits further studies. One can also 
speculate that animals deficient in Cox-2 present fertilization problems an impaired fertility 
due to altered expression of HO-1, as we clearly show that HO-1 is important in several steps 
of reproduction. This work clearly opens the possibility of analyzing this process more accu-
rately in future projects.  
When performing an allogeneic combination using Hmox1+/+ C57/BL6 females mated either 
with Hmox1-/- or Hmox1+/+ BALB/c males, most of the females presenting insemination plug 
were pregnant. When the male was deficient in Hmox1, an 8.6% of abortion was observed, 
against 0% of abortion obtained with the Hmox1+/+ males. These percentages of abortion are 
very similar, and suggest again that the lack of HO-1 in the male does not significantly affect 
pregnancy outcome when HO-1 is present in the female.   
We next genotyped the offsprings (healthy fetuses as well as unviable implantations) in order 
to analyze whether animals deficient in HO-1 were implanted and rejected, which may ex-
plain the low percentage of knockouts in the Hmox1+/- x Hmox1+/- matings. The analysis of 
the genotype of the fetuses and resorptions showed that, surprisingly, the mating of Hmox1+/- 
females with Hmox1-/- males lead only to heterozygous offspring. This result strongly sug-
gests that Hmox1-/- blastocysts were unable to implant or were rejected in a very early time 
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point and not visible at the time of preparation, since fetuses as well as resorptions were het-
erozygous.  
The mating of Hmox1+/- females with Hmox1+/- males led to the typical percentage of knock-
outs obtained from these matings (personal communication from Prof. Soares and personal 
observation from the maintenance of the colony), and this percentage is lower than the ex-
pected Mendelian rate of 25%. Interestingly, the resorptions were again exclusively heterozy-
gous suggesting that the lower percentage of Hmox1-/- fetuses obtained from the 
Hmox1+/- x Hmox1+/- mating is not due to immunological rejection of these fetuses but to the 
lack of implantation of the Hmox1-/- blastocysts. This can be due to the fact that, as reported 
by Chen and co-workers in 2005, blastocysts normally up-regulate HO-1 immediately after 
hatching (Chen et al., 2005), and in Hmox1 deficient blastocysts this can not occur, but may 
be compensated by the presence of HO-1 in the maternal uterus. In the case of heterozygous 
uteruses, the lack of Hmox1 in the blastocysts may not be always sufficiently compensated by 
the HO-1 expression from the uterus, and that may explain why so few Hmox1-/- blastocysts 
are efficiently implanted.  
 
Role of HO-1 in early stages of pregnancy (ovulation, fertilization, implantation) 
 
So far, HO-1 in pregnancy was thought to be important for implantation. The data obtained 
with the IVF now brings new light into the role of HO-1 in pregnancy as we could confirm 
that Hmox-1-/- females are not able to produce as many oocytes as wild type females, indicat-
ing that HO-1 is necessary even at very early stages of reproduction. The difference in the 
oocyte production may be due to differences in the reaction of the Hmox1-/- females to hor-
monal treatment, since ovaries from Hmox1+/+ and Hmox1-/- females showed the same total 
number of follicles per ovary. The changes that take place on the ovary at the site of follicular 
rupture are pathophysiological in nature. This local damage induces hemorrhage in the vicin-
ity of the lesion on the surface of the ovary (reviewed in Espey et al. 2004). Considering the 
importance of the up-regulation of HO-1 in inflammatory processes, especially in events re-
lated to hemorrhage, it is tempting to speculate that the lack of HO-1 may impair the ovula-
tion process in a way that these animals do not manage to induce the follicular rupture. With-
out HO-1, the ability to counteract the inflammatory process related to it is missing. In other 
words, due to the inflammatory nature of ovulation, mature follicles lacking HO-1 may found 
 - 145 -
Summary 
---------------------------------------------------------------------------------------------------------------------------------------- 
it more difficult to induce the rupture of the tissue due the inflammatory nature of the process, 
and may be then less secreted than follicles expressing HO-1. Interestingly, NO, an inflamma-
tory mediator normally associated with HO-1, has been described to be involved in ovulation. 
Studies using eNOS-/- mice have shown that they have reduced fertility due to impaired ovula-
tory efficiency, abnormalities in meiotic maturation, increased oocyte apoptosis and altered 
estrous cyclicity compared to their wild type littermates (Jablonka-Shariff and Olson, 1998; 
Drazen et al., 1999; Hefler and Gregg, 2002). Studies using iNOS-/- mice show that iNOS de-
ficiency does not alter ovulatory capacity, but it may play a role in fertilization (Yang et al., 
2005). Furthermore, the cyclooxygenase (COX) pathway, which is responsible for pros-
taglandin (PG) synthesis, is also important in inflammatory responses, as the HO and NO 
pathways are. Additionally, they have constitutive and inducible isoforms (McGarry et al., 
2005), and they are closely related (Ejima and Perrella, 2004). The two enzymes responsible 
for the synthesis of PGs are COX1 and COX2, being the first constitutive and the second in-
ducible form (Venturini et al., 1998). Although Cox1-/- mice have normal fertility, Cox2-/- fe-
males are infertile and exhibit abnormalities in ovulation due to PG deficiency (Matsumoto et 
al., 2001). Regarding the HO system, interestingly, Hmox2-/- mice do not present reproductive 
problems (Poss et al., 1995), whereas Hmox1-/- do present problems, as shown in the results 
presented in this thesis. These results open the possibility of further analyze the problem in a 
more accurate way, and these studies are being currently done in our group.  
We then analyzed the ovaries from the females used as oocyte donors in order to analyze 
whether the lack of HO-1 is associated with morphological changes. Ovaries from both types 
of females were morphologically similar, but a significant diminution in the number of corpus 
luteum of Hmox1-/- ovaries when compared to Hmox1+/+ ovaries was obtained. This is in ac-
cordance to the lower number of oocytes obtained from Hmox1-/- females. As the number of 
total follicles per ovary was similar when comparing both groups, the difference in the num-
ber of corpus luteum was compensated by a slight augmentation in the number of primordial 
and secondary follicles in Hmox1-/- ovaries when compared to Hmox1+/+ ovaries. It would be 
very interesting to know if Hmox1-/- females can even ovulate without hormonal stimulation. 
This will be performed in our institute as soon as sufficient amount of knockout females are 
available. It will be interesting also to know if these females present normal hormonal levels, 
and if they present normal estrous cyclity. 
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The oocytes obtained from Hmox1-/- females showed additionally a very poor fertilization rate 
(19.78%), suggesting that Hmox1 may also be necessary (but not indispensable) for the fertili-
zation. This may also suggest that Hmox-1-/- oocytes are not as viable as wild type oocytes, 
and may be therefore the reason why the mating of mice heterozygous for HO-1 may yield so 
few Hmox-1-/- progeny (around 3-10% instead of the 25% expected Mendelian rate), and why 
Hmox-1-/- animals do not give viable progeny when paired with Hmox-1-/- males. In order to 
finally confirm that the reason as to why Hmox1-/- animals are not fertile and Hmox+/- do not 
yield the expected Mendelian rate, current experiments with Hmox1 deficient animals are 
being carried out. However, taking into account the results from the different combinations, I 
would speculate that Hmox1 is more important in the oocyte for a successful fertilization. 
Another possible explanation for the lack of progeny of Hmox1-/- could be an impaired im-
plantation. In order to test this hypothesis, the embryos in two-cell stage obtained by in vitro 
fertilization were transferred into recipient females. To test whether Hmox1 is necessary in the 
mother, in the fetus or in both for implantation to occur, Hmox1-/- oocytes were transferred 
into a Hmox1+/+ or into a Hmox1-/- recipient female. Additionally, Hmox1+/+ oocytes were 
transferred into a Hmox1-/- or into a Hmox1+/+ female. The fact that Hmox1-/- oocytes were 
able to implant in a Hmox1+/+ uterus confirms that Hmox1-/- oocytes do not present impaired 
hatching and can therefore implant in a uterus in which HO-1 is expressed. A work from Chen 
et al. shows that, after hatching, oocytes up-regulate HO-1 (Chen et al., 2005). In the context 
of the experiments done for this thesis, the inability to up-regulate HO-1 in Hmox1 deficient 
blastocysts may be compensated by the HO-1 expression in the maternal uterus. On the other 
hand, the fact that Hmox1+/+ or Hmox1-/- oocytes were unable to implant in Hmox1-/- uteruses 
suggests that HO-1 is indispensable in the uterus for implantation to occur. Further, the sole 
expression of HO-1 by the blastocyst may not be sufficient to compensate the inflammatory 
milieu that the implantation of the embryo induces in the maternal uterus and cannot therefore 
contribute to the tolerance state needed after implantation for pregnancy to be maintained. 
Having observed that HO-1 expression in the uterus is important or even indispensable for 
implantation to occur and that a lack of HO-1 leads to both, impaired implantation and im-
paired pregnancy, we next wondered whether HO-1 acts via T-cell dependent pathways. The 
results obtained when transferring Hmox1+/+ or Hmox1-/- oocytes into SCID mice deficient in 
Hmox1 are still very preliminary to make strong conclusions.  By using SCID mice lacking T 
and B cells we next aimed to have a closer look on the participation of T cells in HO-1-
dependent pregnancy success. If HO-1 mediated rejection operates via T cells, the lack of T 
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cells would then rescue from abortion. However, it was very interesting to observe that a 
higher percentage (around 13-15%) of Hmox1-/- progeny is obtained if the mice are in a SCID 
background (personal communication from Prof. Soares). In the experiments done for this 
work, Hmox1+/+ oocytes were able to implant in a SCID female lacking HO-1. However, the 
SCID female used as a control did not implant, making the results difficult for interpretation. 
Nevertheless, the fact that more Hmox1-/- progeny is achieved in SCID background suggests 
that, in immune deficient animals, HO-1 may be not as necessary as in immune competent 
animals. This can be thought taking into account the immune cells present at the feto-maternal 
interface.  
 
Summary and conclusion 
1) Taken all these data together, it can be concluded that HO-1 is essential for successful 
pregnancy to occur. As it has been shown in this work, HO-1 is involved in different 
stages of pregnancy including: 
2) Fertilization, as clearly shown by the significantly diminished fertilization rate ob-
tained in Hmox1-/- combination when compared to a Hmox1+/+ combination. This also 
suggests that HO-1 may be involved in ovulation and oocyte viability 
3) Implantation, as shown by impairment of Hmox1+/+ or Hmox1-/- oocytes in implanting 
in a Hmox1-/- but not in a Hmox1+/+ female after embryo transfer. 
4) Placentation, as shown in vitro by the inability of trophoblast stem cells to differentiate 
into giant cells in the absence of HO-1. 
5) Avoidance of fetal rejection, as demonstrated in vivo by the diminution in the abortion 
rate in abortion-prone animals when injected with an adenoviral vector containing 
HO-1. 
 
This data opens vast opportunities of further analyzing the role of this molecule in a more 
closely way in the different stages of pregnancy, and also helps to elucidate unknown mecha-
nisms related to a process so important as the beginning of a new life. 
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Abortion rates using high doses of adenoviral vectors: 
Table  14 : The application of a higher dose of AdHO-1/GFP did not significantly change abortion rates. 
 N.P S.A. 
S.A. + 1.108PFU 
AdHO-1/GFP 
S.A. + 
1.108 PFU AdEGFP 
Mean 2.61 24.73 19.28 22.16 
SD 5.42 7.06 10.37 12.86 
Median 0 25*** 19.4 25 
Mean, SD and median of abortion rates. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion.***p ≤ 0.001 
when compared to NP by the Mann-Whitney test 
 
 
 
Ex-vivo cytokine production as measured by flow cytometry: 
Table  15 : ex-vivo cytokine production by decidual lymphocytes 
 IL-4 IL-10 IFN-γ TNF-α 
N.P. 3.63 2.73 3.96 9.21 
S.A. 6.75 7.58 10.47 10.66 
S.A. + 1.105 AdHO-1/GFP 13.10 2.76 3.83 23.07 
S.A. + 1.105 AdEGFP 1.00 2.30 4.00 6.38 
S.A. + 1.108 AdHO-1/GFP 9.69 14.68 17.34 18.65 
S.A. + 1.108 AdHO-1/GFP 6.05 2.63 2.69 19.89 
Cytokine production measured by flow cytometry after PMA/Ionomycin incubation in the presence of monensin. 
Data are showed as medians. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. 
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Table  16 : ex-vivo cytokine production by spleen lymphocytes 
 IL-4 IL-10 IFN-γ TNF-α 
N.P. 1.15 0.95 1.08 2.28 
S.A. 0.65 1.00 1.20 6.54 
S.A. + 1.105 AdHO-1/GFP 2.57 1.42 1.13 2.57 
S.A. + 1.105 AdEGFP 0.45 0.38 0.63 1.10 
S.A. + 1.108 AdHO-1/GFP 0.45 0.63 0.60 6.41 
S.A. + 1.108 AdHO-1/GFP 1.45 1.57 1.59 2.58 
Cytokine production measured by flow cytometry after PMA/Ionomycin incubation in the presence of monensin. 
Data are showed as medians. N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. 
 
 
 
Levels of HO-1 mRNA in the groups receiving high doses of adenovirus: 
Table  17 : mRNA levels of HO-1 normalized to β-actin 
 N.P S.A. 
S.A. + 
1.108PFU 
AdHO-1/GFP 
S.A. + 
1.108 PFU 
AdEGFP 
Mean 0,05076 0,03590 0,06676 0,04263 
SD 0,04651 0,01383 0,01629 0,01912 
Median 0,02906 0,02967 0,06846* 0,03584 
N.P.= Normal Pregnancy; S.A.= Spontaneous abortion. *p≤0,05 as analyzed by the Mann-Whitney U-test for 
two particular groups. A significant difference was obtained in the group receiving 1.108 PFU AdHO-1/GFP 
when compared to the S.A. group. 
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